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populations have intensified humankind’s ancient quest to understand the nature of aging. This dissertation
explores mechanisms of mortality through the prism of immunology. To effect defense against pathogens both
exogenous and endogenous, the adaptive immune system leverages the tremendous proliferative capacity with
which it is endowed to generate terminally differentiated lymphocytes that potently eliminate or suppress
threats to organismal health. This proliferative capacity derives from the integrity of genomically encoded
information, and, while considerable, is not infinite: it can be depleted with age and following repeated rounds
of antigen-driven proliferation, for example, when driven by recurring or persisting microbial infections, or
cancer. In the studies detailed herein, genome integrity homeostasis was probed during the immune response
to viral infection. CD8+ T cells were observed to experience significant DNA damage in the course of their
attempts to control viral replication. Multiparametric flow cytometry identified a rare population of antigen-
specific T stem cells that might represent an evolutionary strategy to minimize genotoxicity. The
programming, metabolic profile, anatomic localization, proliferative capacity, and ontogeny of these T stem
cells were analyzed in relation to previously established effector, memory precursor, and central memory
populations. Developmentally, T stem cells were able to self-renew and both give rise to abundant cytotoxic
effector CD8+ T cells in the presence of antigen as well as contribute to the pool of long-term central memory
CD8+ T cells following antigen clearance. Remarkably, partially-differentiated transit-amplifying effector
CD8+ T cells also contributed to long-term central memory, in a process of apparent dedifferentiation.
Programmatically, T stem cells were endowed with superior expression of multiple genome maintenance and
repair activities, including heightened responsiveness to DNA strand breaks, telomerase expression, and
suppression of potentially mutagenic transposition by the ancient LINE-1 retrotransposon. Together, these
features suggest that this characteristic of amplified genome integrity surveillance may be a fundamental
feature of somatic stem cells broadly, and important for the long-term maintenance of antigen-experienced T
cell populations in particular. Additionally, despite relative proliferative quiescence, T stem cells unexpectedly
manifested intense signaling flux. This was associated with robust expression of a panoply of both stimulatory
and inhibitory cell surface receptors, including PD-1. Intensified signaling consequent to genetic ablation of
inhibitory receptors compromised T stem cell viability during acutely-resolving viral infections. These
findings hold significant implications for basic understanding of pathogen-driven peripheral T cell
differentiation, formation of long-term immunological memory, and aging; and for the design of therapeutic,
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ABSTRACT 
 
DEDIFFERENTIATION OF CYTOTOXIC LYMPHOCYTES 
INTO CENTRAL MEMORY CD8+ T CELLS: 
 
LESSONS FROM ANTIVIRAL T STEM CELLS ON THE 
ARCHITECTURE OF AGING & IMMUNOTHERAPY  
Jonathan B. Johnnidis 
 
E. John Wherry 
 
Startling advances in biological gerontology coupled with the ongoing, global 
demographic transition to older populations have intensified humankind’s ancient quest 
to understand the nature of aging.  This dissertation explores mechanisms of mortality 
through the prism of immunology.  To effect defense against pathogens both exogenous 
and endogenous, the adaptive immune system leverages the tremendous proliferative 
capacity with which it is endowed to generate terminally differentiated lymphocytes that 
potently eliminate or suppress threats to organismal health. This proliferative capacity 
derives from the integrity of genomically encoded information, and, while considerable, is 
not infinite: it can be depleted with age and following repeated rounds of antigen-driven 
proliferation, for example, when driven by recurring or persisting microbial infections, or 
cancer.  In the studies detailed herein, genome integrity homeostasis was probed during 
the immune response to viral infection.  CD8+ T cells were observed to experience 
significant DNA damage in the course of their attempts to control viral replication.  
Multiparametric flow cytometry identified a rare population of antigen-specific T stem 
cells that might represent an evolutionary strategy to minimize genotoxicity.  The 
programming, metabolic profile, anatomic localization, proliferative capacity, and 
ontogeny of these T stem cells were analyzed in relation to previously established 
effector, memory precursor, and central memory populations.  Developmentally, T stem 
cells were able to self-renew and both give rise to abundant cytotoxic effector CD8+ T 
cells in the presence of antigen as well as contribute to the pool of long-term central 
memory CD8+ T cells following antigen clearance.  Remarkably, partially-differentiated 
transit-amplifying effector CD8+ T cells also contributed to long-term central memory, in 
a process of apparent dedifferentiation.  Programmatically, T stem cells were endowed 
with superior expression of multiple genome maintenance and repair activities, including 
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heightened responsiveness to DNA strand breaks, telomerase expression, and 
suppression of potentially mutagenic transposition by the ancient LINE-1 
retrotransposon.  Together, these features suggest that this characteristic of amplified 
genome integrity surveillance may be a fundamental feature of somatic stem cells 
broadly, and important for the long-term maintenance of antigen-experienced T cell 
populations in particular.  Additionally, despite relative proliferative quiescence, T stem 
cells unexpectedly manifested intense signaling flux.  This was associated with robust 
expression of a panoply of both stimulatory and inhibitory cell surface receptors, 
including PD-1.  Intensified signaling consequent to genetic ablation of inhibitory 
receptors compromised T stem cell viability during acutely-resolving viral infections. 
These findings hold significant implications for basic understanding of pathogen-driven 
peripheral T cell differentiation, formation of long-term immunological memory, and 
aging; and for the design of therapeutic, prophylactic, and diagnostic applications 
intended to further the cause of maximizing healthy human lifespan. 
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.:: CHAPTER 1 ::. 
 
AGING, IMMUNOLOGICAL MEMORY, AND THE GENOME 
INTEGRITY PARADOX OF T CELL CLONAL EXPANSION 
 
 
1.1 Aging is of ancient and central concern to the human condition 
 
“Our new Constitution is now established, and has an appearance that promises 
permanency; but in this world nothing can be said to be certain, except death and 
taxes.” 
        - Benjamin Franklin, 1789 
 
Writing in a period of transition and intense uncertainty – shortly before his own 
death, and on the occasion of the birth of a new nation – Benjamin Franklin 
opined on the few constants that figure in life.  While the subject of taxation lies 
beyond the scope of inquiry in this work, death lies at its center.  Indeed, 
mortality and the universal process of aging that inevitably precipitates it have 
invited curiosity and concern throughout the history of humankind.  The very birth 
of literature some four thousand years ago – in the Sumerian epic of Gilgamesh 
– centered upon the pain of death and a quest for immortality.  In the present 
day, ongoing demographic transitions in industrially developed and developing 
nations have heightened attention to the issue of graying populations (Olshansky 
et al., 1990; Vaupel, 2010; Olshansky, 2016).  At the beginning of the present 
decade, 13-22% of European, American, and Chinese populations exceeded 60 
years of age, and this figure is projected to rise to 27-34% by 2050.  Globally, 
there will be more than two billion people 60 years of age or older by 2050, by 
which point this class of older individuals will outnumber the population of 
children (0-14 years of age) for the first time in human history (United Nations 
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Department of Economic and Social Affairs Population Division, 2012).  These 
trends pose tremendous challenges at every level of social organization, 
including the maintenance of health and care for the ill.  Beyond any particular 
physiological, lifestyle, or environmental parameter, age itself is the single 
greatest risk factor for the pathologies that inflict the largest burden of morbidity 
and mortality, including cardiovascular disease, cancer, and neurodegenerative 
conditions (Marrero et al., 2012; Kohanski, 2016).  This begs the question of 
whether the aging process can be sufficiently understood in order to enable 
interventions that might potentiate healthier and perhaps longer life trajectories. 
 
 
1.2 History and universality of mortality 
 
While the question of aging has been mooted for millennia, extensively explored 
by titans of literature, and even empirically pursued by notables ranging from 
ancient Chinese emperors to Isaac Newton, only since the birth of cell theory in 
the mid 19th century has it become experimentally tractable.  Building on 
microscopic observations from Theodor Schwann and Robert Remak, the 
pioneering physician, pathologist, and public health visionary Rudolph Virchow 
famously declared that “omnis cellula e cellula” (Virchow, 1855) – all cells are 
derived by way of genesis from pre-existing cells, not begotten from some 
amorphous, inanimate source.  This signal insight in turn opened the door for 
aging to be examined and potentially understood for the first time in terms of an 
observable, tangible, quantity – cells. 
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 The dawn of the modern study of aging had to await the ability to study 
live, actively metabolizing cells as opposed to chemically preserved specimens.  
This moment arrived a half century later with the advent of ex vivo tissue culture.  
In the 19-teens, just a few months before he was awarded the Nobel prize that 
cemented his outsized public stature and further amplified the authority of his 
biomedical pronouncements, Alexis Carrel of the Rockefeller Institute initiated an 
elaborate, decades-long series of experiments involving culture of chicken cells.  
He put fresh cells into culture flasks, and as long as the nutrient medium was 
regularly replenished, he observed that the cells appeared to persist, metabolize, 
and divide without end.  Carrel, his colleagues, and an enthralled public 
interpreted this seemingly ceaseless vitality as being consistent with biological 
immortality (Shay and Wright, 2000).  At the cellular level at least, they believed, 
death need not be foreordained. Though some in the scientific community 
doubted this conclusion and the strength of the data that supported it, this 
interpretation reigned as dogma for the better part of the next 50 years. 
 
 Not more than several dozen paces from where these words are being 
written, Leonard Hayflick and his colleagues turned this notion on its head 
starting in the early 1960's in Philadelphia.  In careful culture experiments with 
primary human fibroblasts, they observed that non-transformed cells consistently 
ceased replicating after 40-50 divisions (Hayflick and Moorhead, 1961).  With the 
notable exception of genetically unstable cancer cells, physiologically normal 
cells in culture appeared to be possessed not of unbounded but rather finite 
replicative potential.  This observation, later termed replicative senescence or the 
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“Hayflick limit” by the immunologist Macfarlane Burnet (Burnet, 1974), is thought 
to represent a cellular model of organismal aging, as mutations in many genes 
that accelerate its onset also cause premature aging in animal models and 
humans (Lombard et al., 2005).  The paradigm of senescence has been 
extended both in vitro to dozens of additional cell types and in vivo across 
multiple organisms (Herbig et al., 2006; Baker et al., 2011), even including 
prokaryotes (Ackermann et al., 2003; Stewart et al., 2005), which until recently 
were believed to represent a key deviation from Hayflick's paradigm 
(Charlesworth, 2000).  Though there may be an intriguing exception in the case 
of hydra (Boehm et al., 2012), Hayflick’s fundamental insight into the lives of cells 
remains a pillar of modern biological inquiry – in short, the lease on life for any 
given cells and the organism they comprise is definite; everything must die. 
 
 
1.3 A central role for the immune system in systemic aging 
 
If death is inevitable, what then is the mechanism of mortality?  In the late 19th 
century the German developmental biologist August Weismann speculated that 
“death takes place because a worn-out tissue cannot forever renew itself” 
(Weismann, 1889).  Since then numerous observations and mechanistic 
explanations have emerged, with most amounting to a time-dependent 
accumulation of various types of cellular damage, including especially to the 
genome and the epigenome (Lopez-Otin et al., 2013; Vijg, 2014), and regulation 
of lifespan by genetic modulation of the net rate of damage accumulation 
(Burnet, 1973; Gladyshev, 2012).  However, how indeterminate deficiencies at 
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the cellular level manifest in the organism-scale loss of functionality and fecundity 
that define aging remains incompletely understood, and is currently the subject of 
exceptionally vigorous investigation across multiple disciplines.  Not long after 
Hayflick’s revelation, and building on earlier work by Burnet concerning somatic 
mutation rates in the immune system and age-dependent autoimmunity (Burnet, 
1959), the gerontologist Roy Walford proposed that of all the separate and 
complex tissues that together comprise the mammalian body plan, the 
interlocking assemblage of leukocytes commonly referred to as the “immune 
system” might be particularly central to overall organismal aging (Walford, 1969).  
Developed extensively over the course of the next several decades, this notion 
that systemic aging is a function of pathological immune processes has been 
borne out by several complementary lines of evidence.   
 
 First among these are multiplying observations that many of the most 
salient infirmities of aging are accompanied by dysregulated immune function, for 
example in the cases of atherosclerosis, wherein senescent macrophages 
accumulate in subendothelial spaces and drive atheroma formation (Childs et al., 
2016); in neurocognitive degeneration, wherein T cell deficiency has been shown 
to diminish the adult hippocampal neurogenesis (Huang et al., 2010) thought to 
underlie substantial aspects of learning, memory, and emotional regulation 
(Eriksson et al., 1998; Spalding et al., 2013); and perhaps most intriguingly in 
cancer, wherein benign tumors may exploit age-diminished adaptive 
immunosurveillance to embark on the transformation to clinically-evident 
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malignancy (Cheney and Walford, 1974; Miller, 1996; Castro et al., 2009; 
Pawelec et al., 2009; Malaguarnera et al., 2010; Chou and Effros, 2013). 
 
 Even more saliently than associations with chronic ailments however, 
immune function in the elderly is often linked to substantially decreased 
functionality with respect to its most familiar role, that of pathogen defense.  This 
nearly universal time-acquired immunodeficiency syndrome limits the protections 
of vaccination and engenders susceptibility to a panoply of communicable 
diseases, including most prominently influenza, herpes zoster, urinary tract 
infections, infective endocartitis, bacterial meningitis, and nosocomial infections 
generally (Gavazzi and Krause, 2002).  Importantly, infectious diseases in the 
aged are both more frequent and more severe, resulting in increased demand for 
clinical services and increased mortality (Gavazzi and Krause, 2002). 
 
 While age-associated immunodeficiency can clearly herald death by 
infection, an inverse correlation has also been documented, in that more robust 
immune status characterizes those who survive into the ninth, tenth, or even 
eleventh decade of life (Strindhall et al., 2007; Sansoni et al., 2008; 
Derhovanessian et al., 2010).  Longevity associated with increased resistance to 
infection has also been documented in mutants of the roundworm Caenorhabditis 
elegans (Garsin et al., 2003), suggesting the possibility of an evolutionarily-
conserved relationship between immunity and organismal aging. 
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1.4 History of immunity 
 
If declining immune function at least in part precipitates overall, organismal 
aging, what is it that drives senescence in the immune system in the first place, 
and why might that process proceed briskly in some individuals and more 
conservatively others?  This dissertation attempts to provide a biological 
framework within which to address these vital questions and discuss their 
implications. 
 
 A reasonable point at which to start dissecting the terminus of immunity is 
the beginning of its understanding, which coincidentally corresponds to the birth 
of modern history 2500 years ago in the form of an Athenian general’s 
unprecedented chronicle of the three decades’ civil war that lead to the 
disintegration of an empire and the collapse of humanity’s first experiment in 
democracy.  In his sweeping History of the Peloponnesian War, Thucydides 
described the social and psychological stresses of repeated sieges, and 
documented the infectious disease outbreaks that terrorized the densely-packed 
citizens of Athens even more so than sightings of advancing Spartan phalanxes.  
Himself a survivor of the devastating 430 BC Plague of Athens that claimed at 
least a full third the population, Thucydides recounted the thoroughly 
indiscriminate nature of the “pestilential disorder” that afflicted commoners and 
elites alike, causing all those affected to “drop like sheep.” Importantly, while 
Athenian society as a whole was devastated by contagion, some individuals 
recovered after having been stricken.  Indeed, Thucydides recorded that  
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“though many lay unburied, birds and beasts would not touch them, or 
died after tasting them… The bodies of dying men lay one upon the 
other… [But] those who had recovered from the disease… had now no 
fear for themselves; for the same man was never attacked twice – at least 
never fatally.” (Thucydides, History of the Peloponnesian War, 2.51). 
 
 Today, the concept of immunological memory recognized as the hallmark 
of the adaptive immune system can be traced to that original observation of 
acquired immunity (from the Latin immunitas, for “exemption”) to subsequent 
microbial infection (Masopust et al., 2007).  Starting 1500 years later in India and 
China and up until the 18th century in Europe, and prompted by the emergence of 
smallpox as a frequent, major killer in urban centers, deliberate transfer of 
pustular fluids from smallpox scabs into the skin of uninfected persons (so called 
“variolation”) was practiced in the hope that a slightly milder yet protective 
infection might result.  Apparently prompted by bucolic folklore, the English 
empiricist Edward Jenner is credited with formalizing the notion that inoculation 
not with live smallpox but rather with the related agent cowpox (or Variolae 
vaccinae as he called it, from the Latin vacca for cow) could offer protection just 
as well but without the certain virulence and mortal risk of a full-blown smallpox 
infection (Baxby, 1999). 
 
 Thereafter, the practice and later the science of “vaccination” (so dubbed 
by Louis Pasteur, in recognition of Jenner’s contribution) advanced in earnest, 
especially with the advent of germ theory and Pasteur’s development of 
reproducible attenuation techniques that for the first time allowed rationally 
converting a virulent microbe into a candidate vaccine that could be empirically 
tested in animal and human test subjects for the ability to confer protective 
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immunity. Successful rabies and anthrax vaccines ensued, followed in the mid 
20th century by effective vaccines for yellow fever (contributed by Max Theiler) 
and polio (Jonas Salk). In prodigious feats of biomedical creativity unlikely to be 
witnessed again, uber-vaccinologist Maurice Hilleman developed 8 of the 14 
vaccines in current vaccine schedules, including those for measles, mumps, 
hepatitis A, hepatitis B, chickenpox, meningitis, pneumonia and Haemophilus 
influenza.  Because of vaccines, the ancient scourge of smallpox has been 
eradicated (Foege, 2001), and polio – which once paralyzed half a million 
annually (Kew et al., 2005) – as well as measles and tetanus have been 
restricted from large swaths of the globe.  Lately, newly-introduced vaccines 
against rotavirus and HPV, respectively, have substantially reduced the 
incidence of severe pediatric gastroenteritis (Parashar et al., 2016) and infection 
with the virus responsible for the vast majority of cervical and anogenital cancers 
(Markowitz et al., 2016).  Most recently, a vaccine against Ebola has been 
developed (Henao-Restrepo et al., 2017), and a candidate vaccine against Zika 
has demonstrated efficacy in mouse and non-human primate model systems 
(Pardi et al., 2017). 
 
 
1.5 Nature of immunological memory 
 
Underlying all of these collectively stupendous achievements in biomedical and 
public health engineering is the capacity of the adaptive immune system to 
remember a primary or “priming” infection and exploit the imprint of this 
experience to respond with greater force and superior efficiency to any 
	 10	
subsequent encounters with the pathogenic agent in question, whether that be a 
virus, bacterium, parasite, tumor, or artificially engineered antigen (i.e., a 
vaccine).  However, though the capacity for remembrance of pathogens past is a 
defining feature of all 65,000 extant vertebrate species, and may even have 
enabled the Cambrian explosion 500 million years ago (Pancer and Cooper, 
2006), the nature of the physiology that underlies it remains incompletely 
understood.  In particular, while so-called “memory” lymphocytes are recognized 
as the repository for immunological experience, and thus the source of recall 
ability, their developmental origins are the subject of lively controversy (Ahmed et 
al., 2009; Restifo and Gattinoni, 2013) and a longstanding holy grail of 
biomedical research (Lefrançois and Masopust, 2009). 
 
 Multifarious are the subtypes of lymphocytes thought to mediate 
immunological memory, including natural killer cells (Sun et al., 2009), B cells, 
and subtypes of T cells (so called because they develop in the thymus) defined 
by expression of either the CD4 or CD8 molecules (Ahmed and Gray, 1996).  Of 
these, T cells are particularly important for the control of tumors, viruses, and 
intracellular bacteria, among other pathogens.  This insight emerged from 
multiple observations of increased susceptibility to infection or tumorigenesis and 
more severe pathogenesis in animals (including non-human and human 
primates, as well as mice) with congenital or acquired deficiencies in T cells or 
genetic factors vital for their function (Kagi et al., 1994; Jin et al., 1999; Stepp et 
al., 1999; Koebel et al., 2007). 
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 Much of the substantial knowledge accumulated about T cell biology has 
come from studies with lymphocytic choriomeningitis virus (LCMV), a human 
pathogen maintained in a rodent host reservoir that was discovered in 1933 by 
Charles Armstrong by way of an encephalitis epidemic in St. Louis (Zhou et al., 
2012).  LCMV is a single-stranded RNA virus and archetypal member of the 
Arenaviridae family.  Its genome consists of two ambisense RNA segments that 
encode four proteins.  Viral entry is mediated by binding of LCMV’s glycoprotein 
to α-dystroglycan, a widely-expressed receptor on host cells that enables an 
unusually broad tropism for LCMV and thus multi-organ dissemination (Cao et 
al., 1998).  Outcomes of infection range from subclinical illness in healthy 
individuals to thrombocytopenia and life-threatening encephalitis in 
immunocompromised individuals, and severe congenital defects (Fischer et al., 
2006).  Infection elicits a vigorous and reproducible immune response in both 
rodents and humans (Kotturi et al., 2011) whose resolution is dependent on 
CD8+ T cells (Byrne and Oldstone, 1984; Moskophidis et al., 1987).  After initial 
exposure to viral antigen, a naïve CD8+ T cell specific for the antigen becomes 
activated and is caused to initiate a phase of rapid proliferation and differentiation 
that spawns abundant clonal descendants over the course of several days or 
weeks (Murali-Krishna et al., 1998).  To maximize organismal survival and 
fitness, most of these progeny cells are robustly endowed with a variety of potent 
molecular effector mechanisms that conduce to purging virus from infected cells, 
or whole infected cells from the host. For example, a particularly prominent 
cytotoxic effector mechanism revolves around the perforin-granzyme pathway 
	 12	
(Kagi et al., 1994), in which perforin and granzyme proteins are exocytosed from 
specialized secretory lysosomes into the cleft formed between the abutting killer 
and virally-infected cell membranes. Perforin, a 67-kilodalton protein with an N-
terminal membrane-attack-complex domain similar to that of cytolysins in Gram+ 
bacteria, oligomerizes into 19-24mers to form pores of roughly 150 Å in the target 
cell’s plasma membrane (Law et al., 2010).  These transiently perturb calcium 
flux and inflict osmotic stress, thereby triggering a stereotypical wounded-
membrane repair response that in turn enables granzymes to access the target 
cell’s cytosol via an endocytic pathway (Law et al., 2010; Thiery et al., 2011).  
Once within the target cell, granzymes, a family of pro-apoptotic serine 
proteases, cleave a series of substrates in the cytosol, mitochondria, and nucleus 
to effect regulated auto-destruction of the cell (as opposed to the disorderly and 
inflammatory alternative of necrosis), thereby efficiently removing it as a threat to 
the overall health of the host organism (Thiery and Lieberman, 2014).  Following 
clearance of virus, the vast majority of the cells generated from the founding, 
antigen-specific naïve CD8+ T cell are no longer needed and commit to apoptosis 
in a process termed contraction (Lau et al., 1994). However, a small percentage 
of cells escapes this culling and persists long-term in order to mediate defense 
should the pathogen ever be re-encountered (Lau et al., 1994; Kaech and 
Wherry, 2007).  This population is what are known as memory T cells. 
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1.6 Provenance of immunological memory: one burning question and 
three clues 
 
While the existence of memory T cells following the resolution of a pathogenic 
perturbation is firmly established, and their properties – including lifelong 
persistence and vast proliferative capacity upon pathogen re-encounter – have 
been examined extensively, the precise sequence of developmental elaborations 
that transform an inert, naïve lymphocyte into a hardened, durable, protective 
memory T cell is hotly contested (discussed in depth in Chapter 2).  In essence, 
that which is in question has been termed the “molecular biography” of the cell 
(Shaywitz and Melton, 2005): whence memory?  Though even a semblance of 
consensus on this matter has remained elusive, several crucial clues to memory 
T cell provenance have emerged. 
 
1.6.1 T cell proliferative potential is finite 
 
The first clue concerns finitude: a single, activated naïve CD8+ T cell can divide 
repeatedly to generate up to 100,000 progeny cells following antigenic 
stimulation (Rocha et al.,1989).  Following resolution, memory cells derived from 
the original cell can execute a similarly expansive feat of multiplication upon 
pathogen re-exposure, as can secondary and tertiary memory cells that emerge 
following repeated rounds of infection and resolution.  Clearly, the proliferative 
capacity of T cells is tremendous. However, it is apparently not unbounded.  
While some of the early experiments in ex vivo culture appeared to indicate that 
human T cells were possessed of unlimited replicative capacity (Morgan et al., 
1976), subsequent analyses revealed these initial interpretations were 
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confounded by the presence of pathologically immortalized, transformed cells 
(Effros, 2004). Instead, clonal populations of untransformed T cells invariably 
ceased proliferating in culture after repeated rounds of mitogenic stimulation 
(Effros, 2004).  Subsequently, this paradigm was extended to the behavior of T 
cells in vivo, wherein clonally-derived T cells were caused to undergo repeated 
rounds of infection-driven expansion and contraction in the context of a serial 
transplantation scenario that maximized the potential for replicative stress.  While 
robust during the first three rounds of antigen-driven proliferation, T cell 
expansion all but ceased when cells were activated by a fourth infection 
(Masopust et al., 2006).  Further in vivo studies have noted a strictly inverse 
relationship between replicative history and future potential for proliferation 
and/or conferring protection from stringent pathogenic challenges (Hinrichs et al., 
2009; Nolz and Harty, 2011; Martin et al., 2012; Fraser et al., 2013, Van 
Braeckel-Budimir N et al., 2017). 
 
 That T cells can undergo extensive yet ultimately finite rounds of 
replication both in vitro and in vivo is highly reminiscent of Hayflick’s seminal 
observations of fibroblast senescence. In fact, though quantitating cell division in 
vivo is challenging, based on estimates of ~15-20 divisions per round of antigen-
driven expansion (Murali-Krishna et al., 1998; Kaech et al., 2002; Masopust et 
al., 2007), it seems likely that the T cells subjected to the replicative stress of 
serial expansion (Masopust et al., 2006) likely underwent a total of 45-60 
divisions before exhausting proliferative capacity.  This corresponds closely to 
the range originally reported for fibroblast senescence (Hayflick, 1965). 
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 What then might be basis for this vital finitude?  In a broader context, this 
amounts to a timeless question: what is the biological substrate of aging? In the 
case of Hayflickian senescence, decades of inquiry have indicated that 
proliferative potential is circumscribed by the accumulation of genomic and 
epigenomic damage.  One example of this is manifested in the progressive, 
division-dependent attrition of telomeres, the nucleoprotein complexes that cap 
chromosome ends and thereby preserve genome integrity (discussed in depth in 
Chapter 3).  While there exists a striking paucity of understanding concerning 
genome integrity homeostasis in leukocytes, a preponderance of evidence 
indicates that T cell telomeres shorten with progressive proliferation and/or age 
(Sallusto et al., 1999; Hodes et al., 2002; Chou et al., 2013).  Beyond telomeres, 
other forms of genomic insults increase, including chromosomal rearrangements 
(Ramsey et al., 1995).  Thus, T cell proliferative potential is potent yet limited, 
apparently like that of any other cell type, and this finitude corresponds with 
decreasing genomic integrity. 
 
1.6.2 Memory T cells are long-lived 
 
A second feature of the biology of memory T cells of relevance to their 
provenance is cellular longevity. Unlike their naive T cell progenitors, whose 
lifespans are limited, at least in rodents (Tsukamoto et al., 2009; Sprent and 
Surh, 2011), memory T cells have the capacity to persist for life (Homann et al., 
2001; Hammarlund et al., 2003; Lang and Nikolich-Zugich, 2011). Remarkably, in 
experimental conditions of serial transplantation into successive young recipient 
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mice, memory T cells have even been observed to exhibit lifespans that exceed 
those of the original mice in which they were generated (Lau et al., 1994). What 
is more, while naïve T cells protected from replicative stress nevertheless 
unmistakably exhibit age-related decline in functionality (Decman et al, 2010), 
similarly unstressed memory T cells retain functionality regardless of the passage 
of time (Haynes et al., PNAS 2003; V. Decman and E.J. Wherry, unpublished 
observations).  That memory T cells can persist apparently indefinitely as well as 
retain functionality – in stark contrast to naïve T cells and indeed most other 
mammalian cell types – suggests that they must be endowed with protective 
mechanisms that confer these extraordinary properties. 
 
1.6.3 Pathogen-driven T cell expansion: a genotoxic maelstrom of mitosis 
 
A third clue to memory T cell origins traces to the first and arguably most 
important phase of adaptive immune responses.  Before any given naïve T cell 
encounters a pathogen for which it is specific, it exists in a state of metabolic and 
proliferative quiescence that is actively maintained by various transcriptional 
programs (Jones and Thompson, 2007; Feng et al., 2011).  Following activation, 
naïve T cells initiate a concerted phase of metabolic exertion, proliferation, and 
differentiation in order to generate pathogen-specific effector T cells that are 
sufficiently numerous to mediate organismal defense.  Importantly, proliferation 
of T cells during this period can be intense: in contrast to the staid cell cycles of 
roughly 20 hours that characterize archetypal mammalian cell types (Posakony 
et al., 1977; Baserga, 1985), pathogen-specific T cells can divide extremely 
rapidly (Murali-Krishna et al., 1998; J. Yewdell, personal communication).  In one 
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notable study, virus-specific naïve T cells labeled with a proliferation-tracking dye 
were exposed to viral antigen in vivo, and subsequent division was monitored 
every 24 hours for several days afterwards.  Strikingly, cell division durations as 
short as 3-4 hours were observed (Figure 1.1).  Such extraordinarily swift 
amplification is understandable in the context of the existential threat of an 
interloping (and itself rapidly multiplying) microbe, though the molecular 
mechanisms that underpin it are unknown.  It is very likely however to have 
important, probably deleterious consequences for genome integrity, as cell 
division even in the most salutary of circumstances is inherently genotoxic.  For 
example, cells of every type are constitutively subjected to DNA damage, 
including: nucleophlic attack by water leading to depurination and depyrimidation, 
which occur at an estimated 10,000 bases/day/cell (Friedberg et al., 2005); 
cytosine deamination (100 bases/day/cell); and oxidative damage from hydroxyl 
radicals generated consequent to quotidian mitochondrial metabolism.  
Importantly, repair of each of these genomic insults is facilitated by the fact they 
occur on one strand of the double-helix, leaving the opposing strand as a 
template for accurate repair (Ruzankina et al., 2008).  During cell division 
however, the double-stranded nature of DNA is suspended. This disruption 
dramatically escalates the chance that any given error, minor and readily 
reversible in most situations, might instead yield a mutation via misrepair or 
neglect.  Worse, un- or mis-processed damaged bases can interfere with or even 
precipitate collapse of progressing replication forks, leading to potentially 
catastrophic double-strand breaks (Ruzankina et al., 2008).  In addition to these 
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elevated risks from commonplace DNA damage, the incomplete fidelity of DNA 
polymerases ensures that at least a handful of mutations will be generated for 
every round of genome replication (Loeb and Monnat, 2008). 
 
 In short, even in the most leisurely of contexts, cell division is a risky 
proposition.  However, proliferating, pathogen-specific T cells cycle to an extreme 
extent that is rarely observed in adult mammalian physiology.  Given indications 
that accelerated proliferation may be associated with threats to genome integrity 
even beyond those inherent in standard, unhurried cell division (Cairns, 1975; 
Wu et al., 2005; Martin et al., 2011; Schoppy et al., 2012), the genotoxic risk for 
activated T cells responding to pathogens is likely to be enormous.  Because the 
cells in which immunological memory resides must transit this mitotic maelstrom 
to survive and mediate potentially life-long defense against further pathogen 
encounters, any explanation for the origins of memory T cells must take into 
account this fundamental problem of information homeostasis. 
 
1.6.4 Memory T cell origins and the paradox of genome integrity 
homeostasis 
 
While memory T cell origins remain a matter of debate, the several clues 
discussed above help delineate the contours of possibility that must be 
considered.  First, T cells can divide extensively but not without limitation, and 
proliferative history correlates with accumulation of (epi)genomic damage.  
Second, at least in the absence of replicative stress, memory T cells can persist 
for tremendously long periods, including without any apparent loss of 
functionality.  Given that almost every other known cell type exhibits an age-
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related decline in quantity, quality, or both, these observations suggest that 
memory T cells are endowed with protective mechanisms that enable these 
characteristics of extraordinary longevity.  Third, despite the fact that cell division 
under any circumstances is inherently genotoxic, T cell proliferation is 
tremendous in both scope and rate when responding to a pathogenic 
perturbation.  That memory T cells both survive this enormously stressful process 
and also retain a capacity for further extensive and rapid division is an additional 
indication suggesting the presence of mechanisms that minimize genotoxicity. 
 
 In sum, to effectively address the ever-present multiplicity of threats posed 
by pathogens of all sorts, T cells need to be able to proliferate extensively, do so 
extremely rapidly, and persist potentially for the duration of a lifespan.  Each of 
these individual stipulations constitutes a substantial threat of compromised 
genome integrity and premature senescence.  How these necessary yet 
apparently mutually exclusive imperatives are reconciled amounts to a major 
paradox in modern immunobiological inquiry: on one hand, extensive proliferation 
and prolonged survival are required to generate and sustain immunity, while on 
the other lies the existential pressure to avoid excessive division as well as the 
inevitable genotoxic ravages of time so as not to prematurely exhaust finite 
replicative potential.  Simply put, how does the immune system manage 
mortality?  This essential question is the animating force for the research 
presented in this dissertation, and it is suggested that the cradle of 
immunological memory may be found in its answer. 
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1.7 Stem cells as a solution to the genome integrity paradox 
 
A possible explanation for this modern immunological conundrum concerns stem 
cells.  The evidentiary basis for this fundamental concept in developmental 
biology began to emerge in the years before and shortly after the second world 
war. 
 
1.7.1 Four-dimensional anatomy: the history of tissue turnover 
 
In 1937, the technique of autoradiography had just recently been pioneered by 
Antoine Lacassagne in Paris, and the Institut du Radium at which he labored was 
abuzz with excitement following the award of the 1935 Nobel prize in chemistry 
to faculty members Frederic and Irene Joliot-Curie.  This recognition was for the 
discovery of methods to synthesize radioactive elements at will, which in turn 
came about in the wake of the two Nobel prizes awarded in 1903 and 1911 to 
Marie and Pierre Curie, Irene’s parents, for their discovery and isolation of 
elemental radium and further, groundbreaking studies on the nature of 
radioactivity. This string of scientific triumphs and the manifest potential of 
radiolabeled molecules as tools in biological research attracted the substantial 
funding necessary to construct a cyclotron at the Institut (Laurie, 2007). In this 
well-resourced environment of intellectual ferment, post-doctoral trainee Charles 
Leblond joined Lacassagne’s research group and mastered autoradiography.  
Early observations demonstrated that metabolism of phosphorous and other 
minerals in adult animal models was unexpectedly rapid. Importantly, these 
findings began to undermine the then-prevailing paradigm of “cellular stability”, in 
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which the principal physiological function of mitosis was held to be for growth 
toward the end of achieving sexual maturity (Leblond, 1995); with minor 
exceptions, the tissues of the human body, like the cogs and wheels of an 
automobile, were thought to stable, permanent structures (Leblond, 1991).  
However, addressing this matter definitively was precluded by technological 
constraints, as the radiographical techniques of the time could visualize tissues 
but not individual cells.  World war interrupted this thread of inquiry, and 
prompted Leblond to flee to Montreal.  When research resumed at McGill 
University, a fruitful collaboration with physicists coupled with exploitation of the 
newly-available radioisotope tritium lead to a methodological breakthrough in the 
form of a hundred-fold improvement in autoradiography resolution, and the 
consequent ability to visualize single cells (Belanger and Leblond, 1946).  For the 
first time, the fourth dimension – that of time itself – was amenable for the study 
of anatomy and physiology in vivo. 
 
 Using these newly refined autoradiography techniques, Leblond and 
colleagues thereafter reported a conceptual breakthrough.  By carefully 
observing the kinetics of radionuclide labelling in the intestines of fully grown 
rodents, they observed not rare but rather frequent mitoses in epithelial cells, and 
calculated that the entire epithelium not only turned over regularly, but did so in a 
mere matter of days (Leblond and Stevens, 1948; Leblond et al., 1948).  This 
notion was such a dramatic departure from the accepted model of post-growth 
cellular stability that it was roundly dismissed, and even mocked by critics 
(Bennett and Bergeron, 2007).  Nevertheless, continued research in Leblond’s 
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group and corroborating reports from others’ eventually established the modern 
consensus that while many tissues in model organisms are indeed comprised of 
mostly or even entirely quiescent cells, several – most prominently including 
bone marrow, alimentary epithelia, epidermis, and the spermatogenic 
compartment – rapidly turn over and continually renew themselves (Messier and 
Leblond, 1960; Leblond, 1995).  Recent developments in accelerator mass 
spectrometry and biomedical adaptation of radiocarbon dating technology 
commonly used in archeology have extended this paradigm to previously 
inaccessible human tissues (Spalding et al., 2005). 
 
 The understanding that the lives of cells in multiple, critical tissues are 
ephemeral rather than perpetual occasioned a profound rethinking of metazoan 
physiology and raised numerous important questions. Perhaps foremost among 
them: if multitudes of cells are being birthed and replaced on a regular and often 
rapid basis, from where do new cells derive – what is the mechanism of self-
renewal (Dor and Melton, 2004)?   
 
1.7.2 Discovery of somatic stem cells as the source of continuously 
generated tissue effector cells 
 
More than a century of independent, discursive threads of inquiry in 
developmental biology and evolutionary theory culminated in a solution to this 
problem.  In a word: “stammzelle”, or stem cells, a concept that the eminent 
German biologist Ernst Haeckel proposed in 1877 as he pondered how a single 
cell – the fertilized egg – might undergo the wondrous transformations that 
eventually give rise to the multitudes of cells and cell types that comprise the 
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mature organism (Ramalho-Santos and Willenbring, 2007).  Contemporaneous 
investigations in embryology paralleled burgeoning research in hematology, 
which sought to elucidate the relationships between and origins of the multiple 
cell types that were coming to be appreciated in blood.  As early as 1896, the 
hematologist Artur Pappenheim hypothesized the existence of a single progenitor 
cell that could give rise to both red and white blood cells (Pappenheim, 1896). 
Later, as the various lineages of the hematopoietic system came into focus 
following the promulgation of the staining techniques developed by Paul Ehrlich 
in the 1870’s, he proposed a remarkably prescient genealogy of hematopoiesis 
rooted in a “polyvalent stem cell” that resembles the accepted modern paradigm 
(Ramalho-Santos and Willenbring, 2007). 
 
 Investigation into the nature of hematopoiesis continued in the following 
decades, often on the basis of observation, supposition and deduction, as 
opposed to direct demonstration.  Following the atomic bombings of Hiroshima 
and Nagasaki however, interest in and funding for the field intensified 
dramatically when it was appreciated that blood was uniquely implicated in the 
pathogenesis of radiation poisoning (Na Nakorn et al., 2002; Weissman, 2014).  
A major goal in the field, inspired by the incipient Cold War and fears of 
impending nuclear conflict, was to discover treatments for ameliorating or even 
reversing this ghastly, greatly feared condition.  Early experiments uncovered 
that lead shielding of spleen or bones (but, for example, not kidneys) during 
exposure to irradiation prevented mortality (Jacobson et al., 1951), and that pre-
treatment with certain substances, for example high dose cysteine, could 
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attenuate subsequent radio-injury (Patt et al., 1949).  However, cysteine 
administration after irradiation was entirely ineffectual (Patt et al., 1949).  The first 
demonstrations of a post-hoc treatment arrived only when it was shown that 
transplantation of spleens or bone marrow could rescue mortality in mice and 
guinea pigs previously exposed to an otherwise-lethal dose of ionizing radiation 
(Lorenz et al., 1951; Jacobson et al., 1951).  
 
 What was the mechanism of this hotly-anticipated cure for radiation 
poisoning? Initial thinking in the field favored the hypothesis that humoral 
substances present in the transplanted tissue somehow effected repair of 
radiation lesions in the recipient hosts.  This notion was discarded after a series 
of elegant experiments exploiting novel xenochimaeric and chromosomal marker 
strategies showed that the freshly-generated blood cells circulating in transplant 
recipients after recovery were unambiguously derived from the donor and not the 
recipient (Ford et al., 1956; Nowell et al., 1956), thus establishing the presence of 
cells with tissue reconstituting activity in adult bone marrow (Weissman, 2014; 
Eaves, 2015).  Several years later, the dynamic Canadian duo of Ernest 
McCulloch and James Till devised methodology to quantify this activity for the 
first time, initially by way of a cumbersome limiting-dilution assay (McCulloch and 
Till, 1960), and then substantially more tractably following the serendipitous 
observation that otherwise-lethally irradiated mice whose hematopoietic systems 
had been reconstituted manifested macroscopic nodules, or  colonies on their 
spleens approximately a week post-transplantation.  Colony abundance 
corresponded linearly to the number of bone marrow cells that had been 
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transplanted, thus offering the ability to readily and rapidly (if retrospectively) 
measure progenitor cell number (Till and McCulloch, 1961). Importantly, after 
noting that the splenic colonies were comprised of multiple cell types including 
erythrocytes, megakaryotcytes, granulocytes, macrophages, and lymphocytes, 
the McCulloch and Till team then devised a clever method of uniquely 
chromosomally marking single hematopoietic cells using low-dose irradiation.  
Using this technique, they observed that the heterogeneous colonies were clonal: 
that is, all cells in a given colony, irrespective of cell type, bore the same, unique 
chromosomal marker, indicating descent from a common progenitor (Becker et 
al., 1963; Wu et al., 1968).  Shortly thereafter, demonstration that serial 
transplantation of donor-derived colonies into secondary irradiated recipient mice 
could themselves form new, multi-lineage colonies and also still rescue 
otherwise-lethal radiation poisoning established the critical principal of 
autopoiesis (Siminovitch et al., 1963) – the ability of a system to recreate itself, 
often referred to somewhat less precisely as self-renewal.   
 
 Thus, the torrid, postwar quarter century of experimentation on irradiation 
pathogenesis and blood formation birthed the theoretical and experimental 
foundations upon which the modern concept of somatic stem cells is rooted.  
These potent cells constitutively maintain, and upon injury can reconstitute their 
tissue of origin by way of the capacities for extensive proliferation, (often but not 
necessarily multi-lineage) differentiation, and self-renewal (Siminovitch et al., 
1963; Eaves, 2015).  A preponderance of less direct, yet nevertheless compelling 
experimentation synergized with these concepts in other tissues and 
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developmental contexts, including epidermis (Storey et Leblond, 1951), 
spermatogenesis (Clermont and 1953), and gastrointestinal epithelia (Cheng and 
Leblond, 1974), thereby indicating that stemness is the biological force 
underlying the continuous renewal of a panoply of both solid and liquid tissues, 
especially those tending towards rapid turnover dynamics. 
 
1.7.3 Genome integrity maintenance – the source of stemness? 
 
Of course, at least within the tissues for which a clear role for stem cells had 
been established, the great question then became: what is the nature of 
stemness?  What characteristics distinguish such cells from non-stem cells, and 
in particular, what processes conduce to their remarkable, life-long generative 
properties?  
 
 Clues to this puzzle began emerging piecemeal decades ago, but weren’t 
consolidated into a coherent theoretical framework until a seminal publication 
situated stem cells within the evolutionary dynamics of carcinogenesis (Cairns, 
1975).  From these considerations emerged a simple, critical question: given the 
inherent genotoxicity of mitosis, how does rapid, ongoing cellular turnover in 
multiple tissues not precipitate an untimely collapse of genome integrity and 
consequent burden of cancer so overwhelming as to utterly squelch reproductive 
fitness (much less survival into old age)?  To reconcile this paradox, Cairns 
posited that cellular and molecular mechanisms must exist that 1) minimize 
genotoxicity in stem cells and 2) minimize the possible damage to organismal 
homeostasis should accumulated mutations transform any given stem cell into a 
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tumor (Cairns, 1975).  Though some of Cairns’ specific predictions have not been 
borne out, the overall framework he proposed to undergird the growing 
evidentiary basis for emerging stem cell theory remains a touchstone in 
contemporary developmental biology. Specifically, Cairns anticipated that key 
stem cell characteristics would include: rarity, to restrict the overall size of the 
long-lived compartment in which transforming mutations might accumulate; 
relative proliferative quiescence, to indirectly minimize the accumulation of 
mutations arising from cell division; and endowment with various molecular 
mechanisms that actively promote the conservation of genome integrity (Cairns, 
1975). 
 
 To varying extents, preceding and subsequently-published data have 
substantiated each of these claims.  A major finding that emerged from early 
hematopoietic transplantation studies in the 1960’s was the fact that less than 
1% of cells in the bone marrow are possessed of reconstitution potential (Fuchs, 
2009), and stem cell populations that have been identified in other tissues are 
almost uniformly tiny fractions of the total cellularity whose homeostasis they 
support.  With respect to cycling dynamics, during early histological examinations 
of spermatogenesis in seminiferous epithelia, Leblond and colleagues deduced 
the presence of spermatogonial stem cells and noted early on that they appeared 
to be proliferatively quiescent relative to differentiating spermatocytes (Clermont 
and Leblond, 1953).  A decade later, early characterizations of hematopoietic 
stem cells recorded resistance to radiation exposure and chemotherapeutic 
drugs known to preferentially target dividing cells, thus suggesting that stem cells 
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in liquid tissue appeared to also be marked by quiescence (Becker et al., 1965; 
Bruce et al., 1966).  More recent studies using pharmacological and genetic 
label-retaining strategies have documented deep proliferative quiescence in 
multiple somatic stem cell compartments (Cotsarelis et al., 1990; Wilson et al., 
2008; Tian et al., 2011; Bernitz et al., 2016), and established the general 
principle that cycling frequency correlates inversely with (re)generative activity – 
essentially that proliferative potential is a function of proliferative past (Fuchs, 
2009).  Cairns’ remaining prediction, that stem cells might be programmatically 
specialized to actively forestall genomic disintegration, so far remains the least 
supported. Briefly however, the activity of at least one important pathway of 
genome integrity homeostasis appears to be substantially enriched in multiple 
somatic stem cell compartments – that of telomerase and the maintenance of 
telomere length (Vaziri et al., 1994; Flores et al., 2008).  The possibility that 
additional genome integrity conservation mechanisms might be at play in stem 
cells is the subject of Chapter 3 in this work. 
 
 Thus, though minimally differentiated with respect to tissue effector 
functions (e.g. oxygen ferrying or hemostatic capacity in blood, action potential 
generation in brain, barrier function in the skin, or nutrient absorption activity in 
the intestine) stem cells may in fact be highly specialized for the maintenance of 
genome integrity through activation of multiple, independent pathways that 
comprise both passive (e.g. proliferative quiescence) and active modalities (e.g. 
DNA repair).  Failure or exhaustion of these mechanisms accelerates 
senescence and the loss of stemness (Allsopp et al., 2003; Rossi et al., 2007; 
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Bernitz et al., 2016).  If self-renewal is the single most defining characteristic of 
stem cells, a strong possibility is that genome integrity maintenance is the 
essence of self-renewal (Rando, 2006). 
 
1.8 Conclusions 
 
In summary, a developmental hierarchy rooted in a rare yet potent stem cell 
population that can repeatedly give rise to abundant effector cells appears to be 
a fundamental, conserved strategy of renewal in multiple tissues and metazoan 
species (Figure 1.2).  This strategy is deployed to rapidly generate – or, upon 
injury, to regenerate – cellularity in a manner that minimizes the inevitable loss of 
(epi)genomic integrity consequent to cell division which would eventually lead to 
either malignant transformation or loss of function and degeneration (i.e. aging).  
 
  Though the proliferative dynamics of tissues have been pondered since 
the advent of cell theory almost a century and a half ago, and empirically 
explored in increasing depth during the modern, postwar period, the full extent of 
the role of stem cell hierarchies in somatic homeostasis remains unsettled.  In 
unprecedented detail, a spate of recent reports has elucidated surprising 
turnover kinetics in tissues including brain, heart, and adipose tissue (Eriksson et 
al., 1998; Spalding et al., 2008; Spalding et al., 2013; Bergmann et al., 2015), 
rekindling in fresh contexts the long-standing question of the mechanism of life-
long cell renewal (Dor and Melton, 2004).  In these newly-scrutinized tissues, in 
others such as liver, pancreas, and skeleton, and even in well-studied tissues like 
blood and intestinal epithelium, multiple, sometimes contrasting reports have 
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emerged questioning, supporting, or substantially revising the role of stem cell 
hierarchies (Tian et al., 2011; Smart et al., 2011; Ali et al., 2014; Sun et al., 2014; 
Yanger et al., 2014; Chan et al., 2015, Kopp et al., 2016).  Comprehensively 
understanding this fundamental matter in each of the complement of tissues that 
comprise the mammalian body plan remains of unsurpassed importance in 
biomedical research given the tremendous implications for basic understanding 
of physiological and pathological processes, as well as for the design of 
interventional prophylactic and therapeutic applications to preserve or potentiate 
human health. 
 
 Curiously, given the field of Immunology’s deep roots in basic principles of 
developmental biology and the recognition of increasingly broad roles for 
lymphocytes in organismal homeostasis, the intertwined matters of stemness and 
genome integrity maintenance in the adaptive immune system have only recently 
begun to receive serious attention. Broadly, this dissertation probes the 
(re)generative nature of the adaptive immune system. Chapter 2 approaches this 
from a cellular perspective, and presents the isolation and characterization of 
rare, antigen-specific stem cells in the T lymphocyte compartment.  These T 
stem cells are shown to underwrite the extraordinarily rapid generation of 
cytotoxic cells that effect defense against microbial infections.  Surprisingly, 
following the resolution of infection-injury, some differentiated, cytotoxic effector 
T cells appear to de-differentiate and re-acquire stemness attributes, thus 
challenging the cardinal rule of irreversible differentiation that has attended the 
overall fields of hematology and immunology for decades.  The broader context 
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and implications of dedifferentiation for developmental biology and the aging 
process are discussed. Chapter 3 probes the maintenance of genome integrity at 
a molecular level, first with respect to two well-known pathways, those of 
telomerase and double-strand break repair.  The chapter concludes with a 
presentation of preliminary evidence suggesting the existence of an entirely new 
genome integrity maintenance mechanism involving endogenous transposons. 
Chapter 4 asks how T stem cells manage intense mitogenic signaling pressure to 
balance the opposing needs for active proliferation and differentiation to combat 
an invading pathogen versus the imperative of quiescence to conserve future 
proliferative potential.  Observations are presented that T stem cells robustly 
express PD-1 and multiple other signal-attenuating receptors, and do so in order 
to prevent hyperactivation-induced depletion. The implications for immunological 
memory formation and immunotherapy applications are discussed. 
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Figure 1.1 
 
 
 
 
Figure 1.1: Precipitous proliferative dynamics of antigen-specific CD8+ T cells 
responding to viral infection. LCMV-reactive TCR-transgenic P14 CD8+ T cells were 
labeled with the proliferation-tracking dye CFSE and transplanted into naïve mice, which 
were subsequently infected with LCMV-Armstrong.  Proliferation – by way of CFSE 
dilution – was monitored over the following 96 hours.  After the adaptive immunological 
reaction commences (~48 hours pi), CD8+ T lymphocyte division is rapid, with cell cycle 
durations as short as ~4 hours. Adapted from Kurachi et al., 2014. 
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Figure 1.2 
 
 
 
 
Figure 1.2: Generic proliferative hierarchy rooted in a stem cell population. Stem 
cell proliferative hierarchies in multiple vertebrate tissues sustain rapid, continuous 
generation of abundant, terminally differentiated tissue effector cells.  Asymmetric 
division (depicted with a small, orange badge) and restrained progenitor proliferation 
minimizes the loss of genomic integrity inherent to mitosis, thereby conserving 
proliferative capacity to meet future physiological demand. Stem cells are depicted in 
blue; transit amplifying cells in green; terminally-differentiated effector cells in red. 
Number of divisions relative to the founding stem cell are indicated above. Adapted from 
Clermont and Leblond, 1953; and Cairns, 1975. 
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.:: CHAPTER 2 ::. 
 
ISOLATION OF T STEM CELLS, AND DEDIFFERENTIATION OF 
CYTOTOXIC LYMPHOCYTES INTO CD8+ CENTRAL MEMORY T 
CELLS 
 
Understanding how development of immunological memory is orchestrated has 
extensive implications for vaccines, cancer immunotherapies, autoimmunity, and 
possibly the aging process.  The first chapter discussed this issue in the context 
of the paramount requirement for the maintenance of genome integrity, and 
suggested that the existence of a stem cell subpopulation might enable 
pathogen-specific T lymphocytes to reconcile the apparently mutually-exclusive 
goals of extensive and extremely rapid proliferation with avoidance of premature 
exhaustion of finite proliferative potential. 
  
2.1 Efflux activity (the side population phenotype) as an unbiased 
technique for isolating novel somatic stem cell populations 
 
Probing the hypothesis that somatic stem cells might underlie immunological 
memory is conceptually straightforward yet technically challenging.  A major, 
long-standing issue in developmental biology is identifying stem cells for a tissue 
of interest in the first place.  Tissue stem cells were first imagined in the mid 19th 
century, formally demonstrated to exist in the 1960’s, and only molecularly 
defined and prospectively isolated in the late 1980’s following decades of 
concerted inquiry in experimental hematology entailing laborious fractionation 
and transplantation experiments (Spangrude et al., 1988).  By evolutionary 
design and biological definition (as discussed in Chapter 1) stem cells are 
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exceedingly rare, and this fact has complicated and to this day continues to 
complicate investigations into the nature of (re)generativity in any given tissue. 
 
 One practical method of circumventing much of this investigational 
complexity arose in the late 1990’s based on observations originating in the 
context of cancer pharmacology three decades previously. During the dawn of 
anti-neoplastic chemotherapy, it was observed in treatment of both patients and 
transformed cell lines in vitro that resistance arising against one drug often 
engendered cross-resistance to a range of other drugs with disparate chemical 
structures and biological modes of action (Kessel et al., 1968). This phenomenon 
became known as multidrug resistance and is one of the most frequent forms of 
chemotherapy resistance (Muller et al., 1994). Mechanistic dissection of this 
process led first to the biochemical (Juliano and Ling, 1976) and ultimately the 
genetic isolation (Gros et al., 1986; Cole et al., 1992; Doyle et al., 1998) of the 
molecular factors involved, which turned out to be a subset of the ABC 
superfamily of transporters with promiscuous substrate specificities.  These ATP-
dependent enzymes are embedded in the plasma membrane and extrude a 
broad range of structurally diverse, xenobiotic substrates (including 
chemotherapeutic agents) from the cell against a concentration gradient 
(Schinkel and Jonker, 2003).  This activity decreases intracellular drug 
concentration and thus confers resistance. 
 
 Separately, ongoing characterization of hematopoiesis coupled with 
advances in flow cytometry technology generated the intriguing insight that 
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hematopoietic stem cells (HSC) efficiently extrude certain fluorescent dyes such 
as Rhodamine-123 and Hoechst-33342, and that this property could be used to 
crudely isolate rare HSC from the complex and far more abundant mixture of 
non-stem-cell bone marrow cells that readily take-up and retain dyes (Pallavicini 
et al., 1985; Spangrude and Johnson, 1990).  Using newly-generated monoclonal 
antibodies, a subsequent study elucidated the mechanistic basis for this: 
although broad, expression of MDR-related ABC proteins was observed to be 
particularly high on HSC, and furthermore correlated with fluorescent dye efflux 
activity (Chaudhary and Roninson, 1991).  A methodological refinement several 
years later led to the observation of a so-called “side population” phenotype in 
which dye-stained bone marrow cells evaluated flow cytometrically exhibited 
strong, dual-emission peak fluorescence throughout, except for a visually distinct, 
quantitatively minor fraction of cells at the lower end of the spectrum of staining 
intensity.  This fraction was isolated and shown in transplantation experiments to 
contain the vast majority of HSC activity (Goodell et al., 1996).  Further studies 
genetically potentiating or abrogating expression of the MDR-related ABC genes 
ABCB1 and ABCG2 directly confirmed that these were principally responsible for 
the side population phenotype, and revealed that hematopoietic cells genetically 
deficient in efflux capacity were hypersensitive to chemotherapeutic drugs and 
other xenobiotics (Bunting et al., 2000; Zhou et al., 2001; Zhou et al., 2002).  
Perhaps most importantly from the broader perspective of developmental 
biology, the efflux / side population staining technique perfected by Goodell et al. 
enabled HSC to be isolated with remarkable ease and purity on the basis of a 
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defined physiological capacity, i.e. without any other a priori knowledge of HSC 
biology (e.g. unique proteomic or transcriptomic signatures).  Together with 
Chaudhary and Roninson’s earlier observation, this indicated the possibility that 
heightened efflux capacity might be an important aspect of stem cell biology 
generally, and offered the unprecedented opportunity to explore this notion in a 
methodologically tractable manner.  Indeed, wide deployment of the side 
population technique subsequently uncovered confirmed or candidate stem cell 
populations in multiple tissues, including muscle, intestinal epithelium, 
endometrium, breast, testis, brain, solid tumors, and liquid tumors (Lassalle et al., 
2004; Challen and Little, 2006; Golebiewska et al., 2011; Maruyama et al., 2013; 
von Furstenberg et al., 2014) and even across multiple species (Goodell et al., 
1997).  Thus, the “side population” technique of isolating candidate stem cell 
populations on the basis of a physiological profile of uniquely efficient dye efflux 
capacity can be a broadly effective strategy for discerning the presence of and 
initially isolating a putative stem cell population with an unknown proteomic 
signature (i.e. marker profile) in any given tissue. In short, the side population 
technique can sidestep much (though not necessarily all) of the laborious, 
iterative fractionation associated with historical searches for stem cells. 
 
 
2.2 Efflux activity in antiviral CD8+ T cells identifies CD62L as a 
candidate marker of T stemness 
 
Given its demonstrable utility in identifying or clarifying progenitor cells in a 
multitude of other contexts, the side population technique seemed an opportune 
approach to begin to address the theoretical possibility that a rare population of 
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stem cells might exist within the sizeable pool of T lymphocytes that respond to 
invading pathogens.  Since it is likely that the greatest threat to T cell genome 
integrity arises consequent to the hyper-proliferation, intense metabolism, and 
elaborate epigenetic transformations that attend the expansion phase of the 
adaptive immune response to pathogen invasion (as discussed in Chapter 1), 
and since stem cells are perhaps most likely to be physiologically required or at 
least experimentally evident in this context, analysis was focused primarily on 
this initial, priming period.  As such, mice (C57Bl/6 strain) were infected 
intraperitoneally with the acutely-resolving, Armstrong strain of LCMV.  A single 
cell suspension of splenocytes was prepared from spleens harvested during the 
expansion phase of the infection (d6 pi), incubated with Hoechst 33342 dye, and 
counter-stained with both fluorochrome-conjugated antibodies against a panel of 
surface proteins and a peptide-MHC tetramer to distinguish virus-specific T cells.  
When H33342 fluorescence was visualized simultaneously at 450 nm and 675 
nm, a quantitatively minor side population was plainly evident in CD8+ T cells 
(Figure 2.1, left).  This was intriguing, and suggested the possibility that a 
subpopulation of CD8+ T cells with stem cell characteristics might actually exist. 
 
 To facilitate investigation of the cells in this side population, it was 
desirable to identify cell surface antigens that could distinguish them. Prior 
literature has established that side populations and non-side populations are 
antigenically distinct in multiple tissues (Challen and Little, 2005).  Therefore, 
expression of a panel of markers of known relevance to memory CD8+ T cell 
differentiation was screened in the side population versus the non-side 
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population of CD8+ T cells during the expansion phase of the response to viral 
infection.  From this it emerged that the protein CD62L was expressed to a 
greater extent in the side population, rather substantially in the total population of 
CD8+ T cells (Figure 2.1, right) and less dramatically in the LCMV GP33-41-
specific subpopulation thereof (discussed later in the chapter). 
 
 
2.3 Scrutiny of cellular heterogeneity during the antiviral expansion 
phase and re-evaluation of effector/memory T cell differentiation 
models prompted by unexpected expression of CD62L 
 
The selectin CD62L is a cell adhesion molecule that interacts with specialized 
endothelial cells in lymphoid tissues and thereby plays an important role in the 
homing of lymphocytes (Gallatin et al., 1983).  That CD62L was expressed 
preferentially in the side population of antigen-specific CD8+ T cells suggested 
the possibility that this readily-measurable antigen might possibly be a marker for 
a hypothesized T stem cell subpopulation. However, that CD62L was expressed 
at all on antigen-specific T cells during the antigen-driven expansion phase of 
robust LCMV infection was unexpected, given the predominant consensus that 
all CD8+ T cells during the expansion phase are firmly engaged with and 
committed to the effector fate; that such effector cells are marked by the absence 
of CD62L protein expression, and that any expression of CD62L during antiviral 
T cell expansion is negligible or at most irrelevant; and that instead CD62L 
expression marks preceding naïve T cells and succeeding T cells that emerge 
from effector T cell progenitors and subsequently commit to the memory fate 
weeks after antigen clearance and resolution of an acute infection (Kaech et al., 
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2002; Wherry et al., 2003; Masopust, Murali-Krishna, et al., 2007; Pauken and 
Wherry, 2015).  This surprising observation prompted closer scrutiny of 
heterogeneity in CD8+ T cells in the expansion phase of the immunological 
response to viral infection, and a re-assessment of the principal models for 
memory T cell differentiation. 
 
2.3.1 Contrasting developmental models for memory T cell formation 
 
Despite the numerous mechanistic insights into the origins of T cell memory that 
have been gained in recent years, considerable debate remains concerning how 
long-lived memory CD8+ T cells form (Ahmed et al., 2009; Kaech and Cui, 2012; 
Restifo and Gattinoni, 2013).  Two distinct models have been proposed to 
explain this process. First, the post-effector model proposes that long-lived, self-
renewing memory CD8+ T cells are the progeny of cytotoxic effector CD8+ T cells 
that emerge during the expansion phase.  This model is supported by lineage 
tracing experiments that defined the developmental relationships of effector and 
memory T cells (Jacob and Baltimore, 1999; Opferman et al., 1999; Kaech et al., 
2003; Wherry et al., 2003; Joshi et al., 2007; Sarkar et al., 2007; Harrington et 
al., 2008; Bannard et al., 2009).  Functional studies also failed to observe CD8+ T 
cells with key memory properties during the expansion phase, supporting the 
notion that memory CD8+ T cells differentiate from surviving effector CD8+ T cells 
following the clearance of antigen (Kaech et al., 2002). An alternative model 
proposes that memory T cells arise prior to effector T cell formation, and that 
effector T cells are generated from the progressive differentiation of memory T 
cells (Sallusto and Lanzavecchia, 2011; Restifo and Gattinoni, 2013; Fuertes 
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Marraco et al., 2015).  Recent observations of phenotypic heterogeneity arising 
as early as the first division of activated naive cells (Chang et al., 2007; Metz et 
al., 2016) are consistent with a model in which the emergence of memory T cells 
does not require transit through an effector stage.  Thus, the literature is tangled 
in a classic chicken-and-egg problem of ontogeny, with dueling models proposing 
either that cytotoxic effector differentiation exclusively precedes memory 
differentiation, or alternatively, the converse.  Discerning which (if either) of these 
models most accurately reflects biological reality has been a long-standing goal 
in immunology and has tremendous implications for basic principles of 
developmental biology as well as numerous applications with relevance to 
human health.  Here, this challenge is addressed directly. Data are presented 
that elucidate classical concepts of stem cell biology in danger-driven peripheral 
cytotoxic T lymphopoiesis, and also identify an unexpected and 
hematopoietically-unprecedented pattern of effector T cell de-differentiation in the 
post-antigen phase that plays an important yet non-essential role in memory T 
cell formation. Together, these findings support both pre- and post-effector 
models of CD8+ T cell memory formation and conduce to a unified framework for 
memory T cell ontogeny. 
 
 
2.4 Characterization of a CD8+ T cell subset present during the 
expansion phase that expresses CD62L 
 
To further investigate the surprising result of the side population assay – in which 
a sub-population of CD8+ T cells expressing CD62L despite the presence of 
antigen was revealed – the heterogeneity of antigen-specific CD8+ T cells was 
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scrutinized during the antigen-driven clonal expansion phase of acutely resolving 
viral infection.  Previous work has identified IL-7Rα and KLRG1 as markers that 
define so-called “memory precursor” and terminally differentiated effector CD8+ T 
cell subsets, respectively (Kaech et al., 2003; Huster et al., 2004; Joshi et al., 
2007).  While the great majority of cells within the splenic KLRG1lo IL-7Rαhi 
subset lacked robust expression of CD62L protein, clearly evident was a distinct 
subpopulation of LCMV GP33-41-specific, TCR-transgenic P14 CD8+ T cells with 
pronounced CD62L expression at d8 pi with LCMV-Armstrong (Figure 2.2).  The 
presence of this KLRG1lo IL-7Rαhi CD62Lhi subset in the expansion phase was 
not unique to P14 TCR-transgenic CD8+ T cells or LCMV and was observed in 
CD8+ T cell responses to bacterial and other viral infections (Figure 2.3), as well 
as in endogenous, non-TCR-transgenic responses to LCMV (Figure 2.4).  
CD62L-expressing cells were also evident in other sub-populations defined by 
KLRG1 and IL-7Rα, but were most frequent and most consistently present 
across different infection types in the KLRG1lo IL-7Rαhi population (Figures 2.2 
and 2.3). 
 
 CD8+ T cells expressing CD62L despite the presence of antigen have 
been observed previously (Wherry et al., 2003; Wherry et al., 2004; Huster et al., 
2004; Marzo et al., 2005; Sarkar et al., 2007, Lin et al., 2016), but detailed 
examination of the properties of such cells is lacking, especially in contexts not 
complicated by supraphysiological manipulations (e.g. the use of TCR-transgenic 
naïve precursor T cells spiked in at extremely high frequencies) that greatly ease 
experimentation yet substantially compromise interpretability.  Thus, to dissect 
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the properties of CD62L-expressing cells to the greatest extent possible, the 
expression of additional phenotypes and markers of effector and memory CD8+ T 
cell differentiation was analyzed in the CD62Lhi KLRG1lo IL-7Rαhi subset 
(depicted in blue; hereafter called the CD62Lhi subset for simplicity). While these 
cells retained expression of CD95, Bcl-2, and the transcription factor TCF-1 at 
levels similar to those of naïve CD8+ T cells, this subset also robustly 
upregulated expression of numerous markers of activation and differentiation, 
including CD44, CD38, CXCR3, CD122, IL-18R, Sca, CD27, and CD28 (Figures 
2.5A and 2.5D). The transcription factor Eomes is required for optimal central 
memory CD8+ T cell formation following acutely-resolving infection (Banerjee et 
al., 2010; Zhou et al., 2010; Paley et al., 2013).  Eomes was highly and 
preferentially upregulated in the CD62Lhi subset at d8 pi compared to naïve CD8+ 
T cells (depicted in grey) or compared to the CD62Llo KLRG1lo IL-7Rαhi (depicted 
in green; hereafter called the IL-7Rαhi subset) or the CD62Llo KLRG1hi IL-7Rαlo 
(depicted in red; hereafter called the KLRG1hi subset) effector subsets (Figure 
2.5A).  In contrast, T-bet and Blimp-1, transcription factors that coordinately 
specify effector CD8+ T cell differentiation (Intlekofer et al., 2005; Rutishauser et 
al., 2009; Xin et al., 2016), were modestly upregulated in the CD62Lhi subset 
relative to naïve precursors, but to a markedly lesser extent compared to the IL-
7Rαhi or KLRG1hi effector subsets (Figure 2.5A).  As expected given initial 
results indicating greater expression of CD62L in the CD8+ side population, efflux 
activity was markedly enriched in the CD62Lhi subset relative to the IL-7Rαhi and 
KLRG1hi subsets (Figure 2.6). 
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 The phenotypic characteristics of this expansion phase CD62Lhi subset 
shared some features with previously described putative memory stem cells 
(TSCM) in terms of CD95, CXCR3, and Sca expression (Restifo and Gattinoni, 
2013).  However, these previous studies also suggested that TSCM are more akin 
to naïve CD8+ T cells, including, in some cases, low expression of CD44 (Zhang 
et al., 2005; Gattinoni et al., 2009), which differs from the CD62Lhi subset 
identified here that are clearly distinct from naïve CD8+ T cells and are CD44hi 
(Figures 2.5A and 2.5D).  Moreover, relative to naïve CD8+ T cells, the effector-
associated molecules Granzyme A and Granzyme B were modestly upregulated 
in the CD62Lhi subset (Figures 2.5C and 2.5D), though expression of these 
molecules was higher in the IL-7Rαhi or KLRG1hi subsets. This CD62Lhi subset 
also readily expressed the cytokines IFNγ and TNF upon antigenic restimulation 
ex vivo (Figure 2.5B), but was the only expansion-phase population that 
efficiently produced IL-2  (Figure 2.5B). Thus, during the expansion phase of 
LCMV infection the CD62Lhi subset exhibits phenotypic and functional features of 
CD8+ T cell memory as well as limited effector differentiation. 
 
 One possibility was that these CD62Lhi cells simply were not fully activated 
following antigen encounter.  However, vital-dye-mediated proliferative history 
tracking using physiological numbers of LCMV GP33-specific TCR-transgenic 
P14 CD8+ T cells demonstrated that the vast majority of cells in the CD62Lhi 
subset had undergone at least 8 divisions by the peak of expansion (Figure 2.7). 
These findings unambiguously preclude the possible interpretation that the 
	 45	
CD62Lhi population might be merely an artifact of incomplete recruitment (i.e., 
aberrant or aborted activation) of naïve CD8+ T cells into the immune response, 
as has been observed in some experimental scenarios (Kaech and Ahmed, 
2001). 
 
 Interestingly, the proliferative history data for all three antigen-specific 
populations indicated that the CD62Lhi subset divided fewer times than the IL-
7Rαhi and KLRG1hi subsets. This pattern was modestly evident in contexts of 
physiological numbers of precursor naïve P14 T cells, and substantially more so 
when supraphysiological numbers were used (Figures 2.8A and 2.8B). Thus, it 
appeared that CD62Lhi cells were distinguished not only functionally and 
phenotypically, but also by unique proliferative dynamics. To probe this matter in 
greater depth, multiple independent methods were used to monitor cell division in 
the CD62Lhi, IL-7Rαhi, and KLRG1hi subsets towards the end of the expansion 
phase.  Short-term (24 hr) BrdU pulsing from d7-8 pi, Ki-67 expression at d8 pi, 
and TCR-transgenic P14 CD8+ T cells on a Fucci-transgenic cell cycle reporter 
background (Sakaue-Sawano et al., 2008) all indicated less cell cycling in the 
CD62Lhi subset compared to the other two subsets between days 7-8 pi (Figure 
2.8C).  This hierarchy of proliferation was reflected in the absolute abundance of 
cells in each subset that had accumulated in the spleen at the peak of the 
expansion phase (Figure 2.8D).  As such, the CD62Lhi subset of CD8+ T cells 
identified in the expansion phase exhibits a distinctive pattern of differentiation 
including robust expression of key factors associated with T cell memory and 
minimal expression of effector-associated molecules.  Moreover, these cells had 
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proliferated extensively, indicating they were not simply weakly activated, and yet 
nevertheless exhibited a degree of proliferative quiescence relative to more the 
more rapidly-cycling IL-7Rαhi, and KLRG1hi subsets. Together, these 
observations suggested that CD62Lhi cells may have unique characteristics 
among the pool of CD8+ T cells responding to infection in vivo, and raise the 
question of what their developmental role might be. 
 
 
2.5 Self-renewal of the CD62Lhi subset and ontogenetic relationship 
to effector and memory lineages 
 
The functional, phenotypic, and proliferative characteristics of the CD62Lhi subset 
in the expansion phase suggested possible connections both to emerging 
concepts (that is, within the field of immunology) of stem cell biology as well as 
well-established T cell memory. However, the developmental relationship 
between this subset and the two known CD62Llo effector CD8+ T cell subsets as 
well as long-term memory CD8+ T cells was not clear.  To address these 
questions, it was important to delineate the lineage relationships between the 
CD62Lhi, IL-7Rαhi, and KLRG1hi subsets in vivo, and define the contribution of the 
CD62Lhi subset to long-term memory.  Thus, the three subsets were flow 
cytometrically isolated at d6 pi and transplanted into separate, congenically-
disparate recipients at d4 pi (Figure 2.10A). All donor populations were labeled 
with a proliferation tracking dye. The numerical recovery, proliferation, and 
developmental potential of each subset was then assessed at the peak of the 
expansion phase of the infected recipient animals.  At d8 pi the CD62Lhi subset 
had given rise to the most abundant population of virus-specific progeny, the vast 
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majority of which had extensively proliferated as indicated by full proliferation dye 
dilution (Figure 2.10B, 4C).  The IL-7Rαhi subset also gave rise to many dye-
diluted cells, but the numerical recovery was lower than for the CD62Lhi subset.  
In contrast, the KLRG1hi subset gave rise to few recovered cells and many of 
these cells had not extensively divided. These observations are consistent with 
the terminal nature of the KLRG1hi subset of effector CD8+ T cells.  These data 
also identify the CD62Lhi subset as a population with superior ability to generate 
progeny during antigen-driven clonal expansion.  
 
 The three different donor subsets also differed in their capacity to give rise 
to progeny cells in each of the other CD8+ T cell subsets.  The terminally-
differentiated KLRG1hi subset gave rise almost exclusively to progeny with an 
identical phenotype (Figures 2.10D and 2.10E). IL-7Rαhi effector CD8+ T cells 
gave rise to both IL-7Rαhi and KLRG1hi progeny, but did not appreciably produce 
CD62Lhi cells in this expansion-phase assay (Figs. 4D and 4E).  By contrast, 
CD62Lhi cells generated all three subsets including additional CD62Lhi cells 
(Figures 2.10D and 2.10E).  This latter observation, together with the CTV 
dilution data demonstrating that nearly all cells of the CD62Lhi donor subset 
divided (Figure 2.10C), is consistent with self-renewal of the CD62Lhi subset in 
this setting of antigen-driven proliferation.  Thus, a positive association was 
revealed between developmental potential and proliferative output: the CD62Lhi 
KLRG1lo IL-7Rαhi subset is endowed with self-renewal capacity and the broadest 
developmental potential. Consistent with established principles of stem cell 
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biology, this subset also appeared to possess the greatest proliferative reserve 
and capacity to generate abundant new progeny.  
 
 It was next of interest to probe the relationship of this CD62Lhi progenitor 
subset to well-defined CD8+ T cell memory present following the clearance of 
antigen.  A cardinal attribute of CD8+ T cell memory is the capacity to persist in 
the absence of antigen and mount a proliferative recall response to antigenic re-
encounter (Kaech and Wherry, 2007).  Thus, each of the three CD8+ T cell 
subsets were sort-purified from the peak of the expansion phase of viral infection 
and transplanted in equal numbers to separate, naive recipient mice.  A month 
later, these recipient mice were challenged with the persisting, clone 13 strain of 
LCMV and the expansion and phenotype of cells derived from each of the donor 
subsets was examined.  One week following rechallenge, robust recall (Figure 
2.12A) and the presence of CD62Lhi cells (Figure 2.12B) were evident in the 
progeny of the CD62Lhi progenitor subset, indicating the capacity to persist, 
mount a vigorous proliferative response upon antigen re-encounter, and self-
renew.  The IL-7Rαhi subset also manifested recall capacity, though to a lesser 
extent than the CD62Lhi subset, raising the possibility that this IL-7Rαhi subset 
had acquired at least some attributes of the memory fate despite substantial 
effector differentiation during the expansion phase (Figure 2.5).  The KLRG1hi 
subset, as expected (Joshi et al., 2007; Sarkar et al., 2008), gave rise to few cells 
capable of mediating effective recall responses.  In a related experiment, the 
three CD8+ T cell subsets were sort-purified from the peak of the expansion 
phase of viral infection, transplanted into separate naïve recipient mice, and 
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challenged with LCMV clone 13 immediately (as opposed to one month later) 
(Figure 2.13A).  Approximately three weeks post challenge a comparable 
hierarchy of donor-derived cell abundance was evident, with the progeny of the 
CD62Lhi subset clearly advantaged over those of the two CD62Llo effector 
subsets (Figure 2.13A).  To ensure that these observations weren’t skewed by 
any differences in environmental variables including viral load, this experiment 
was repeated but modified to co-transplant congenically disparate CD62Lhi and 
IL-7Rαhi subsets into the same recipient mice, followed by immediate challenge 
with LCMV clone 13.  Nine days post challenge the progeny of the CD62Lhi 
subset substantially outnumbered those of the IL-7Rαhi subset (Figure 2.13B).  
Thus, the CD62Lhi subset appears to be endowed with robust recall capacity that 
is superior to that of cells lacking CD62L expression; it also appears to be 
markedly advantaged with respect to proliferative capacity and/or survival ability 
in the context of immediate and enduring replicative stress. 
 
 These observations prompted further probing of the phenotypic and 
functional attributes of cells derived from antigen-specific, expansion-phase 
subsets adoptively transferred into antigen-free recipient mice.  Thus, the 
CD62Lhi or IL-7Rαhi subsets isolated at d8 pi and transplanted into naive recipient 
mice to examine antigen-independent maintenance differentiation status with 
respect to cardinal attributes of central memory.  The KLRG1hi effector subset 
persisted poorly under these conditions (data not shown), consistent with data 
above (Figures 2.10, 2.12, 2.13) and published observations (Joshi et al., 2007; 
Sarkar et al., 2008).  Following transplantation of the CD62Lhi subset, the donor 
	 50	
cells recovered were mostly CD62Lhi six months (Figure 2.11A-B) or two weeks 
later (Figure 2.11C-D).  Moreover, cells in the CD62Lhi subset were able to 
undergo homeostatic proliferation between days 8-21 pi more efficiently than 
cells that lacked CD62L expression or cotransferred, control naïve OT-1 cells 
(Figure 2.11E). These characteristics align with the well-described properties of 
central memory (Sallusto et al., 1999; Wherry et al., 2003), and suggest that the 
pool of CD62Lhi memory CD8+ T cells in the post-antigen phase draws 
substantially from the CD62Lhi subset in the expansion phase.  Indeed, 
phenotypic and functional examination of the CD62Lhi subset during the 
expansion and the post-antigen phases revealed both core similarities (e.g. 
heightened anticipatory DNA damage surveillance) as well as differences (e.g. 
extent of CD43 and CD62L expression) suggesting that fundamental memory 
properties are engendered during the antigen-driven expansion phase, and 
perhaps further evolve following antigen clearance (Figure 2.14). 
 
 Because the entire IL-7Rαhi subset (i.e. independent of CD62L expression) 
has previously been shown to be the source of long-lived memory CD8+ T cells 
(Kaech et al., 2003), it was important to determine whether this central memory 
developmental potential could be fully explained by the expansion phase CD62Lhi 
subset. Thus, the IL-7Rαhi subset (i.e. IL-7Rαhi cells depleted of CD62Lhi cells; 
>99% of sorted cells were CD62Llo) isolated at d8 pi was transplanted to antigen-
free mice.  Six months (Figure 2.11A-B) and two weeks (Figure 2.11C-D) post-
transfer a substantial fraction of cells derived from IL-7Rαhi CD62Llo donor cells 
now expressed CD62L as well as CXCR3, an additional phenotypic feature of 
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central memory.  IL-7Rαhi CD62Llo-derived cells also displayed evidence of 
homeostatic proliferation (Figure 2.11E) consistent with long-term, self-renewing 
memory CD8+ T cells arising from CD62Llo IL-7Rαhi effector CD8+ T cells. Thus, 
while the expansion phase CD62Lhi subset examined here is endowed with 
multiple stemness characteristics and contributes to the pool of long-term 
memory CD8+ T cells, the IL-7Rαhi effector subset, partially differentiated 
consequent to intense antigenic and inflammatory signaling, surprisingly also 
appears possessed of memory potential, albeit at a markedly lower efficiency 
than the CD62Lhi subset.  This observation of unanticipated developmental 
plasticity is consistent with the notion of dedifferentiation, a phenomenon that has 
been recently appreciated in other mammalian tissues but that is unprecedented 
in hematopoietic lineages (Figure 2.15). 
 
 
2.6 Discussion 
 
There has been considerable debate concerning the ontogeny of long-lived 
memory T cells. Here, a subpopulation of antigen-specific CD8+ T cells is 
identified during antigen-driven expansion that in fact robustly expresses CD62L. 
This CD62Lhi population of CD8+ T cells manifests a unique constellation of 
properties – including multiple stem cell-like characteristics – that distinguishes it 
from other CD8+ T cell subpopulations identifiable in the presence of antigen.  
Examination of this rare CD62Lhi population has provided a fresh perspective on 
the formation of long-lived memory T cells. 
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2.6.1 CD62Lhi cells constitute a distinct subpopulation of expansion-phase 
CD8+ T cells 
 
The data presented suggest that the CD62Lhi subset makes a robust contribution 
to immunological memory.  These cells have an immunophenotype (e.g. KLRG1lo 
IL-7Rαhi CD122hi CD27hi CD44hi) suggesting that they are more closely related to 
previously described memory precursor cells (Kaech et al., 2003; Huster et al., 
2004) than to terminally differentiated, cytotoxic effector cells.  However, in both 
form and function, the rare CD62Lhi subset is clearly distinct from the more 
abundant CD62Llo subset of KLRG1lo IL-7Rαhi cells classically referred to as 
“memory precursors.”  The CD62Lhi subset expresses more CXCR3 and less 
CX3CR1, and, unique among antigen-specific cells in the expansion phase, 
highly expresses a multitude of molecules implicated in progenitor biology 
including Sca, a marker of hematopoietic stem cells in the bone marrow and a 
determinant of their developmental potential (Spangrude et al., 1988; Ito et al., 
2003); CD47, a molecule on hematopoietic stem cells that interacts with SIRPα 
on macrophages to provide protection from errant phagocytosis in inflammatory 
milieux (Jaiswal et al., 2009); and TCF-1, a critical executor of the of the ancient 
Wnt signaling pathway that animates self-renewal activity in numerous 
embryonic, somatic, and cancer stem cell populations (Reya et al., 2003; Reya 
and Clevers, 2005).  As detailed in chapters 3 and 4, additional progenitor-
associated molecules expressed by the CD62Lhi subset include telomerase 
(Morrison et al., 1996), and CXCR5 (Wu et al., 2015; He et al., 2016; Im et al., 
2016; Leong et al., 2016).  Notably, the activities of many of these progenitor-
associated factors have also been implicated in memory fate commitment in both 
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CD8+ and CD4+ T cells (Kaech et al., 2002; Gattinoni et al., 2009; Van et al., 
2012; Lin et al., 2016).   
 
 In addition to progenitor-associated molecules, expansion-phase CD62Lhi 
CD8+ T cells exhibited the lowest expression of the effector-fate-promoting 
transcription factors T-bet and Blimp-1, and were unique in their high expression 
of the memory-fate-promoting transcription factor Eomes and ability to synthesize 
the memory-associated cytokine IL-2.  Despite their proliferative quiescence 
relative to the CD62Llo effector subsets, these cells nevertheless had divided at 
least 7-10 times by the peak of the expansion phase and had acquired the ability 
synthesize the effector-associated cytokines IFNγ and TNFα.  Moreover, these 
cells retained robust proliferative capacity and could give rise to all effector 
subsets while simultaneously regenerating themselves.  Together, these data 
describe a set of properties that identify this CD62Lhi subset of antigen-specific 
CD8+ T cells arising in the expansion phase as a distinct cell type with substantial 
relevance both for generating abundant cytotoxic effector cells in the presence of 
antigen signaling, and for contributing to long-term T cell memory following 
infection resolution and antigen clearance. 
 
2.6.2 Implications of the Side Population / efflux phenotype 
 
An intriguing aspect of the differentiation state of the CD62Lhi population was its 
preferential efflux activity (i.e. relative to the two CD62Llo effector populations), as 
identified in the side population assay.  In these studies, CD62L as a marker of 
progenitor T cell populations first came to light in the context of a quest using this 
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assay for long-hypothesized T stem cells.  In retrospect, this association between 
CD62L expression and efflux activity is not surprising, given that the transcription 
factor FoxO1 is a positive upstream regulator of the ABC-family pump Mdr1 
(Kang et al., 2010), and preliminary indications that FoxO1 is highly expressed in 
the CD62Lhi population (data not shown).  Another ABC-family pump strongly 
implicated in multi-drug resistance and efflux activity is Bcrp. This factor is known 
to be upregulated on hematopoietic progenitor cells by hypoxia (Krishnamurthy et 
al., 2004).  Of note, lymphoid tissue is often hypoxic, with oxygen tension ranging 
from 1-5% (Caldwell et al., 2001), and the CD62Lhi population is preferentially 
localized thereto (discussed in Chapter 4).  Thus, expression of FoxO1 and 
localization to a hypoxic microenvironment are likely factors involved in regulating 
the efflux activity of the CD62Lhi population.  
 
 Matters of regulation notwithstanding, the precise role of efflux in antigen-
specific CD8+ T cells remains unclear.  Since mice (and particularly their stem 
cells) genetically deficient in ABC-family efflux pumps are highly susceptible to 
the cytotoxic effects of ABC-family efflux substrates such as chemotherapeutic 
drugs or endogenous porphyrins generated as a byproduct of quotidian 
metabolism (Jonker et al., 2002; Zhou et al., 2002; Krishnamurthy et al., 2004), a 
likely possibility is that efflux activity minimizes exposure to cytotoxic substances 
and thus potentiates long-term survival of progenitor populations.  An additional, 
non-exclusive possibility is that ABC-family pump substrates include endocrine or 
paracrine pro-differentiation factors.  Thus, efflux capacity in cell populations with 
stemness characteristics may assist in the maintenance of the undifferentiated 
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(with respect to effector function) state — a fundamental aspect of self-renewal.  
There is some precedent for this in other systems (Challen and Little, 2005; Lin 
and Goodell, 2006).  Future studies should address this possibility directly in the 
CD8+ T cell progenitor compartment, possibly beginning with a biochemical 
survey of substrates associated with ABC-family efflux pumps expressed therein.  
Additionally, mice genetically deficient for ABC-family factors (e.g. Bcrp and 
Mdr1) and upstream regulators thereof (e.g. FoxO1) are available, and can be 
used to directly address some of the many questions raised by the efflux activity 
of CD8+ T cells during pathogen infection: is efflux activity at all diminished 
consequent to FoxO1 deficiency or relative oxygen abundance?  Is the 
differentiation or maintenance of the CD62Lhi progenitor population impaired in 
the absence of ABC family members, both in unmanipulated conditions and 
those of deliberate exposure to cytotoxic substances (e.g. chemotherapy 
treatment)?  
 
2.6.3 Transcriptional circuitry and fate determination 
 
The transcription factor expression pattern of the expansion phase CD62Lhi 
subset – TCF-1hi Eomeshi and T-betlo Blimp-1lo – would be expected to promote 
the memory fate and suggests a distinct inductive event for these cells.  One 
possibility is that TCF-1 expression is sustained or induced in the CD62Lhi subset 
via preferential Wnt signaling, as has been suggested using models of in vitro 
priming in the presence of Wnt3a (Gattinoni et al., 2009), or via asymmetric 
partitioning of Wnt signaling cascade factors (Lin et al., 2016).  Additionally, or 
alternatively, the expression pattern of key chemokine receptors (e.g. CX3CR1lo 
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CXCR3hi CXCR4hi CXCR5hi) and lymphoid localization bias in vivo suggest these 
cells may have preferential access to signals that induce early commitment to the 
memory fate (discussed in Chapter 4).  Whether this reflects instructive signals 
from antigen presenting cells as might occur during asymmetric division or 
whether preferential access to cytokine or growth and differentiation factors 
influences these decisions is unclear.  Regardless, it will be of considerable 
interest in the future to determine how these cells acquire their unique 
differentiation state. 
 
2.6.4 Reconciliation via dedifferentiation: toward a unified model of T cell 
memory formation 
 
“In science, ideology tends to corrupt; absolute ideology [corrupts] absolutely” 
 - Robert Nisbet 
 
The data presented herein concerning the existence of a proliferative hierarchy 
and the lineage relationships between CD62Lhi progenitor cells and CD62Llo 
effector cells bear obvious implications for models about the formation of 
immunological memory.  One model of memory CD8+ T cell formation posits that 
memory fate commitment occurs early after initial activation such that memory 
and effector CD8+ T cells co-exist during the expansion phase (Kaech and Cui, 
2012).  Support for this model comes from studies of stem cell-like memory T 
cells (TSCM) in which cells with phenotypic and functional properties of memory 
arise directly from naïve T cells upon stimulation (Restifo and Gattinoni, 2013).  
Observations of cells with apparent memory properties arising in vivo after early 
asymmetric division (Chang et al., 2007) or in vitro in the presence of IL-15 
(Manjunath et al., 2001) or Wnt signaling agonists (Gattinoni et al., 2009) 
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reinforce the notion that the genesis of T cell memory does not depend upon 
transit through an effector phase, and in turn that effector differentiation is 
inimical to memory potential.  Alternatively, a second model holds that memory 
CD8+ T cells are the progeny of cells that have differentiated into cytotoxic 
effector CD8+ T cells and subsequently further differentiate to acquire memory T 
cell properties following antigen clearance (Kaech and Cui, 2012).  The potential 
for effector cells to give rise to memory is diminished by increased or prolonged 
TCR stimulation (Sarkar et al., 2008), but in any case, memory fate commitment 
occurs well after effector differentiation and the resolution of infection.  Lineage 
tracing experiments where cells with an effector phenotype or expressing genes 
reporting effector differentiation can develop into memory T cells (Jacob and 
Baltimore, 1999; Opferman et al., 1999; Kaech et al., 2003; Wherry et al., 2003; 
Joshi et al., 2007; Sarkar et al., 2007; Harrington et al., 2008; Bannard et al., 
2009) provide support for this model, as do functional studies that failed to 
observe CD8+ T cells during the expansion phase with cardinal memory 
properties of robust proliferative capacity in response to antigenic or homeostatic 
signals (Kaech et al., 2002). 
 
 How to reconcile these opposing models, each with extensive support, 
has been a longstanding challenge, and fundamental questions thus remain.  
How is the pool of developing effector T cells maintained, and what population or 
populations of cells have the potential to continue to generate new progeny 
during robust infections?  The data presented here may resolve some of these 
questions in two ways. 
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 First, a highly activated yet relatively proliferatively quiescent 
subpopulation of cells present early in the expansion phase is identified that 
gives rise to effector CD8+ T cells.  This CD62L-expressing population is 
phenotypically and functionally endowed with multiple manifestations of both 
stemness and memory T cell biology.  While previous analyses of the expansion 
phase have identified cellular heterogeneity in CD62L and KLRG1 expression 
and have inferred lineage dynamics between these subpopulations based on 
mathematical modeling (Buchholz et al., 2013), herein direct evidence is 
presented that CD62Lhi CD8+ T cells in the expansion phase can give rise to the 
full spectrum of effector subsets upon antigenic stimulation.  Moreover, these 
CD62Lhi CD8+ T cells are demonstrated to self-renew during the expansion 
phase.  This may explain why antigen-specific populations are not rapidly 
depleted during vigorous expansion, and suggests a mechanism for the 
generation and maintenance of responses during scenarios of persisting 
antigenic stimulation, such as chronic infections or tumorigenesis.  
 
 Second, through lineage tracing experiments, the data presented here 
show that the post-antigen phase pool of memory cells is seeded in part from the 
stem-cell-like CD62Lhi subset present during the expansion phase, consistent 
with the pre-effector model.  However, in support of the post-effector model, IL-
7Rαhi CD8+ T cells depleted of CD62Lhi cells also appear to contribute to the pool 
of long-lived central memory CD8+ T cells, which recent evidence has 
unambiguously indicated to be (or be substantially comprised of) stem cells 
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(Graef et al., 2014).  Thus, somewhat surprisingly, this observation suggests that 
long-lived, self-renewing CD8+ T cell memory can be derived not only from 
developmentally and proliferatively potent CD62Lhi cells that emerge soon after 
(if not at the moment of) initial activation at the inception of an adaptive immune 
response, but also from CD62Llo cells that have proliferated more extensively 
and undergone at least partial, antigen-driven effector differentiation, but then in 
a process of apparent dedifferentiation, reacquired memory-progenitor properties 
following clearance of antigen and waning inflammation. 
 
 Until quite recently, the possibility of physiological dedifferentiation was 
believed to be strictly impossible in mammals. This thinking stemmed largely 
from interpretations of theoretical work developed in the mid 20th century by 
Conrad Waddington, the British embryologist-philosopher.  Most notably, 
Waddington proposed a conceptual framework that sought to explain several 
fundamental observations in embryology (Waddington, 1957).  Among these 
were the remarkable overall consistency of development from zygote to well-
apportioned neonate, despite nearly unfathomable complexity with respect to 
prodigious proliferation and intertwined processes of differentiation and 
morphogenesis.  Despite so many trillions of possibilities for fate choices to go 
spectacularly awry, they usually didn’t.  How was this possible? 
 
 A related curiosity concerned apparent cellular stability: if an amorphous, 
utterly undifferentiated progenitor cell could undergo the tremendous 
transformations in form and function necessary to become any of the diverse 
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array of highly specialized cell types that are necessary to sustain the physiology 
of the mature organism – say, a rhythmically contracting cardiomyocyte or a 
neuron transducing action potentials – what was to stop this transformational 
process from proceeding in reverse?  Surely, Waddington reasoned, there must 
be some inhibitory mechanism, as chaos would undoubtedly ensue if 
spontaneous changes in differentiation state were to lead cardiomyocytes to stop 
pulsating or neurons to cease generating electrical impulses (Merrell and 
Stanger, 2016). 
 
 To account for these phenomena, Waddington conceptualized 
differentiation as a series of successive branching decisions embedded in a 
three-dimensional epigenetic landscape whose contours are sculpted by the 
activity of genes (Figure 2.15A).  Importantly, fate commitments in development 
proceeded much like a marble poised to roll down a hill to the point of lowest 
local elevation.  Both the consistency and irreversibility of differentiation were 
functions of the increasingly steep ridges arising between the valleys of potential 
that the marbles (cells and incipient tissues) traversed; when a cell reached its 
position at the bottom of the hill, there was no going back uphill (Mills and 
Sansom, 2015).  Though first conceived as early as 1940, thus even before the 
recognition of DNA as the molecular basis for heredity, Waddington’s metaphor 
has become a useful and highly cited construct for thinking about the nature of 
cell type identity and the formative processes that conduce to it during 
development (Rajagopal and Stanger, 2016). 
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 As originally envisioned, Waddington’s topography exerted an inexorable 
pull on developing cells and tissues – as it were, an unavoidable epigenetic 
gravity.   Even at the outset however, this was not interpreted in the most 
absolute sense of precluding reverse differentiation in all possible scenarios.  For 
example, contemporaneous experiments demonstrated that mature salamander 
cells could dedifferentiate and redifferentiate to regenerate amputated limbs 
(Hay, 1958), and that the fate of a terminally differentiated frog genome could be 
reverted to the ancestral, pluripotent state of its embryonic progenitor  in the 
extreme experimental scenario of nuclear transplantation (Gurdon, 1962).  
Nevertheless, this observation was generally regarded as a curious exception, 
one perhaps idiosyncratic to relatively short-lived amphibians.  Moreover, any 
conceivable dedifferentiation events in mammals, arguably more complex and 
dependent upon structural consistency, were believed to be of universally 
pathological import.  Indeed, dating from the 19th century hypotheses of Virchow 
and his student Julius Conheim, tumorigenesis has long been imagined as errant 
embryogenesis (Conheim, 1875), and modern investigation has substantiated 
this notion by way of the observation of cancer initiation precipitated by 
dedifferentiation of lineage-committed cells into a stem-like state (Krivtsov et al., 
2006). 
 
 Given these many considerations, it was thus a significant shock when 
mammalian dedifferentiation was dramatically and unambiguously reported, first 
purely phenomenologically in the case of cloned sheep (Wilmut et al., 1997), and 
then with mechanistic precision by way of pluripotent stem cells induced in vitro 
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by defined factors (Takahashi and Yamanaka, 2006).  Thus, contrary to long-
standing dogma, it turns out that dedifferentiation as a general matter is possible, 
including in mammals: epigenetic gravity, as envisioned in Waddington’s 
topography, can be defied (Figure 2.15C).  Importantly, while these extreme, 
experimentally-induced cases exemplify complete loss of lineage identity and 
consequent resumption of developmental pluripotency, dedifferentiation per se 
need not entail traversing such drastic epigenetic distances.  A formal definition 
holds that “dedifferentiation refers to the reversion of a committed or 
differentiated cell (defined by the expression of differentiation markers or other 
features of a specialized cell) into a cell with greater developmental potential” 
(Merrell and Stanger, 2016).  Thus, in Drosophila gonads, both female and male 
germ cells can regain stem cell identity after initiation of differentiation (Brawley 
and Matunis, 2004; Kai and Spradling, 2004), while in rodents, lineage-
committed B lymphocytes can dedifferentiate into progenitor cells following 
genetic manipulation in vivo, yet still retain hematopoietic character (Cobaleda et 
al., 2007). 
 
 Despite these important conceptual advances, questions remain 
concerning the relevance of mammalian dedifferentiation in physiological 
circumstances.  Recently, dedifferentiation in vivo has been reported in the 
contexts of murine spermatogenesis (Nakagawa et al., 2010), intestinal epithelia 
(van Es et al., 2012), pulmonary epithelia (Tata et al., 2013), and hepatocytes 
(Tarlow et al., 2014).  Together, these observations suggest that dedifferentiation 
may play a major role in the physiology of multiple mammalian tissues and cell 
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types.  However, to date there have been no reports of physiological 
dedifferentiation in cells of the immuno-hematopoietic lineage, though 
speculation on this matter – including particularly in CD8+ T cells – has been 
published (Joshi and Kaech, 2008). Furthermore, all of the aforementioned 
observations source from experimentally contrived scenarios of genetic, 
chemical, or physical injury.  It remains unknown whether dedifferentiation can 
occur spontaneously in mammals. 
 
 Thus, the observations presented in the studies herein that intermediately-
differentiated IL-7Rαhi effector T cells (which lack robust CD62L expression) can 
reacquire phenotypic (e.g. CD62L expression) and functional manifestations of 
the CD62Lhi progenitor cells that developmentally precede them, are a notable 
indication that dedifferentiation may play a role not only in mammalian germinal, 
epithelial, and hepatic lineages, but also in immuno-hematopoietic tissue as well.   
Moreover, these data provide evidence for multiple developmental origins of 
memory CD8+ T cells, and thereby help reconcile the longstanding dichotomy of 
the pre- and post- effector models for memory formation.  Because the CD62L-
depleted IL-7Rαhi effector T cells gave rise to central memory CD8+ T cells 
slightly less efficiently, these data further support a linear model of effector 
differentiation with decreasing potential for memory formation.  Expansion phase 
CD62Lhi CD8+ T cells with minimal effector differentiation have the most per-cell 
memory potential, followed by intermediately-differentiated IL-7Rαhi effector CD8+ 
T cells lacking CD62L expression, with the fully effector-differentiated KLRG1hi 
subset contributing little to the long-term, self-renewing memory pool. Thus, 
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these data indicate a parsimonious model in which long-term central memory 
sources during the expansion phase from not one but rather multiple clonal 
subsets of differing extents (i.e. minimal versus extensive) of effector 
differentiation (Figure 2.16). 
 
 
2.7 Conclusions 
 
Interrogating the CD62Lhi subset of CD8+ T cells during the expansion-phase of 
the adaptive immune response to viral infection uncovered novel biological 
features that enrich and extend our understanding of the molecular programming 
and developmental sequencing underpinning the generation of memory and 
effector T cells. 
 
 An abiding paradox in the field centers on the question of how activated T 
cells can divide extensively and extraordinarily rapidly (Figure 1.1) – putatively 
with toxic consequences for the integrity of their genomes – yet nevertheless 
retain long-term viability and the potential to extensively (and rapidly) proliferate 
upon subsequent encounters with pathogen-derived antigens, or upon continued 
antigen presence and sustained replicative stress (e.g. in the context of chronic 
microbial infections or cancers).  In other tissues with intense turnover kinetics, 
for example the gastrointestinal epithelium, stem cells present a solution to a 
similar problem by asymmetrically dividing and thereby unequally apportioning 
the burden of proliferation to downstream, transit-amplifying cells (Figure 1.2).  
However the existence of stem cells and their possible relationship with the 
memory T cell fate have been controversial.  The data presented in this chapter 
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identify a rare subset of antigen-specific CD8+ T cells during the expansion 
phase that resemble somatic stem cells in other tissues, including with respect to 
immunophenotype, transcriptional programming, and relative proliferative 
quiescence.  These features include heightened expression of protective 
molecules that confer resistance to apoptosis (e.g. Bcl-2), resistance to errant 
phagocytosis (e.g. CD47), and xenobiotic efflux activity.  Additionally, this 
CD62Lhi subset highly expressed molecules that potentiate self-renewal, 
including Sca-1 and executors of the primordial Wnt signaling pathway.  
Collectively, and along with the genome integrity surveillance and signal 
calibration activities that are the subjects of chapters 3 and 4, respectively, these 
features render CD62Lhi cells uniquely capable of withstanding the intense, 
multifaceted stresses inherent in the expansion phase of adaptive immune 
responses to pathogenic perturbations.  In turn, these CD62Lhi cells are equipped 
to subserve the evolutionarily ancient imperative of immunological memory: long-
term preservation of clonal integrity to avoid selective deficiency in the repertoire 
of antigen-specific lymphocytes; and to maintain the capacity for further 
responsiveness to renewed or sustained encounter with antigen (Intlekofer et al., 
2006). 
 
 An additional, long-standing question in immunobiology concerns the 
nature of the developmental pathways which naïve, antigen-inexperienced T 
cells must traverse in order to acquire the cardinal properties of memory T cells.  
To a large extent, enduring controversy about this matter has amounted to a 
chicken-and-egg problem (Ahmed et al., 2009; Restifo and Gattinoni, 2013): do 
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effector T cells precede memory T cells, as was first assumed by many, or do 
stem-like memory T cells spawn effectors, as has more recently been 
suggested?  Multiple observations herein indicate support for the second view.  
In particular, CD8+ T cell clonal expansion is structured according to a classical 
proliferative hierarchy rooted in a rare stem/progenitor population.  This CD62Lhi 
population bears multiple phenotypic and functional manifestations of classically-
defined central memory, and efficiently gives rise to CD62Llo effector CD8+ T 
cells.  This linear, memory-to-effector differentiation pathway has been recently 
corroborated by varied, largely inferential reports in the literature that 
developmentally situate the memory fate prior to the effector fate on the basis of 
mathematical modeling (Buchholz et al., 2013), transcriptional analyses 
(Roychoudhuri et al., 2015), and epigenetic surveys (Pauken et al., 2016; Scott-
Browne et al., 2016).  However, the data herein also support a prominent 
contribution to (at least primary) long-term cell central memory from the partially-
differentiated IL-7Rαhi subset of effector CD8+ T cells.  This observation was 
surprising given traditional interpretations of Waddington’s epigenetic landscape 
(Waddington, 1957) holding that effector differentiation from a stem cell 
progenitor is strictly unidirectional.  However, reacquisition of progenitor-fate 
properties is consistent with the emerging appreciation of substantial mammalian 
developmental plasticity.  In the present context, CD62Llo effector T cells whose 
fate is arrived at after that of CD62Lhi stem-memory-like T cells in the presence of 
antigen appear to dedifferentiate into CD62Lhi long-term memory cells following 
the cessation of antigen and/or inflammatory signaling.  Thus, instead of 
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dichotomous views maintaining that the memory fate exclusively precedes the 
effector fate, or the converse, it appears that memory-like cells differentiate into 
effector cells, which in turn can give rise to memory cells.  As such, a subset of 
effector cells (those highly expressing IL-7Rα) are simultaneously the egg and 
the chicken. 
 
 Important directions of future investigation will entail substantiating this 
reconciliatory ontogeny, given the caveat that developmental state in these 
studies was distinguished on the basis of a single cell surface marker, i.e. 
CD62L.  Comprehensive transcriptional evaluation of the CD62Lhi and IL-7Rαhi 
subsets – an important biological aim in its own right – may uncover additional 
differential protein expression that can be used to flow cytometrically distinguish 
these two subsets for more precise lineage tracing experiments.  Global 
epigenetic profiling can also help to define cell states and the full extent of 
developmental distance between the CD62Lhi and IL-7Rαhi subsets, both in the 
presence of antigen and after it has been cleared. 
 
 Beyond, a major question raised by these observations concerns any 
potential differences between long-term stem/central memory T cells that derive 
from cells that always manifested a stem/progenitor fate (e.g. the CD62Lhi 
subset) versus those that arise consequent to dedifferentiation from partially 
differentiated IL-7Rαhi effector cells (Figure 2.16).  As one prominent Drosophila 
biologist has put it, is there any difference between counterfeit and original stem 
cells (Spradling and Fan, 2010)?  Given the very different histories of proliferation 
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and deployment of various protective programs between these two expansion 
phase T cell subsets, one might indeed expect substantial differences (Mills and 
Sansom, 2015), which in turn could be of functional consequence for the overall 
capacity of long-term T cell memory.  Consistent with this expectation is the 
observation that IL-7Rαhi cells, in stark contrast to CD62Lhi cells, were almost 
bereft of ability to persist in conditions of enduring replicative stress (Figure 2.13).  
Nevertheless, future work will need to probe this matter empirically, as well as 
the related matter of these two populations’ relative contributions to both primary 
and secondary long-term (i.e. “central”) memory formation.  At present, the 
studies presented herein clarify the developmental origins of CD8+ T cell memory 
and point to novel opportunities to further dissect the molecular basis of 
immunological memory and progenitor cell biology. 
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Figure 2.1 
 
 
 
 
Figure 2.1: Efflux activity during the CD8+ T cell response to viral infection 
enriches for expression of CD62L.  Splenocytes from mice d6 pi LCMV-Armstrong 
were incubated in Hoechst 33342 for 90 minutes at 37° C and then counter-stained with 
fluorescently-labeled antibodies against surface markers. Simultaneous, dual-
wavelength visualization of Hoechst 33342 fluorescence in CD8+ T cells revealed an 
actively effluxing, so-called “side population” (left). Analysis of CD62L expression (right) 
in the side population (blue histogram) versus all remaining, non-effluxing cells (gray 
histogram) revealed a marked enrichment in the former. 
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Figure 2.2 
 
 
 
 
Figure 2.2: An antigen-specific, central memory-like CD62Lhi CD27hi subpopulation 
exists during the antiviral expansion phase and is enriched within the KLRG1lo IL-
7Rαhi population.  Bivariate plots of flow cytometric data depict the immunophenotypes 
of splenocytes harvested at d8 pi LCMV-Armstrong from CD45.2+ C57Bl/6 mice that had 
been transplanted prior to infection with CD45.1+ LCMV-specific P14 TCR-transgenic 
CD8+ T cells.  The CD45.1+ P14 population of antigen specific cells is identified at the 
top-left, and then sub-fractionated by various markers.  Of particular note is the KLRG1lo 
IL-7Rαhi CD62Lhi CD27hi sub-population (bottom right).  Numbers denote frequency 
within the gated population.     
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Figure 2.3 
 
 
 
 
Figure 2.3: Presence of a CD62Lhi KLRG1lo IL-7Rαhi subset in antigen-specific CD8+ 
T cells during the expansion phase of  bacterial and viral infections.  A) C57Bl/6 
mice received 5,000 congenically disparate P14 TCR-transgenic CD8+ T cells and then 
were infected intravenously with Listeria monocytogenes expressing the LCMV gp33 
epitope (LM-gp33).  The presence of the three expansion phase subsets of CD8+ T cells 
was determined for responding P14 cells by flow cytometry at d8 pi.  B) C57Bl/6 mice 
received 50,000 congenically disparate OT-I TCR-transgenic CD8+ T cells and then 
were infected intravenously with vesicular stomatitis virus (VSV) expressing OVA (VSV-
OVA).  The presence of expansion phase subsets of CD8+ T cells was determined for 
responding OT-1 cells by flow cytometry at d8 pi. 
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Figure 2.4 
 
 
 
 
Figure 2.4: Presence of a CD62Lhi KLRG1lo IL-7Rαhi subset in endogenous, 
antigen-specific CD8+ T cells during the expansion phase of the adaptive immune 
response to LCMV infection.  C57Bl/6 mice were infected with LCMV-Armstrong.  At 
d8 pi, splenocytes were stained with peptide-MHC tetramers to detect CD8+ T cell 
populations specific for the subdominant DbGP276 (A) and DbGP33 (B) epitopes, and 
the dominant DbNP396 epitope (C). 
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Figure 2.5 
 
 
 
Figure 2.5: Immunophenotypic characterization of the antigen-specific CD62Lhi 
population during the expansion phase of acute viral infection. Subsets of GP33-
specific splenocytes were flow-cytometrically evaluated at d8 pi LCMV-Armstrong for 
expression of the factors implicated in the activation and differentiation of CD8+ T cells.  
A) Histograms depicting expression of markers implicated in lymphocyte stemness (left), 
and of transcription factors associated with memory vs. effector fate decisions.  B) 
Expression of cytokines after ex vivo restimulation with GP33 peptide in the presence of 
100 μM TAPI-2 in LCMV-specific CD8+ T cell subsets (indicated in blue, green, and red) 
and polyclonal naïve CD8+ T cells (indicated in grey).  C) Expression of Granzyme B in 
LCMV-specific CD8+ T cell subsets and polyclonal naïve cells.  D) Heatmap depicting 
relative protein expression determined by flow cytometry for indicated markers; red 
indicates higher expression, while blue indicates lower expression.   
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Figure 2.6 
 
 
 
 
Figure 2.6: Preferential efflux activity in antigen-specific CD62Lhi CD8+ T cells.  
Splenocytes from mice d8 pi LCMV-Armstrong were incubated in Hoechst 33342 for 90 
minutes at 37° C and then counter-stained with DbGP33 tetramer and antibodies against 
surface markers. A side population of actively effluxing cells was evident in antigen-
specific CD8+ T cells (left), and in subsets thereof (right).  The extent of effluxing was 
observed to be greatest in the CD62Lhi compartment. 
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Figure 2.7 
 
 
 
 
Figure 2.7: Extensive proliferation in the antigen-specific CD62Lhi population 
precludes the possible interpretation of incomplete recruitment.  Naïve TCR-
transgenic P14 CD8+ T cells were labeled with the proliferation-tracking dye CTV and 
transplanted into naïve recipient mice. These were subsequently infected with LCMV-
Armstrong.  At d8 pi splenocytes were harvested and analyzed flow cytometrically to 
evaluate CTV dilution in the unfractionated P14 population (middle panel) and the 
CD62Lhi subset  thereof (bottom panel). The top panel depicts CTV dilution in P14 cells 
transplanted in supra-physiological quantities, which, owing to the skewed ratio of 
antigen-specific T cells to antigen presenting cells, might be expected to manifest a 
pattern of limited proliferation consistent incomplete recruitment or aberrant activation. 
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Figure 2.8 
 
 
Figure 2.8: Proliferative index, proliferative history, and absolute abundance 
suggest expansion phase, antigen-specific CD8+ T lymphocyte subsets may be 
structured in a proliferative hierarchy.  A-B: Proliferative history of P14 CD8+ T cells 
and subsets thereof under conditions of physiological and supraphysiological naïve 
precursor numbers.  A) C57Bl/6 mice received physiological (2 x 103, top panels) or 
supraphysiological (2 x 106, bottom panels) numbers of proliferation-dye-labeled P14 
cells, and were then infected with LCMV-Armstrong.  At d8 pi, proliferation dye dilution 
was measured by flow cytometry in donor P14 cells in the spleen.  Dye dilution is 
depicted in total P14 populations (large, upper panels) and in the CD62Lhi, IL-7Rαhi and 
KILRG1hi subsets (smaller, lower panels).  B) Statistical summary of the data in part A.  
Asterisks indicate statistical significance (p < 0.05) determined by one-way analysis of 
variance (ANOVA).  Error bars depict mean ± SEM. C) Proliferative index analyzed at 
the end of the expansion phase.  Top: Mice containing P14 cells were pulsed with BrdU 
at d7 pi and BrdU incorporation in the three LCMV-specific CD8+ T cell subsets (and 
naïve CD8 T cells) was assessed at d8 pi.  Middle: Ki-67 expression was examined at 
d8 pi in the three subsets and in naïve CD8+ T cells.  Bottom: Expression of the cell 
cycle reporter Fucci-mAG was assessed in the three subsets indicated.  D) Abundance 
of cells in each of the three LCMV-specific subsets at d8 pi in the spleen.    
D
<Pacific Blue-A>: BrdU
<A
F 
70
0-
A>
: C
D4
4
0.694
<Pacific Blue-A>: BrdU
<A
F 
70
0-
A
>:
 C
D
44
23.1
<Pacific Blue-A>: BrdU
<A
F 
70
0-
A>
: C
D4
4
29
<Pacific Blue-A>: BrdU
<A
F 
70
0-
A
>:
 C
D
44
34.5
BrdU
<FITC-A>: Ki-67
<A
F 
70
0-
A
>:
 C
D
44
75.7
<FITC-A>: Ki-67
<A
F 
70
0-
A>
: C
D4
4
71.5
<FITC-A>: Ki-67
<A
F 
70
0-
A>
: C
D4
4
66.3
<FITC-A>: Ki-67
<A
F 
70
0-
A>
: C
D4
4
3.43
Ki-67
<FITC-A>: Fucci Reporter
<Q
D
 8
00
-A
>:
 C
D
44
1.8
<FITC-A>: Fucci Reporter
<Q
D
 8
00
-A
>:
 C
D
44
4.26
<FITC-A>: Fucci Reporter
<Q
D
 8
00
-A
>:
 C
D
44
10.7
Fucci-mAG
C
D
44
0.7 23 29 35
1.8 4.3 11
3.4 66 71 76
LC
M
V-
sp
ec
ifi
c 
T 
ce
lls
 / 
Sp
le
en
10 8  
10 7
10 6
10 5
MP
_C
D6
2L
hi
MP
_C
D6
2L
lo
TE
_C
D6
2L
lo
5
6
7
8
# 
o
f A
g
-s
p
ec
ifi
c 
C
D
8+
 T
 c
el
ls
2014.04.06d8 pi LCMV-Arm, splenocytes gated on CD8+ CD45.1+, n=5
17.01.30 formatting for SF4
2 x 103 P14s
MP
_C
D6
2L
hi
MP
_C
D6
2L
lo
TE
_C
D6
2L
lo
0.0
0.2
0.4
0.6
0.8
%
 C
TV
 n
ot
 fu
lly
 d
ilu
te
d
*
ns
*
2 x 106 P14s
MP
_C
D6
2L
hi
MP
_C
D6
2L
lo
TE
_C
D6
2L
lo
0
8
16
24
32
%
 C
TV
 n
ot
 fu
lly
 d
ilu
te
d
ns
*
*
JBJ403 d8 pi LCMV-Arm, spleen; n=4 per group
<450/50 Violet-A>: CTV
<P
er
C
P
-C
y5
-5
-A
>:
 C
D
8
5.e-3
<450/50 Violet-A>: CTV
<P
er
C
P
-C
y5
-5
-A
>:
 C
D
8
0.0102
<450/50 Violet-A>: CTV
<P
er
C
P
-C
y5
-5
-A
>:
 C
D
8
0.18
<450/50 Violet-A>: CTV
<P
er
C
P
-C
y5
-5
-A
>:
 C
D
8
1.04
<450/50 Violet-A>: CTV
<P
er
C
P
-C
y5
-5
-A
>:
 C
D
8
6.65
<450/50 Violet-A>: CTV
<P
er
C
P
-C
y5
-5
-A
>:
 C
D
8
22.2
0 102 103 104 105
<450/50 Violet-A>: CTV
<Per
CP-C
y5-5
-A>:
 CD8
8.83e-3
0 102 103 104 105
<450/50 Violet-A>: CTV
<Per
CP-C
y5-5
-A>:
 CD8
10.2
C
D
8 
cell division 
<0.01 
22.20 6.65 1.04 
0.18 0.01 0.00 
10.20 
2 x 10
6 P
14 cells 
2 x 10
3 P
14 cells 
C
TV
 n
ot
 fu
lly
 d
ilu
te
d 
(%
 o
f i
nd
ic
at
ed
 s
ub
se
t) 
2 x 103 P14 cells 2 x 106 P14 cells 
C
A B
	 77	
Figure 2.9 
 
 
 
 
Figure 2.9: Mitochondrial-biased metabolism characterizes and drives abundance 
of the CD62Lhi subset. A) Measurement of mitochondrial mass by way of MTG 
(mitotracker-green) fluorescence in naïve CD8+ T cells and subsets of P14 splenocytes 
isolated at d8 pi LCMV-Armstrong. B-C: Treatment with increasing doses of Rapamycin 
progressively increases the relative and absolute abundance of the CD62Lhi subset.  In 
this experiment, mice were treated with daily injections of PBS or Rapamycin at 75 μg/kg 
or 300 μg/kg following infection with LCMV-Armstrong.  At d8 pi, PBMC were evaluated 
for the abundance of antigen-specific subsets.  Flow cytometry plots in B) depict CD62L 
and CD27 expression within the GP33+ KLRG1lo IL-7Rαhi compartment; C) statistically 
depicts the abundance of GP33+ CD62Lhi KLRG1lo IL-7Rαhi cells (i.e. the CD62Lhi 
subset).    
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Figure 2.10 
 
 
 
 
Figure 2.10: Self-renewal and lineage relationships of expansion phase LCMV-
specific CD8+ T cell subsets.  A) Schematic of experimental design to determine 
lineage relationships and proliferative capacity.  B) Expansion potential of the CD62Lhi, 
IL-7Rαhi and KLRG1hi LCMV-specific CD8+ T cell subsets isolated and transplanted to 
infected mice as indicated in part A.  Representative flow cytometric plots from recipient 
mice (n=5 per group; left) and quantification of absolute number of recovered donor P14 
cells for the indicated subsets (middle).  C) Proliferation dye dilution in donor-derived, 
LCMV specific CD8+ T cell subsets from part B, relative to control, co-transplanted 
population of unrelated OT-I cells (grey).  D) Phenotype of cells recovered from each 
donor subsets from part B.  Left: phenotype of donor cell with respect to IL-7Rα and 
CD62L expression (note, lower “red” population was 99.97% KLRG1hi).  Right: 
phenotype of P14 cells recovered after transplant of the indicated populations on the left.  
E) Summary of phenotypes of P14 cells recovered after transplant as outlined in part A.  
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Figure 2.11: Lineage relationships between expansion-phase and post-antigen-
phase subsets.  A) Experimental design: splenic P14 subsets were sorted at d8 pi (B, 
left) and transplanted into congenically disparate naïve recipient mice.  After 6 months, 
the frequency of donor cells with a CD62Lhi “central memory” phenotype was determined 
in recipient spleens (B, right flow cytometry plot and bar graph). C) Experimental 
design: CD62Lhi, IL-7Rαhi and KLRG1hi P14 subsets were sorted at d8 pi LCMV and 
proliferation dye-labeled. After mixing with congenically disparate, proliferation dye-
labeled OT-I naïve CD8+ T cells as a control, sorted P14 cells of each subset were then 
transplanted into congenically disparate, naïve recipient mice. Two weeks later the 
immunophenotype (D) and extent of proliferation dye dilution (E) of donor cells were 
evaluated in recipient mouse spleens (orange histograms denote P14 cells, grey 
histograms denote control, co-transplanted naïve OT-I cells).    
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Figure 2.12: Superior memory-recall capacity of the antigen-specific CD62Lhi 
population.  Experimental design: splenic P14 subsets were sorted at d8 pi and 
transplanted to congenically disparate naïve recipient mice. A) One month later, 
recipient mice were challenged with LCMV clone 13 and the abundance of donor P14 
cells was assessed in spleens on d7 pi. B) The immunophenotype of donor-derived cells 
was evaluated (left), and the frequency of regenerated CD62Lhi subset cells was 
determined (right).   
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Figure 2.13: Superior potential of the CD62Lhi population to persist under 
conditions of immediate and enduring replicative stress. A) Top: experimental 
design: CD62Lhi, IL-7Rαhi and KLRG1hi P14 subsets were sorted at d8 pi LCMV and 
equal numbers were transplanted into congenically disparate naïve recipient mice.  
These were immediately challenged with LCMV clone 13, and the abundance of donor 
cells was evaluated in PBMC at 23 dpi (bar graph, bottom).  B) Top: experimental 
design: CD62Lhi and IL-7Rαhi P14 subsets were sorted at d8 pi LCMV from congenically 
disparate donor mice and equal numbers were co-transplanted into naïve recipient mice.  
These were immediately challenged with LCMV clone 13, and the abundance of donor 
cells was evaluated in spleens at d9 pi (bottom).   
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Figure 2.14: Phenotypic and functional differences between CD62Lhi subsets 
during the antigen-driven expansion phase and the post-antigen phase.  A-C) 
PBMC were isolated from mice at d8 pi and > 2 months pi LCMV-Arm and stained 
separately with anti-CD8α conjugated to distinct fluorophors.  Following CD8α staining, 
samples were combined and stained together for CCR7, CD43, congenic marker (to 
identify P14 cells), and lineage markers.  CD62L expression was examined within the 
KLRG1lo IL-7Rαhi progenitor compartment (gated on LCMV-specific cells) at 8 days and 
> 2 months pi, and depicted as bivariate plots in (A) and as overlaid histograms in (B).  
C) Expression of CCR7 (left), CD43 (middle), and PD-1 (right) on polyclonal naïve cells 
(grey), and LCMV-specific CD62Lhi KLRG1lo IL-7Rαhi cells at 8 days pi (light blue) and > 
2 months pi (dark blue).  D) Phosphorylation of H2AX following ex vivo irradiation was 
assessed as in Fig 3C, and is here depicted as the capacity of LCMV-specific CD62Lhi 
KLRG1lo IL-7Rαhi cells to phosphorylate H2AX relative to that of polyclonal naïve cells.  
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Figure 2.15 
 
 
 
Figure 2.15: Differentiation and Dedifferentiation.  A-B) Differentiation entails 
traversing an epigenetic landscape, as originally conceptualized by Conrad Waddington, 
with concomitant acquisition of specialized form and function.  In this schematic 
“progenitor” cells correspond to the CD62Lhi subset of antigen-specific CD8+ T cells; 
“differentiating cells” correspond to the IL-7Rαhi subset; and “differentiated cells” 
correspond to the KLRG1hi subset discussed in the text.  C) Though cellular 
specialization was believed to be unidirectional, convincing data in amphibians and more 
recently in mammals has demonstrated that differentiated cells can partially or entirely 
revert to or assume the undifferentiated state of their progenitors.  Adapted from 
Waddington, C.H. The Strategy of the Genes: a Discussion of Some  Aspects of 
Theoretical Biology. London: Allen & Unwin, 1957. Reproduced with permission from 
Merrell AJ and Stanger BZ. Adult cell plasticity in vivo: de-differentiation and 
transdifferentiation are back in style. Nat Rev Mol Cell Biol. 2016 Jul; 17(7):413-25.   
A
B
C
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Figure 2.16 
 
 
 
 
Figure 2.16: Model for stem-cell-driven effector T cell differentiation in the 
presence of antigen and subsequent dedifferentiation into memory T cells in the 
absence of antigen. A naïve T cell is activated by encounter with cognate antigen in the 
context of immunological danger and gives rise to a clonal stem cell hierarchy marked by 
increasing proliferation, and progressive cytotoxic effector differentiation.  Following 
antigen elimination and the resolution of acute infection, terminally-differentiated effector 
cells (red) largely commit to apoptosis, whereas intermediately effector-differentiated 
memory precursor cells (green) gradually reacquire the stemness of their progenitors 
(blue).  In the post-antigen phase, the pool of memory T cells, composed of TSC and TSC’ 
populations, is heterogeneous with respect to proliferative past and history of effector 
differentiation. 
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.:: CHAPTER 3 ::. 
 
SPECIALIZED FUNCTION FOR T STEM CELLS IN CONSERVING 
GENOME INTEGRITY; IMPLICATIONS FOR AGING CLOCKS 
 
3.1 Genome integrity maintenance and the stem cell theory of aging 
 
DNA damage is an ongoing, daily occurrence with which all cells must contend.  
For example, it’s been estimated that the average cell experiences roughly 
100,000 spontaneous DNA lesions per day (Lindahl, 1993).  While damage to 
any of the structures that constitute the cell — e.g. lipid membranes, RNA 
species, proteins, cytoskeletal components, various macromolecular machines 
and organelles, — can threaten viability and as such must be addressed, if repair 
is not practical, outright replacement is always a possibility, assuming energy and 
raw building blocks are available to support de novo synthesis.  In contrast, 
because chromatin is the ultimate repository for the information that templates all 
other cellular structures, any injuries thereto can be uniquely pernicious. In 
parallel to cosmological considerations about the nature of black holes, mere 
matter can always be retrieved, recycled, or rebuilt, as necessary; however, once 
lost, information is gone forever. As such all nucleated cells in all known species 
deploy multitudinous, complementary surveillance and repair mechanisms to 
minimize genomic damage (Blanpain et al., 2011).  The fidelity of maintenance 
and repair activities is incomplete, however, and numerous datasets across 
multiple species indicate that errors occur, accumulate, and gradually diminish 
genome integrity over time (Herbig et al., 2006; Lopez-Otin et al., 2013). 
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  The idea that declining genome integrity might be involved in the aging 
process has been pondered for decades.  But is this merely one of the many 
curious features of aging, or is it actually important? Though cause and effect 
relationships concerning information maintenance can be exceedingly difficult to 
discern, there is growing support for the notion that declining genome integrity 
not only accompanies the aging process at the cellular and organismal levels, it 
also drives it.  This is perhaps most dramatically evident in the progeroid 
syndromes that manifest in both model organism systems and humans 
consequent to mutations in factors involved in genome maintenance (de Boer et 
al., 2002; Kujoth et al., 2005; Burtner and Kennedy, 2010). Moreover, while 
inactivation of genome maintenance factors abbreviates lifespan in multiple 
species with broadly varying lifespans, genetic analyses have indicated that a 
major determinant of the lifespan differences between species is the extent or 
nature of the activity of DNA damage surveillance and repair factors (Lorenzini et 
al., 2009; Ma et al., 2016). Thus, with respect to the aging process, genomic 
information is vitally important: corruption thereof causally leads either to loss-of-
function or hyperplastic gain-of-function, and almost invariably to decreased 
fitness and an earlier ultimate demise. 
 
 However, developmental biologists have long appreciated that most of the 
cells that constitute a metazoan soma over a lifetime have a finite, often very 
limited lifespan, and are replenished from self-renewing stem cell compartments, 
either continuously or in injury-regeneration scenarios. As such, while all 
nucleated cells must monitor and sustain chromatin fidelity to some extent, an 
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extensive body of theoretical writing and more limited empirical evidence suggest 
that stem cells may be particularly important for and invested in the genome 
maintenance and repair activities that ultimately are most proximally related to 
organismal aging (Cairns, 1975; Blanpain et al., 2011). Together, these notions 
constitute the so-called stem cell theory of aging, which holds that stem cells 
have a prominent, perhaps predominant role in conserving overall, organismal 
genome integrity; and that the accumulation of genomic and epigenomic 
mutations that nevertheless inevitably accumulate in stem cells ultimately 
diminishes their function and thereby hastens organismal death (Krishnamurthy 
and Sharpless, 2007; Brunauer et al., 2015). In this chapter, this hypothesis is 
probed with respect to T stem cells. Is genomic integrity relevant to the functions 
of anti-pathogen T cells? Do T stem cells resemble other stem cell populations in 
terms of specialized functions with respect to genomic integrity conservation?  
Can analysis of genome integrity in T cells, which replicate uniquely rapidly, in 
turn inform understanding of stem cell biology more generally? 
 
 
3.2 Superior surveillance of genome integrity in T stem cells 
  
The observations presented in the previous chapter revealed the existence of a 
quantitatively minor subset of cells in the anti-viral T cell expansion phase with 
unique developmental features, including robust yet restrained proliferation, 
substantial efflux activity, and a protein expression profile that intersects with that 
of stem and progenitor cells in other developmental contexts.  In many biological 
systems there is a known (if little understood) association between progenitor 
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cells in proliferative hierarchies and the maintenance of genomic integrity (Flores 
et al., 2008).  Analysis of global gene expression in unfractionated, antigen-
specific CD8+ T cells isolated at various time points before, during, and after an 
acutely-resolving viral infection indicated that the cellular DNA damage response 
machinery is highly dynamically regulated (Figure 3.1).  This offered an initial 
indication that DNA damage and/or the response thereto is likely to be important 
in the lives of CD8+ T cells responding to pathogenic perturbations, and provided 
the impetus to specifically interrogate this issue in the three expansion phase 
subsets of CD8+ T cells first described in the prior chapter.  
 
 To begin to assess DNA damage in the three subsets, the alkaline comet 
assay (Olive and Banáth, 2006) was employed to directly measure DNA breaks. 
This approach clearly revealed increased tail moments indicative of DNA 
damage in the KLRG1hi subset, while both the IL-7Rαhi and CD62Lhi subsets 
exhibited lower tail moments (Figure 3.2).  While these data suggested that 
terminal differentiation may be associated with loss of genome integrity, the 
resolution of this assay was insufficient to discern whether differences existed in 
the IL-7Rαhi and CD62Lhi subsets.  An alternative approach was called for.  A 
major mechanism by which cells monitor DNA damage operates through 
phosphorylation of the variant histone H2AX, which in turn leads to the 
recruitment of DNA repair machinery (Bonner et al., 2008). Therefore H2AX 
phosphorylation was measured directly ex vivo during the effector phase. The IL-
7Rαhi subset of LCMV-specific CD8+ T cells displayed slightly lower pH2AX 
relative to naïve CD8+ T cells, while pH2AX was even lower in the KLRG1hi 
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subset, suggesting diminished efficiency of DNA strand break surveillance in this 
terminally-differentiated subset.  In contrast, H2AX phosphorylation was 
markedly elevated in the LCMV-specific CD62Lhi subset, with ex vivo pH2AX 
expression 24% greater than naïve CD8+ T cells and 41% greater than observed 
in the IL-7Rαhi subset (Figure 3.3A). These data suggested the CD62Lhi subset 
was characterized by either greater DNA damage or enhanced surveillance of 
genome integrity.  To test whether these differences reflected the ability of cells 
to respond to experimentally induced DNA strand breaks, each subset and 
control naïve CD8+ T cells were exposed to equal amounts of DNA damage 
using controlled ionizing irradiation ex vivo at a dose known to affect progenitor 
cell biology (Mohrin et al., 2010).  While all subsets upregulated H2AX 
phosphorylation following irradiation, the extent of induction in IL-7Rαhi and 
KLRG1hi effector subsets was lower than that of naïve CD8+ T cells (Figure 
3.3B).  In contrast, the CD62Lhi subset was substantially more efficient in 
initiating the H2AX-mediated DNA damage response pathway compared to naïve 
CD8+ T cells or compared to either of the two CD62Llo effector CD8+ T cell 
subsets (Figure 3.3B); the CD62Lhi subset was ~33-100% more efficient than 
the other subsets of CD8+ T cells examined (Figure 3.3B, right panel).  These 
results suggested that the CD62Lhi subset may be preferentially endowed with 
the ability to surveil and respond to DNA damage, while the IL-7Rαhi and 
KLRG1hi effector subsets may be disadvantaged in this respect. 
 
 Interestingly, the Wnt signaling pathway has been implicated in the 
regulation of genome maintenance activities (Kendziorra et al., 2011; Hoffmeyer 
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et al., 2012), and the data reported in the prior chapter indicated that TCF-1, a 
principal transcriptional effector of transduced Wnt signals, is preferentially 
expressed in the CD62Lhi subset relative to the CD62Llo subsets (Figures 2.5A 
and 2.5D). To probe whether a causal relationship existed between TCF-1 
expression and heightened responsiveness to DNA damage, TCR-transgenic 
P14 CD8+ T cells conditionally deficient for TCF-1 (by virtue of CD4-Cre 
expression in thymocyte precursors driving excision of a floxed TCF-1 allele) 
were generated, transplanted into naïve recipient mice, and assessed for their 
ability to phosphorylate H2AX 8 days pi LCMV.  Relative to WT controls, cells in 
the TCF-1-deficient CD62Lhi subset (but not the IL-7Rαhi or KLRG1hi subsets) 
exhibited diminished basal pH2AX expression (Figure 3.4).  Unexpectedly, no 
difference was observed in  the ability of cKO vs. WT CD62Lhi CD8+ T cells to 
upregulate H2AX phosphorylation following ex vivo irradiation.  This may be due 
to contamination of the putative cKO fraction by cells bearing the Cre and floxed 
target allele genotype that nevertheless escaped phenotypic excision and 
deletion of TCF-1 as a consequence of the known incomplete efficiency of the 
CD4-Cre driver utilized in these experiments.  In any event, there does appear to 
be a causal relationship between TCF-1 expression and H2AX phosphorylation,  
to some extent.  The full import of this should be explored in future experiments 
that exploit more efficient Cre driver alleles or fluorescent-reporter strategies to 
exclude false-positive cells that have not completely excised their TCF-1 alleles. 
 
 To further interrogate pathways of genome maintenance, telomerase 
activity was examined in antigen-specific CD8+ T cell subsets during the 
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expansion phase.  After sort-purifying CD62Lhi, IL-7Rαhi, and KLRG1hi subsets, 
telomerase holoenzyme activity was assessed.  The CD62Lhi subset exhibited 
markedly higher telomerase activity than either naïve CD8+ T cells or the CD62Llo 
effector subsets (Figure 3.5). This elevated telomerase activity suggests that the 
CD62Lhi subset acquires multiple genome surveillance and maintenance 
activities following initial activation of naïve precursors. 
 
 The data above suggested that the CD62Lhi subset was endowed with 
greater capacity to withstand and/or respond to DNA damage.  To directly 
interrogate this question in vivo, a genome integrity disruption assay was 
designed.  Mice were infected with LCMV and exposed to the DNA damaging 
agent doxorubicin during the expansion phase at a time point – d6 pi – when all 
three LCMV-specific subsets are robustly dividing.  Doxorubicin exposure 
dampened the expansion of responding LCMV-specific CD8+ T cells in a dose-
dependent manner (Figure 3.6A, bottom), and quantitatively impacted all three 
subsets. The KLRG1hi subset was markedly diminished and the IL-7Rαhi subset 
was modestly enriched (Figure 3.6B).  In contrast, the CD62Lhi subset was 
preferentially resistant to doxorubicin exposure (Figure 3.6B).  Though the 
precise mechanism is unclear, this result is consistent with the restrained 
proliferation of the CD62Lhi subset, its substantial efflux activity, and its superior 
capacity to respond to DNA damage induced by ionizing irradiation ex vivo.  
Together these observations point to genome integrity surveillance and 
maintenance as key properties necessary for a robust CD8+ T cell response to 
infection, and particularly for the generation or survival of the CD62Lhi subset. 
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3.3 Retrotransposon dynamics during T stem cell and T effector 
differentiation 
 
First discovered by Barbara McClintock in the 1940’s, jumping genes or 
transposable/mobile elements are important players in evolution (McClintock, 
1950) and comprise an enormous proportion of mammalian genomes – around 
40%, depending on species (Bodak et al., 2014). Among transposable elements, 
LINE-1’s (long interspersed nuclear element 1, hereafter L1) are particularly 
abundant and the most well-studied.  L1 loci span 6 kilobases and contain a 5’ 
untranslated region with internal promoter activity, and two non-overlapping 
ORFs encoding a chaperone / RNA binding protein and an endonuclease / 
reverse transcriptase.  Roughly 500,000 L1 copies stud the (human) genome, 
comprising about 17% of its total, while 600,000 L1 copies amount to 19% of the 
mouse genome (Bodak et al., 2014).  The passage of time since the initial 
infection and integration into the germline millions of years ago has mutated the 
vast majority beyond any semblance of retrotranspositional competence; 
however roughly 0.02-0.5% of L1 loci have retained the capacity for expression 
and quasi-random genomic reintegration, and are termed “hot”. Copy-and-paste 
retrotransposition can be highly genotoxic if integration events disrupt function at 
a critical locus or introduce gain-of-function mutations in an oncogene, and 
indeed seminal studies have recently implicated L1 activity in the aging process 
(Li et al., 2013) and a substantial percentage of human cancers (Lee et al., 2012; 
Shukla et al., 2013; Ewing et al., 2015).  Because of these deleterious 
consequences, with rare exceptions (Kano et al., 2009), mammalian tissues 
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normally suppress hot L1 loci.  However, recent observations indicate that 
transient derepression may occur consequent to cell division (Abyzov et al., 
2013) or epigenetic remodeling (Klawitter et al., 2016). Given that activated CD8+ 
T cells divide rapidly and extensively (cf. Figure 1.1), and undergo substantial 
epigenetic transformations during effector differentiation (Pauken et al., 2016; 
Scott-Browne et al., 2016), it seemed reasonable to wonder whether L1 
expression, normally tightly controlled, might be perturbed in these cells.   
 
3.3.1 Mobilome matters: effector T cell differentiation is associated with 
derepression of the ancient retrotransposon LINE-1 
 
LINE-1 RNA abundance was measured in naive CD8+ T cells and in the three 
antigen-specific CD8+ T cell subpopulations present during the expansion phase 
of the adaptive immune system’s response to viral infection.  Naive cells 
manifested only background LINE-1 levels.  In contrast, activated, antigen-
specific cells exhibited upregulation of LINE-1, with modest levels in minimally-
differentiated T stem cells, intermediate quantities in intermediately-differentiated 
effector cells, and heightened levels in terminally-differentiated effector cells 
(Figure 3.7, right).  Interestingly, preliminary experiments indicated that this 
pattern of LINE-1 re-expression correlating with effector T cell differentiation 
manifested at both the RNA and DNA levels, suggesting that the dormant L1 
transposon is not only re-expressed at the RNA level, but also continues its 
lifecycle to make protein and reverse transcribe its RNA genome into DNA.  
Given that reverse transcription is usually known to occur in the nucleus via a 
process termed target-primed retrotransposition (Gorbunova et al., 2014), it is 
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very likely that at least some of this DNA is being integrated into the nuclear 
genome.  Irrespective of future experiments to test this hypothesis directly, this 
finding of effector T cell differentiation associated with transposon re-expression 
has implications for basic principles of genome integrity maintenance and 
developmental biology.  Additionally, these observations may also serve as 
platform for several useful experimental and clinical applications including highly 
tractable lineage tracing in vivo and an irreversible, granular biological clock to 
report physiological as opposed to chronological age. 
 
3.3.2 Heightened expression of the antiretroviral cytidine deaminase 
Apobec3 in T stem cells  
 
To preserve genome integrity against the existential threat of mutagenic 
transposition, mammalian cells mount a variety of defenses to suppress 
expression of jumping genes, perhaps most prominently the retroelement 
restriction factor Apobec3 (Esnault et al., 2005; Muckenfuss et al., 2006).  Given 
that T stem cells preferentially express multiple genome integrity maintenance 
activities including telomerase and heightened DSB surveillance, and considering 
the genotoxic threat posed by endogenous retroelements, it is reasonable to 
hypothesize that expression of Apobec3 might be an additional mechanism by 
which CD62Lhi T stem cells maintain genome integrity.  Thus, expression was 
evaluated at the RNA level in naive CD8+ T cells and in the three principal 
antigen-specific CD8+ T cell subpopulations present during the expansion phase 
of the adaptive immune system’s response to viral infection.  Apobec3 
expression was negligible in naive CD8+ T cells but markedly upregulated in T 
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stem cells, and sharply diminished in differentiated, CD62Llo effector CD8+ T cells 
(Figure 3.7, left).  It is notable that within the three principal antigen-specific 
CD8+ T cell subpopulations, this expression pattern of Apobec3 is exactly the 
inverse of that of LINE-1 (described above).  While a role for Apobec3 in 
restricting LINE-1 expression has been published in vitro, to date no evidence for 
this has been uncovered in vivo. Together, these observations of Apobec3 and 
L1 expression lead to the hypothesis, testable in future work making use of 
Apobec3-deficient T cells, that the former has a causal role in regulating the latter 
in vivo, quite possibly in the service of preventing L1 retrotransposition and 
consequent diminished genome integrity.  Additional experimentation should 
address whether there are any consequences to CD8+ T cell function arising 
from unrestrained retrotransposition. 
 
 
3.4 Conclusions 
 
One of the more distinguishing features of these expansion phase CD62Lhi CD8+ 
T cells was the stark upregulation of genome maintenance pathways, as 
evidenced by a superior anticipatory response to irradiation-induced DNA 
damage, a marked increase in telomerase activity, and elevated expression of 
the retrotransposon restriction factor Apobec3a.  One suggestion about stem-like 
memory T cells arising early after stimulation is that such cells simply remain 
more naïve-like and by remaining less differentiated thereby maintain better 
memory potential.  While the CD62Lhi expansion-phase CD8+ T cells studied here 
are indeed more proliferatively quiescent and restrained with respect to the 
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elaboration of a full effector gene expression program, upregulation of genome 
integrity surveillance is a major change distinguishing these cells from naïve or 
subsets of CD62Llo effector CD8+ T cells.  Thus, this CD62Lhi subset does not 
simply remain less differentiated.  Instead, this population acquires a markedly 
different pattern of differentiation compared to naïve, IL-7Rαhi or KLRG1hi cells.  
Proliferative hierarchies subserve tissue homeostasis in many settings of rapid 
cellular turnover including hematopoiesis and epithelial barrier maintenance 
(Weissman, 2000; Simons and Clevers, 2011) and such proliferative hierarchies 
have been previously implicated in effector CD8+ T cell generation (Sarkar et al., 
2008; Buchholz et al., 2013; Gerlach et al, 2013).  The data presented here now 
provide mechanistic understanding for a key feature of this proliferative hierarchy 
in CD8+ T cells in the induction of a genome integrity maintenance circuit.  With 
antigen-driven CD8+ T cells dividing as fast as once every 4 hours during the 
expansion phase, it is likely that much of the genomic damage that occurs is due 
to replication fork errors and/or chromosomal segregation.  It is interesting that in 
other cell types slowing cell division time by as little as 20 minutes can be 
sufficient to allow repair of genomic instability and damage (Sansregret et al., 
2017).  In this respect, while the CD62Lhi subset has divided extensively, its 
slower cell division rate may be an additional feature of the genome integrity-
protective module deployed by these cells. Future studies should evaluate the 
implications of different types of genomic stress on these cells.  A model is 
presented in which the lineage relationships elucidated in the prior chapter are 
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correlated with the genome integrity status inferred from the data presented in 
the present chapter (Figure 3.8). 
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Figure 3.1 
 
 
Figure 3.1: Dynamic regulation of DNA damage response circuitry during antiviral 
CD8+ T cell proliferation & differentiation. The gene ontology term “DNA damage” 
was used to construct a set of genes associated with DNA damage; transcript levels of 
these genes, as measured by oligonucleotide microarrays, were then clustered 
according to the similarity of their transcriptional regulation in antigen-specific CD8+ T 
cells responding to acute viral infection. Splenic T cells were profiled in naïve mice, and 
days 6, 8, 15, and 30 post infection with LCMV-Armstrong (as detailed in Crawford et al., 
2014).  Each row represents a transcript, and each column represents data from a single 
microarray; there are three or four replicates per time point.  It is evident that the 
transcriptional response to DNA damage is dynamically regulated in CD8+ T cells over 
the course of their response to infection. 
d30d15d8d6Naïve
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Figure 3.2 
 
 
 
 
Figure 3.2: Elevated DNA damage in terminally-differentiated, antigen-specific 
CD8+ T cells. Alkaline comet assays indicating extent of chromatin disintegration were 
performed for sorted subsets of splenic, antigen-specific CD8+ T cells isolated at d8 pi 
LCMV-Armstrong.  Naïve CD8+ T cells were used as a negative control; naïve CD8+ T 
cells exposed ex vivo to 250 rads of ionizing irradiation served as a positive control.  
Representative microscopic images of negative control and positive control cells are 
inlaid. 
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Figure 3.3 
 
 
 
 
Figure 3.3: Elevated basal and DNA damage-inducible H2AX phosphorylation in 
antigen-specific T stem cells.  A) Basal phosphorylation of H2AX measured directly ex 
vivo in the indicated LCMV-specific CD8+ T cell subsets isolated at d8 pi LCMV-
Armstrong or naïve CD8+ T cells.  C)  Damage-induced phosphorylation of H2AX in the 
indicated LCMV-specific CD8+ T cell subsets isolated at d8 pi LCMV-Armstrong or naïve 
CD8+ T cells.  Cells were exposed to 250 rads of ionizing radiation ex vivo and then 
incubated at 37°C for 90 minutes. Histograms (left) depict the extent of basal (black 
lines) and irradiation-induced (red lines) pH2AX. Bar graph depicts the inducibility of 
pH2AX, calculated as the difference between the basal and irradiation-induced values.  
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Figure 3.4 
 
 
 
 
Figure 3.4: Diminished basal H2AX phosphorylation in TCF1-deficient T stem 
cells.  Differentially congenic WT P14 CD8+ T cells and P14 CD8+ T cells conditionally 
homozygously deficient for TCF-1 were mixed in a 1:1 ratio and co-transplanted into 
naïve recipient mice. Following infection with LCMV-Armstrong, splenocytes were 
obtained at d8 pi and evaluated flow cytometrically for phosphorylation of the variant 
histone H2AX on antigen-specific WT and cKO CD62Lhi subset cells. 
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Figure 3.5 
 
 
 
 
Figure 3.5: Elevated telomerase activity in antigen-specific T stem cells during 
viral infection. Telomerase activity was assessed by QTRAP assay (see methods) for 
the indicated splenic LCMV-specific CD8+ T cell subsets isolated at d8 pi LCMV-
Armstrong or naïve CD8+ T cells.  Heat-inactivated 293T cells were used as a negative 
control. 
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Figure 3.6 
 
 
 
 
Figure 3.6: Antigen-specific T stem cells preferentially survive genotoxic insult in 
vivo.  A) Top: experimental design for in vivo doxorubicin (dxr) treatment.  Bottom: the 
frequency of donor P14 cells (CD45.1+) with as a function of dxr dose at d8 pi LCMV 
Arm.  B) Fold enrichment or reduction of the frequency of each of the three LCMV-
specific CD8+ T cell subsets of total P14 cells at d8 pi with LCMV Arm in mice treated 
with dxr (8 mg/kg) vs. PBS. treated mice. 
 
  
A
d6 d8
↑
doxorubicin analysis
↓
LCMV
Arm
d0
↓
PBS
dxr
8 mg/kg
dxr
16 mg/kg
CD8
fo
ld
 c
ha
ng
e 
in
 p
op
ul
at
io
n 
fre
qu
en
cy
B
<PE-TxRed-A>: CD8
<P
ac
ifi
c 
B
lu
e-
A
>:
 C
D
45
_1
0.0916
<PE-TxRed-A>: CD8
<P
ac
ifi
c 
B
lu
e-
A
>:
 C
D
45
_1
0.739
<PE-TxRed-A>: CD8
<P
ac
ifi
c 
B
lu
e-
A
>:
 C
D
45
_1
2.66
2.7 0.8 0.1
C
D
45
.1
Fold Change in Subpopulation Prevalence Following Doxorubicin Treatment
CD
62
L
hi  C
D2
7
hi  K
LR
G1
lo  C
D1
27
hi
CD
62
L
lo  K
LR
G1
lo  C
D1
27
hi
CD
62
L
lo  K
LR
G1
hi  C
D1
27
lo
-1
0
1
2
3
fo
ld
 c
ha
ng
e 
in
 p
op
ul
at
io
n 
fre
qu
en
cy
 
2012.12.23: d8-LCMV.Arm after d5.5 Doxorubicin treatment
2012.12.23: d8.6-LCMV.Arm, gated on CD45.1+ GP33+.
Doxorubcin treatment (200 µg in 100 µL volume) was administered i.v. on d5.625 pi.
Here, fold changes are calculated as frequency of population in untreated vs treated mouse.
[2013.10.08 re-analysis]
	 105	
Figure 3.7 
 
 
 
 
Figure 3.7: Elevated expression of the retroelement restriction factor Apobec3 in 
antigen-specific T stem cells correlates with relaxed suppression of the ancient 
retrotransposon LINE-1 during antiviral CD8+ T cell differentiation.  RNA isolated 
from subsets of P14 splenocytes sorted at 8 pi LCMV-Armstrong was used for qPCR 
analysis of the abundance of Apobec3 and LINE-1 mRNA. 
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Figure 3.8 
 
 
 
 
Figure 3.8: Model for effector and memory T cell differentiation and 
dedifferentiation including genome integrity.  N.b. the schematic above is an 
elaboration of Figure 2.16; here, the parameter of genome integrity is considered.  A 
naïve T cell is activated by encounter with cognate antigen in the context of 
immunological danger and gives rise to a clonal stem cell hierarchy marked by 
increasing proliferation, progressive cytotoxic effector differentiation, and diminishing 
genome integrity (underlying “power bars” in red and black; these refer to multiple 
aspects of genome integrity, including telomere length, unresolved or misrepaired 
double strand breaks, proliferation-induced point mutations, and putative activation-
induced retrotransposon retro-integration events).  Following antigen elimination and the 
resolution of acute infection, terminally-differentiated effector cells (red) largely commit to 
apoptosis, whereas intermediately effector-differentiated transient-amplifying / memory 
precursor cells (green) gradually reacquire the stemness of their progenitors (blue).  In 
the post-antigen phase, the pool of memory T cells, composed of TSC and TSC’ 
populations, is heterogeneous with respect to proliferative past and history of effector 
differentiation, and putatively as well in terms of genome integrity (which corresponds to 
a multitude of potential parameters, including accumulated mutations, retrotransposion 
reintegrations, single and double strand breaks, and telomere length). 
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.:: CHAPTER 4 ::. 
 
SIGNAL FLUX IN AND SIGNALING-DEPENDENT ABUNDANCE 
OF T STEM CELLS; IMPLICATIONS FOR IMMUNOTHERAPY 
 
4.1 Command and control: multifactorial regulation of T cell function 
 
That T cells are equipped with tremendously potent effector mechanisms with the 
potential to profoundly remodel organismal physiology is perhaps most saliently 
manifest in recent reports of cancer immunotherapies, wherein therapeutic 
manipulation of T cell function in human patients has been shown to precipitate 
dramatic and durable remissions of even large or disseminated tumors in a highly 
specific manner and with minimal off-target pathophysiology (Figure 4.1).  
Conversely, the destructive potential of T cells is equally apparent, as evidenced 
by the profound burden of suffering borne by those afflicted with autoimmune 
disorders, many of which are T cell-dependent (Bluestone et al., 2010).  
Accordingly, 500 million years of evolution since the dawn of adaptive immunity 
have conspired to construct an elaborate apparatus regulating T cell functionality 
such that these cells’ considerable physiological force maximally subserves 
organismal fitness and minimizes the potential for mischief.  An overarching 
research aim for decades has been to decipher this regulatory regime, both to 
better understand basic immunological phenomena as well to develop the ability 
to rationally manipulate immune function for prophylactic and therapeutic ends. 
 
 A leading model to explain the regulation of lymphocyte function posits 
that they integrate both positive and negative micro-environmental signals that as 
a whole conduce to either activation (initial or continued) or inhibition.  This 
notion originated in the so-called “two signal” hypothesis (Bretscher and Cohn, 
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1970; Lafferty et al., 1974) that was subsequently elaborated by Janeway and 
Matzinger, and which held that in order to spring forth from dormancy into 
concerted action, lymphocytes required not only recognition of their cognate 
antigen, but also receipt of a second, “costimulatory” signal to provide contextual 
information, such as whether the antigen in question was initially encountered in 
a pathological or physiological scenario (e.g., respectively, a potentially 
dangerous viral infection, or a foreign yet nevertheless innocuous food substance 
in the gastrointestinal tract).  Since then a variety of additional classes of signals 
have been recognized that complexify the original model, such that not just two 
but rather multiple external signals are sensed and interpreted by lymphocytes in 
a manner that enables a nuanced, highly calibrated response to prevailing 
environmental conditions (Smith-Garvin et al., 2009).  The molecular nature of 
these signals and their mechanisms of transduction has been elucidated in 
increasing detail in recent years (Attanasio and Wherry, 2016).  However, from a 
cellular perspective, it remains very much unclear the extent to which any given 
signal is sensed by and directs the function of the many subsets of lymphocytes 
known to exist.  For example, CD28 is a prominent receptor of costimulatory 
signals that enhance TCR- (i.e., antigen) induced proliferation of T cells.  
However, since its identification in the early 1980’s, it’s become clear that CD28 
is not uniformly expressed on T cells. Instead, there can be a broad range of 
expression on different T cell subsets, suggesting that signals transduced by 
CD28 and a rapidly growing list of related molecules may differentially impact 
cells depending on T cell subtype. 
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 Here, these matters are explored with respect to the CD62Lhi T stem cell 
population whose isolation and initial characterization was detailed in previous 
chapters.  Therein, this rare population of cells was shown to be uniquely potent, 
for example with respect to the capacity to generate legions of cytotoxic effector 
cells.  How is this power engaged, directed, and regulated?  Data are presented 
in this chapter indicating that T stem cells highly express a panoply of sensors for 
multiple classes of signals, both activating and inhibitory. Far from being inert 
with respect to signaling, as originally envisioned given their relative proliferative 
quiescence, T stem cells instead appear to be remarkably sensitive to and 
interconnected with their environments.  Unexpectedly, this quantitatively minor 
subset may in fact reside at an cellular signaling nexus that can powerfully initiate 
immune responses de novo, or potentiate or terminate existing ones. 
 
 
4.2 Anatomic localization of T stem cells 
 
While environmental signals and the intracellular interpretation thereof are 
important for all cells, they appear to be particularly pertinent for stem/progenitor 
cells whose decisions regarding state and fate commitments impact not only 
themselves but also many multitudes of downstream progeny cells and all the 
various cells and tissues with which those cells interact.  Moreover, perhaps due 
to their unique requirements for life-long persistence and generative output, stem 
cells rely considerably on external inputs from neighboring cells, for example in 
terms of signals and nutrients that minimize cellular stress and promote survival 
(Mendez-Ferrer et al., 2010).  This notion that stem cells function not strictly 
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autonomously in an amorphous void but rather exist in and depend upon a 
biologically-defined niche was originally proposed in an attempt to explain 
discrepancies between predicted and observed behavior in hematopoietic stem 
cells isolated from different anatomic locations (Schofield, 1978). Decades later, 
demonstration and cellular delineation of stem cell niches – first in Drosophila 
ovaries (Xie and Spradling, 2000) and subsequently in multiple rodent tissues 
(Lander et al., 2012) – substantiated this hypothesis and cemented the modern 
concept that niches are micro-environments with specific compositions of 
supporting cell types, hormones, nutrients, mechanical forces, and gas tensions 
(Simon and Keith, 2008; Mendez-Ferrer et al., 2010; Sun et al., 2012).  Together, 
this surrounding ensemble sustains stem cell populations and helps modulate 
their delicate balance between self-renewal and terminal differentiation.  
Therefore, understanding stemness includes but extends well beyond merely 
isolating and studying stem cells themselves. In short, anatomy matters.  
 
 To begin to understand the environmental circumstances in which T stem 
cells exist and that might bear on understanding mechanisms by which they are 
regulated, a gross anatomical survey of the abundance of CD62Lhi T stem cells 
was undertaken.  The CD62Lhi population was rare but evident in all tissues 
examined 8 days pi with LCMV, and present at the highest frequency in lymph 
nodes (Figure 4.2A).  Beyond gross anatomy, the micro-anatomical residence of 
the three virus-specific CD8+ T cells subsets was analyzed in the spleen using 
intravascular antibody labeling, a technique that indicates localization in the 
blood-accessible splenic red pulp relative to the blood-inaccessible, lymphoid 
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white pulp (Galkina et al., 2005; Anderson et al. 2014).  Evident was a clear a 
hierarchy of labeling (Figure 4.2B).  As a reference point, naïve CD8+ T cells 
exhibited the lowest extent of intravascular labeling, reflecting the known 
residence of these cells in the white pulp (Figure 4.2B).  The two CD62Llo 
effector CD8+ T cell subsets were highly labeled, indicating homing to the red 
pulp and consistent with previous observations (Jung et al., 2010; Seo et al., 
2016).  In contrast, the CD62Lhi subset exhibited intermediate intravascular 
antibody labeling, indicating preferential localization to the lymphoid white pulp 
among the three antigen-specific CD8+ T cell subsets (Figure 4.2B).  This is 
consistent with the preferential lymph node localization of the CD62Lhi subset 
(Figure 4.2A), and suggests the possibility that effector and memory CD8+ T cell 
differentiation might correlate with anatomical positioning.  Indeed, recent studies 
have indicated that T cells localized to the white pulp during the expansion phase 
have greater potential to contribute to immunological memory than those in the 
red pulp (Seo et al., 2016).  Moreover, these gross- and micro-anatomical 
patterns of lymphoid-biased residence evident in the CD62Lhi subset were 
paralleled by pronounced expression of CXCR3 and CXCR5 (Figure 4.3), 
localization molecules associated with memory and progenitor T cell biology, 
respectively (Sung et al., 2012; Im et al., 2016).  Simultaneously, the CD62Lhi 
subset exhibited very low expression of CX3CR1 (Figure 4.3), a localization 
factor associated with effector T cell differentiation (Gerlach et al., 2016).  The 
CD62Lhi subset also highly expressed CD69 (Figure 4.3), a molecule that 
strongly promotes lymphoid localization (Mackay et al., 2015), together with 
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CXCR5.  Thus, the expansion phase CD62Lhi subset resides preferentially in 
specific gross- and micro-anatomical regions, namely those with lymphoid 
character.  Coincidentally, this geography is matched by expression of molecules 
that drive lymphoid homing.  Together, these anatomical and molecular features 
distinguish the CD62Lhi T stem cell subset from the two CD62Llo subsets as well 
as from precursor naïve T cells, and suggest that it is distributed not randomly 
but instead in a defined niche.  This is likely to be important for committing to and 
sustaining memory and progenitor fate decisions. 
 
 
4.3 T stem cells’ TCR signaling flux and sensory apparatus 
 
That T stem cells exhibited unique patterns of both localization (Figure 4.2) and 
proliferation (Figure 2.8) suggested possible differences in signal reception 
and/or transduction.  To assess whether CD62Lhi T stem cells exhibited evidence 
of differential stimulation during the expansion phase relative to the other 
subsets, Nur77-GFP reporter mice were exploited.  In this construct, GFP 
expression reflects recent TCR stimulation (Moran et al., 2011). GFP expression 
was readily apparent, yet similar, in the two LCMV-specific CD62Llo effector 
CD8+ T cell subsets at d5 pi (Figure 4.4).  In contrast, CD62Lhi T stem cells 
expressed considerably higher GFP than either of the two CD62Llo subsets, 
suggesting stronger and/or more recent TCR signal transduction (Figure 4.4).  In 
point of fact, this indication of stronger stimulation was reflected in elevated 
expression on the CD62Lhi subset of CD3 and CD8 (Figure 4.5), essential 
elements of the TCR signal transduction complex. This was also the case for 
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CD28 (Figure 4.6), the stereotypical immunoglobulin (Ig) superfamily receptor for 
costimulatory signals that plays critical roles in both the initiation of T cell 
responses as well as in the therapeutic potentiation thereof in the context of 
immunotherapies for cancers and chronic viral infections (Hui et al., 2017; 
Kamphorst et al., 2017). The preferential expression by CD62Lhi cells of CD28 
was matched by a similar pattern of expression of a bevy of additional 
costimulatory receptors, including CD27, ICOS, and GITR (Figure 4.6). What is 
more, CD62Lhi cells also robustly expressed receptors for multiple additional 
classes of stimulatory signals, including those denoting inflammatory state (aka 
signal 3, Figure 4.7) and licensing help from kindred lymphocyte populations 
(e.g. CD4+ T cells and/or B cells; Figure 4.8).  Together, these observations 
indicate that T stem cells, relative to their downstream CD62Llo progeny, are both 
exceptionally sensitive to their environmental surroundings and also robustly 
transduce signals therefrom. 
 
 The simultaneous observations of heightened receptivity to stimulatory 
signals in tandem with elevated expression of the downstream Nur77 
transcription factor appeared paradoxical given the relatively attenuated 
proliferation of the CD62Lhi subset (Figure 2.8A-C).  Recent studies have 
demonstrated that expansion-phase CD8+ T cells in the white pulp exhibit lower 
two-dimensional effective affinity relative to CD8+ T cells in the red pulp (Seo et 
al., 2016).  The CD62Lhi T stem cell subset was enriched in the white pulp, but 
appeared to receive stronger stimulation, rather than the weaker stimulation that 
would be predicted based on lower effective affinity unless these cells possessed 
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a mechanism to limit the effects of TCR stimulation.  One way by which T cells 
modulate their sensitivity to antigen signaling is by deploying expression of 
inhibitory receptors that attenuate stimulatory signals.  For example, one 
prominent such receptor is CTLA-4, first established as a negative regulator of T 
cell function more than two decades ago (Walunas et al., 1994; Krummel and 
Alison, 1995).  CTLA-4, absent on naïve T cells, is rapidly expressed on the 
surface of T cells following activation and is upregulated by ligation of CD28.  
Engagement of CTLA-4 can dampen the amplitude of T cell responses by 
disrupting AKT signaling and/or by outcompeting CD28 for its activating ligands, 
in either case restraining costimulation and overall T cell functionality (Parry et 
al., 2005). The essentiality of this restraint in maintaining self-tolerance and 
limiting collateral tissue damage during immune responses is manifest in the 
severe autoimmunity induced by pharmacological blockade of CTLA-4 in the 
context of human anti-cancer immunotherapies, and in the lymphoproliferation 
and lethal, multiorgan immunopathology that rapidly emerge in mice genetically 
deficient for CTLA-4 (Tivol et al., 1995). 
 
 Given that CD62Lhi cells exhibit such a strongly activated phenotype, and 
since CTLA-4 is such an important regulator of T cell function, its expression was 
evaluated during the expansion phase of viral infection. A hierarchy of expression 
existed in LCMV-specific CD8+ T cell subsets: interestingly, the CD62Lhi subset 
expressed the highest amount of CTLA-4, whereas progressive effector 
differentiation in the two CD62Llo subsets was associated with lower CTLA-4 
abundance (Figure 4.9).  This pattern of expression was evident for multiple 
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additional inhibitory receptors, including PD-1 and LAG-3, which act as rheostats 
to tune antigen-responsiveness in peripheral tissues (Okazaki et al., 2013; 
Honda et al., 2014), and CD5, an additional negative regulator of T cell signaling 
whose expression has been shown to be proportional to TCR signaling strength, 
at least in the thymus (Azzam et al. 1998) (Figure 4.9).   
 
 The elevated expression of PD-1 on the CD62Lhi subset was particularly 
remarkable, given the rich biological and clinical context in which this molecule is 
situated.  A member of the CD28 Ig receptor superfamily, PD-1 shares a number 
of inhibitory features with CTLA-4, yet differs from it in several structural and 
mechanistic respects (Parry et al., 2005).  Functionally, PD-1 attenuates T cell 
function both by antagonizing TCR signaling (Okazaki et al., 2013) and by 
disrupting CD28-mediated costimulatory signals (Hui et al., 2017, Kamphorst et 
al., 2017).  PD-1 is expressed primarily on leukocyte populations, while its ligand 
PD-L1 can be upregulated by IFNγ signaling in multiple cellular lineages, 
including both hematopoietic and epithelial cells.  Notably, pharmacological 
blockade of the PD-L1—PD-1 signaling axis can dramatically potentiate 
suppressed T cell responses to persisting pathogens in the context of chronic 
microbial infections (Barber et al., 2006) and cancers (Topalian et al., 2015).   
 
 Intriguingly, when PD-L1 expression was measured in subsets of antigen-
specific CD8+ T cells during the expansion phase of viral infection, a pattern 
similar to that of PD-1 was detected (Figure 4.10A). Specifically, among antigen-
experienced T cells, the CD62Lhi subset expressed the greatest amount of PD-
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L1, whereas PD-L1 expression was diminished in CD62Llo subsets.  When the 
CD62Lhi population was itself subsetted based on its heterogeneous expression 
of PD-1 (Figure 4.9), higher PD-L1 expression was observed on the 
subpopulation of CD62Lhi cells that expressed more PD-1, indicating that both 
the PD-1 inhibitory receptor and its ligand are simultaneously expressed by 
CD62Lhi T stem cells (Figure 4.10B). 
 
 In summary, attenuated proliferation during the expansion phase and 
constrained effector differentiation of the CD62Lhi subset despite elevated TCR 
signaling (as evidenced by Nur77 expression) and activation status (expression 
of CD69, as well as additional markers such as CD11a and CD38 – cf. Figure 
2.5) is associated with heightened expression of a constellation of inhibitory 
receptors known to restrain T cell activation and terminal differentiation.  In at 
least one instance, this robust inhibitory receptor expression is paralleled by 
similarly pronounced expression of its own ligand, underscoring the depths to 
which inhibition and restraint may be fundamentally important themes in the lives 
of CD62Lhi T stem cells. 
 
	
4.4 Sensitivity to Strength of Stimulus 
 
Given the multiple indications that CD62Lhi T stem cells appeared to be a focal 
point for the sensing of environmental cues, it was important to explore this 
notion further and ask whether varying the strength of signaling inputs might 
have functional consequences. For example, at least at the level of bulk (i.e. 
unsubsetted) antigen-specific CD8+ T cell populations, it has been established 
	 117	
that strength of TCR signaling impacts the balance of effector vs. memory fate 
commitment decisions (Marzo et al., 2005; Sarkar et al., 2007; Sarkar et al., 
2008).  Thus it was of interest to ask whether the abundance of the CD62Lhi 
subset varied in populations of endogenous, epitope-specific CD8+ T cell 
populations that are known to receive different amounts of stimulation (Sarkar et 
al., 2007).  Consistent with the notion that subdominant responses receive less 
stimulation, a higher frequency of the CD62Lhi subset was evident in the 
subdominant GP276-specific response compared to the more dominant GP33- or 
NP396-specific responses (Figure 4.11A).  To examine the relationship between 
the CD62Lhi subset and strength of TCR stimulation in more detail, graded doses 
of naïve P14 CD8+ T cells were transplanted into naïve recipient mice, and these 
chimaeras were then infected with LCMV.  Supra-physiological numbers of TCR-
transgenic CD8+ T cells are known to increase competition between responding 
cells for stimulatory signals, thereby decreasing the average stimulation available 
to any given T cell (Butz and Bevan, 1998; Marzo et al., 2005).  Indeed, with 
increasing dose of transferred naïve P14 cells, a higher frequency of the CD62Lhi 
subset was observed at d8 pi (Figure 4.11B), consistent with previous studies 
(Wherry et al., 2003; Marzo et al., 2005; Sarkar et al., 2007).  This pattern was 
paralleled by increased expression of CD62L itself within CD62Lhi cells (Figure 
4.11B), as well as decreased expression within the overall antigen-specific P14 
“tissue” of the effector-differentiation-promoting transcription factor Blimp-1 
(Figure 4.11C).  Additionally, the enhanced emergence of the CD62Lhi subset in 
the context of attenuated strength of stimulation also corresponded to an 
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increase in the frequency of cells that had proliferated to a lesser extent, as 
indicated by incomplete CTV dilution (Figures 2.8A, bottom, and 2.8B, right).  
Thus, CD62Lhi T stem cells are characterized by superlative signal flux, and this 
matters functionally: attenuated strength of external antigen signals impacted the 
proliferation and differentiation state of CD62Lhi cells, and increased their 
frequency amongst total populations of epitope-specific CD8+ T cells. 
 
 
4.5 Compromise of T stem cell compartment consequent to genetic 
deficiency of inhibitory receptors 
 
Given that attenuating signal strength potentiated T stem cells, it was of interest 
to determine whether intensifying signal strength might have the opposite effect. 
That unperturbed T stem cells naturally experience high signal flux (Figure 4.4) 
even while robustly expressing a formidable array of signal-attenuating factors 
(Figures 4.9 and 4.10) renders this question particularly salient – could 
increased strength of signaling deleteriously impact T stem cells?  To address 
this possibility, P14 CD8+ T cells were generated to be genetically deficient for 
the inhibitory receptor PD-1.  Naïve WT and PD-1-deficient P14 cells were mixed 
together in a 1:1 ratio and co-transplanted into recipient mice, and these 
chimaeras were subsequently exposed to viruses that generate acutely-resolving 
infections (Figure 4.12A).  In the settings of Flu and LCMV-Armstrong infections 
administered intranasally, the splenic PD-1-deficient CD62Lhi T stem cell 
population was diminished at d8 pi, consistent with the hypothesis; however, this 
phenotype was not observed following intraperitoneal infection with LCMV-
Armstrong (data not shown).  Though the explanation for the dependence of the 
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phenotype upon route of infection is unclear, intranasal but not intraperitoneal 
infection can engender presentation of processed viral antigen that persists for 
months after replication-competent virus has been cleared, resulting in long-
lasting T cell stimulation (Zammit et al., 2006; Takamura et al., 2010). These 
considerations are consistent with the notion that signal strength may be toxic to 
T stem cells above a certain threshold, and that this threshold was exceeded by 
the overall integration of the strength and duration of signaling in intranasally- but 
not intraperitoneally-initiated infections.  To probe this hypothesis, a strategy was 
devised to further intensify signal strength within the context of an 
intraperitoneally-initiated infection by ablating expression of an additional signal-
attenuating factor.  Accordingly, P14 CD8+ T cells were generated to be 
simultaneously deficient for PD-1 and LAG-3, a CD4-homologous inhibitory 
receptor with a known role in restraining the proliferation of activated T cells 
during viral infections, both per se (Workman et al., 2004) and in synergistic 
cooperation with PD-1 (Blackburn et al., 2009).  Hence, the aforementioned 
experiment was repeated using doubly-IR-deficient P14 cells and LCMV infection 
initiated via the intraperitoneal route.  In this setting, doubly-IR-deficient CD8+ T 
cells expanded to a greater extent than did WT cells; however, the IR-deficient 
CD62Lhi T stem cell compartment was markedly diminished (Figure 4.12B).  
Thus, T stem cells appear to be programmatically equipped to sense and 
transduce strong environmental signals, including at the high levels that attend 
the mitotic maelstrom of the expansion phase of microbial infections.  However, 
intensifying the strength of this signaling eventually overwhelms the buffering 
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mechanisms that T stem cells deploy to maintain a careful balance between self-
renewal, terminal differentiation, and death: in the absence of a single inhibitory 
receptor – PD-1 – T stem cell viability is compromised in some (intranasally-
introduced infections) but not all scenarios.  When signal attenuation capacity is 
further undermined by combined inhibitory receptor deficiency, T stem cells 
appear invariably diminished.   
 
 
4.6 Conclusions and Future Directions 
 
By way of heightened expression of multiple classes of signal receptors, and to a 
greater extent than other subsets, CD62Lhi T stem cells were observed to be 
highly sensitive to environmental cues.  The full import of this observation 
remains undefined; however, given CD62Lhi cells’ role as progenitors that spawn 
abundant downstream progeny upon demand, exquisite environmental sensitivity 
on the part of these cells makes sense in terms of carefully calibrating T 
lymphopoietic output with organismal requirements.  I.e., to either activate or 
amplify, or alternatively to attenuate or terminate T cell responses to pathogenic 
perturbations, it is not difficult to envision multiple signals conveying either peril 
or calm efficiently converging on T stem cells, which in turn respond by 
escalating or diminishing proliferative output. 
 
 In the studies herein, the expression of  a broad range of signal receptors 
(and various regulators thereof) has been measured.  Future work should 
undertake a comprehensive transcriptomic and proteomic survey to grasp the full 
breadth of T stem cells’ signaling sensitivity.  This is important for both basic 
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understanding of T cell immunobiology, as well as for the design of 
immunomodulatory therapeutics and prophylactics.  For example, T stem cells 
robustly express the receptor for IL-18, a a potent proinflammatory cytokine.  
Leukocytes and other cells utilize multiple additional factors to signal 
inflammatory status, including IL-12, ΙFNα, and IFNγ. Do T stem cells express the 
apparatus necessary to sense and interpret these signals?  If so, how do each of 
these cells influence T stem cell fate and state, especially with respect to 
balancing proliferation versus quiescence, or self-renewal versus differentiation?   
Of note, T stem cells robustly express Sca-1 (Figure 2.5), which is known to play 
an important role in the transduction of IFNα signaling (Essers et al., 2009).  
Furthermore, hematopoietic stem cells, from which T stem cells ultimately derive, 
and with which they very likely overlap transcriptionally (Luckey et al., 2006; Im et 
al., 2016), are highly sensitive to both IFNα and IFNg and modulate their 
proliferative output in response to those signals (Essers et al., 2009; Baldrige et 
al., 2010).  Additional signals known to be important in shaping memory and 
effector T cell fate commitment decisions include the anti-inflammatory molecule 
IL-10 (Laidlaw et al., 2015) and the alarmin IL-33 (Bonilla et al., 2012).  It is likely 
that T stem cells express receptors for these signals, perhaps quite robustly; this 
possibility should be empirically determined. 
 
 Beyond local agents, organism-wide parameters and behaviors have been 
associated with various immunological outcomes of interest, and separately with 
specific signaling events.  For example, emerging evidence suggests that 
moderate (but not exhaustive) exercise can enhance responsiveness to 
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vaccination against a variety of viral pathogens, including varicella zoster virus 
(Irwin et al., 2007) and  influenza (Kohut et al., 2004; Hallam and Kohut 2013.  
Intriguingly, musculature has recently been appreciated as a facultative 
endocrine tissue that – exclusively in the context of physical exertion – secretes a 
variety of hormones (called “myokines”) that can potently remodel organismal 
physiology (Rao et al., 2014; Schnyder and Handschin, 2015).  It is worth noting 
that one such myokine is IL-15 (Rinnov et al., 2015); that IL-15 is critical for the 
homeostatic proliferation and long-term maintenance of CD8+ T cell memory 
(Goldrath et al., 2002); and furthermore that CD62Lhi T stem cells very highly 
express CD122 (Figure 2.5), a key component of the IL-15 receptor complex.  
Future work should empirically probe whether these coincidences arise from 
mechanistic intersections.  Overall, given the desirability of understanding the 
interplay between unfolding adaptive immune responses and both proximal and 
broader environmental cues, and of enhancing immune responses to both 
prophylactic and therapeutic modulations, it will be important to achieve a 
comprehensive grasp of the signaling sensitivity of T stem cells. 
 
 Irrespective of breath of environmental sensitivity, it is readily apparent 
that CD62Lhi T stem cells are acutely responsive to external signals. They may 
therefore deploy inhibitory receptors to prevent over-stimulation and consequent 
depletion (via excessive terminal differentiation and/or death).  This notion is 
borne out in the compromised T stem cell compartment that is observed in the 
genetic absence of inhibitory receptors.  The longer-term functional implications 
of this result for immunological memory formation remain to be established; 
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however, given that stem cells are essential for long-term tissue homeostasis, 
especially in the context of constitutive or on-demand rapid turnover (cf. Chapter 
1), it is challenging to envision constructive outcomes with respect to overall 
organismal homeostasis and immunocompetence.  What is more, clinical anti-
cancer treatment strategies are currently being contemplated or developed that 
entail permanent incapacitation of PD-1 function, and/or transient suppression of 
not just one but multiple signal-attenuation factors in T cells (Wolchock et al., 
2013; Liu et al., 2015; Nolan et al., 2017).  These efforts may conceivably 
conduce to control of tumors refractory to other treatment modalities and are 
worthy of consideration; however, the possibilities of T stem cell toxicity and likely 
consequent accelerated immunosenescence and immunodeficiency must not be 
discounted, and should be carefully monitored and weighted in the strategic cost-
benefit calculus.  This is important both for the treatment of primary tumors, and 
for engendering the immunological memory that may be necessary to prevent 
future cancer recurrence. 
 
 
  
	 124	
Figure 4.1 
 
 
 
Figure 4.1: Proof-of-principle of curative immunotherapy for advanced cancer.  A 
patient was treated with immunotherapy for a bulky, ulcerating, metastatic tumor.  The 
therapy elicited a complete regression that endured for at least five years. Reproduced 
with permission from: Crompton JG, Sukumar M, and Restifo NP. Uncoupling T cell 
expansion from effector differentiation in cell-based immunotherapy. Immunol 
Rev. 2014 Jan; 257(1):264-76. 
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Figure 4.2 
 
 
 
 
Figure 4.2: Gross- and micro-anatomical analysis reveals preferential lymphoid 
localization of antigen-specific CD62Lhi T stem cells during the CD8+ T cell 
expansion phase of viral infection. A) Frequency of the CD62Lhi subset of CD8+ T 
cells (among total P14 cells) in various tissues at d8 pi LCMV-Armstrong. B) 
Accessibility to splenic blood compartment (i.e. red pulp) of the different LCMV-specific 
CD8+ T cell subsets by intravascular antibody staining at d8 pi LCMV. 
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Figure 4.3 
 
 
 
 
Figure 4.3: Expression of localization molecules on antigen-specific CD8+ T cell 
subsets during the expansion phase of the CD8+ T cell response to viral infection. 
Along with naïve CD8+ T cells, subsets of splenic, GP33-specific CD8+ T cells were 
evaluated at d8 pi LCMV-Armstrong by flow cytometry for expression of CXCR3, 
CX3CR1, CXCR5, and CD69. 
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Figure 4.4 
 
 
 
 
Figure 4.4: Expression of the signal-strength reporter Nur77GFP in subsets of 
antigen-specific CD8+ T cells. P14 CD8+ T cells transgenic for a GFP reporter of the 
TCR-signaling strength-responsive locus Nur77 were transplanted into naïve recipient 
mice.  Following infection with LCMV-Armstrong, subsets of P14 splenocytes were flow-
cytometrically evaluated for GFP expression at d5 pi. 
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Figure 4.5 
 
 
 
 
Figure 4.5: Signal 1 -- Robust expression of antigen receptor factors on antigen-
specific T stem and progenitor cells during the expansion phase of the CD8+ T cell 
response to viral infection. Subsets of GP33-specific splenocytes were flow-
cytometrically evaluated at d8 pi LCMV-Armstrong for expression of the antigen co-
receptor CD8, and CD3, the signal-transducing constituent of the antigen receptor. 
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Figure 4.6 
 
 
 
Figure 4.6: Signal 2 -- Robust expression of multiple costimulatory receptors on 
antigen-specific T stem and progenitor cells during the expansion phase of the 
CD8+ T cell response to viral infection. Subsets of GP33-specific splenocytes were 
flow-cytometrically evaluated at d8 pi LCMV-Armstrong for expression of the co-
stimulatory receptors CD27, CD28, ICOS, and GITR. 
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Figure 4.7 
 
 
 
Figure 4.7: Signal 3 -- Elevated expression of IL-18R on antigen-specific T stem 
and progenitor cells during the expansion phase of the CD8+ T cell response to 
viral infection. Subsets of GP33-specific splenocytes were flow-cytometrically 
evaluated at d8 pi LCMV-Armstrong for expression of the receptor for the inflammatory 
cytokine IL-18. 
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Figure 4.8 
 
 
 
 
Figure 4.8: Signal 4 -- Elevated expression of IL-21R on antigen-specific T stem 
and progenitor cells during the expansion phase of the CD8+ T cell response to 
viral infection. Subsets of GP33-specific splenocytes were flow-cytometrically 
evaluated at d8 pi LCMV-Armstrong for expression of the IL-21 receptor.  As an internal 
positive control, expression of IL-21R on B cells is depicted in the histogram overlaid in 
yellow. 
 
  
IL-21R
T N
ai
ve T S
C MP TE
0
100
200
300
400
500
IL
-2
1R
 M
FI
Ag-Specific & Polyclonal IL-21R Expression
<PE-Cy5-A>: IL-21R
GP33+ histogram overlays from mouse #2
d8 pi LCMV-Arm; spleen; n=5; gated on CD8+ GP33+
<PE-Cy5-A>: IL-21R
<PE-Cy5-A>: IL-21R
CD8+ GP33+ 
polyclonal CD8+
polyclonal CD4+
note: yellow histograms = B cells
IL-21R
blue = KLRG1lo CD127hi CD44hi CD62Lhi
red = KLRG1hi CD127lo CD44hi CD62Llo
blue = CD127hi CD44hi CD62Lhi
red = CD127lo CD44hi CD62Llo
* *
ns
T N
ai
ve T S
C MP TE
0
100
200
300
400
500
IL
-2
1R
 M
FI
Ag-Specific & Polyclonal IL-21R Expression
-Cy5-A>: IL-21R
GP33+ histogram overlays from mouse #2
d8 pi LCMV-Arm; spleen; n=5; gated on CD8+ GP33+
<PE-Cy5-A>: IL-21R
<PE-Cy5-A>: IL-21R
CD8+ GP33+ 
polyclonal CD8+
polyclonal CD4+
note: yellow histograms = B cells
IL-21R
blue = KLRG1lo CD127hi CD44hi CD62Lhi
red = KLRG1hi CD127lo CD44hi CD62Llo
blue = CD127hi CD44hi CD62Lhi
red = CD127lo CD44hi CD62Llo
* *
ns
IL
-2
1R
 (
M
FI
)
	 132	
Figure 4.9 
 
 
 
 
 
Figure 4.9: Heightened expression of multiple inhibitory receptors on antigen-
specific T stem and progenitor cells during the expansion phase of the CD8+ T cell 
response to viral infection. Subsets of GP33-specific splenocytes were flow-
cytometrically evaluated at d8 pi LCMV-Armstrong for expression of the signal-
attenuating inhibitory receptors PD-1, LAG-3, CTLA-4, CD5, and VISTA. 
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Figure 4.10 
 
 
Figure 4.10: Heightened expression of PD-L1 on expansion-phase antigen-specific 
T stem cells and coordinate regulation of the PD-1/PD-L1 receptor-ligand pair 
therein. A) Naïve CD8+ T cells and subsets of GP33-specific splenocytes were flow-
cytometrically evaluated at d5 pi LCMV-Armstrong for expression of PD-L1, the ligand of 
the inhibitory receptor PD-1.  B) The CD62Lhi T stem cell population (blue bar), 
heterogeneous with respect to PD-1 expression, was subsetted based on high (orange 
bar and histogram) and low (purple bar and histogram) expression of PD-1. PD-L1 was 
then examined in these PD-1high/low subsets. 
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Figure 4.11 
 
 
 
 
Figure 4.11: Attenuation of signaling strength diminishes antiviral CD8+ T cell 
effector differentiation and augments T stem and progenitor cell abundance.  A) 
Frequency of the splenic CD62Lhi subset at d8 pi for endogenous, non-TCR transgenic, 
virus-specific CD8+ T cell populations specific for LCMV DbNP396-404, DbGP33-41, DbGP276-
286.  B-C) Naïve P14 CD8+ T cells of increasing numbers (from 2 x 103 up to 2 x 106) 
were transplanted into groups of recipient mice. Following infection with LCMV-
Armstrong, splenocytes were obtained at d8 pi and evaluated flow cytometrically. B) 
Expression of cardinal markers of effector and memory differentiation (left), and 
frequency of the CD62Lhi subset as a function of the abundance of naïve precursor P14 
cells transplanted prior to viral infection.  C) Expression in the total P14 population of a 
YFP reporter of Blimp-1 expression as a function of naïve P14 precursor abundance. 
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Figure 4.12 
 
 
 
 
Figure 4.12: Diminished antigen-specific T stem/progenitor compartments in acute 
viral infection consequent to deficiency of inhibitory receptors.  A) Experimental 
design: differentially congenic WT P14 CD8+ T cells and P14 CD8+ T cells genetically 
deficient for inhibitory receptors were mixed in a 1:1 ratio and co-transplanted into naïve 
recipient mice. B) Following intraperitoneal infection with LCMV-Armstrong, PBMC were 
obtained at d8 pi and evaluated flow cytometrically for the subset composition of WT 
P14 cells, and P14 cells doubly-deficient for PD-1 and LAG-3 (“dKO”). 
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.:: CHAPTER 5 ::. 
 
PERSPECTIVE 
 
5.1 Summation 
 
In recent years substantial progress in basic understanding of adaptive immunity 
has been matched by an explosion of popular interest in immunological science. 
Serious infectious disease, once dismissed in industrially developed nations as a 
mostly vanquished problem, has resurged following recent outbreaks of, to take 
but two recent examples, measles and Ebola. The former has served to re-
introduce a complacent public to the importance of vaccination (Foege, 2001; 
Orenstein and Ahmdied, 2017), while the latter has underscored the enduring 
urgency of further development in basic and applied vaccinology. Meanwhile, 
after nearly a century of dormancy, the notion of harnessing the adaptive immune 
system’s unparalleled potency and specificity to combat cancer is finally 
beginning to flourish. Advances in cancer immunology are regularly reported in 
the literature, and even given prominence in the popular press.  Furthermore, 
given the growing appreciation of the immune system as a critical, cell-extrinsic 
tumor suppressor (Pawelec et al., 2009; Schreiber et al., 2011), interest is 
emerging in potentiating adaptive immunity not only therapeutically against 
established cancers but also prophylactically to prevent their occurrence — or 
reoccurrence, following remission of primary cancers — in the first place. 
 
 Ultimate success in all of these avenues of inquiry — both prophylactic 
and therapeutic manipulation of immunity to counter infection as well as 
malignancy — depends upon the generation of memory lymphocytes, which can 
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simultaneously initiate novel immune responses against re-encountered antigens 
(e.g. in the context of pathogens or tumors) while maintaining the capacity to 
spawn additional or sustain long-persisting immune responses upon subsequent 
encounters.  
 
 However, despite decades of research and notwithstanding recent major 
advances in the field, understanding of the developmental origins of memory 
lymphocytes has remained confounded by dramatically conflicting literatures and 
glaring gaps in knowledge (Ahmed et al., 2009; Restifo and Gattinoni, 2013). 
 
  Empirically, it is straightforward to start with an antigenically 
inexperienced vertebrate animal, immunize it with it with a defined antigen and a 
strong adjuvant, and be able to readily identify and isolate memory lymphocytes 
several weeks later. However, the process of transformation from a naive, 
transient lymphocyte into a durable, functionally robust memory lymphocyte is 
largely a black box. What signals and imprints define and potentiate this 
process? From what developmental origins do memory lymphocytes issue, and 
when and where during the awesomely complex dynamics of adaptive immune 
responses do they emerge? 
 
 In particular, ever since the seminal publication late last century of an 
initial developmental structure of memory lymphopoiesis (Sallusto et al., 1999), a 
fundamental question has concerned the potential existence of lymphocyte stem 
cells. Given that adaptive immune responses by their very nature entail 
prodigious proliferation causing the generation and regeneration of lymphocytic 
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tissue, thinkers in the field noted early on the strong parallels of this process to 
stem cell-mediated physiology in other tissues with rapid tissue turnover kinetics 
such as blood, epidermis, intestinal epithelium and sperm (Fearon et al., 2001; 
Lanzavecchia and Sallusto, 2002; Luckey et al., 2006).  If stem cells therein are 
ultimately responsible for the generation and continual regeneration of mature 
erythrocytes, epithelial cells, et cetera, might a hypothetically equally rare and 
equally potent lymphocyte stem cell mediate similar functions in the adaptive 
immune compartment, and perhaps represent the long-sought root origin of 
memory lymphocytes? If so, could understanding the nature of these agents of 
regeneration enrich our understanding of both physiology and pathology, and 
offer novel opportunities for prophylactic and therapeutic interventions? 
 
 These considerations have animated the research presented here from its 
inception, and have culminated in the following findings: 
 
1. Developmental dynamics of anti-pathogen T cell proliferation: A 
classical proliferative hierarchy rooted in a rare yet potent stem cell 
population drives anti-pathogen CD8+ T lymphopoiesis. 
 
2. Elucidation of extraordinary developmental plasticity in T 
lymphopoiesis: A salvage pathway of Teffector to Tmemory cell dedifferentiation 
maximizes proliferative reserve available for future immunity and reveals 
dual cellular pathways to immunological memory.  
 
3. A new frontier of T cell retrotransposition dynamics: T cell activation 
triggers reawakening of an ancient DNA parasite, with implications for an 
irreversible molecular clock embedded in T stem cells. 
 
 
	 139	
4. Organismal and cellular perspectives on getting old: Effector T cell 
differentiation as a microcosm of organismal aging, and a specialized role for 
stem cells as guardians of genome integrity. 
 
5. Insight into mechanisms of immunosenescence & immunotherapy: 
Heightened expression of inhibitory receptors on and hyperactivation 
sensitivity of T stem cells. 
 
 
5.1.1 A classical proliferative hierarchy rooted in a rare yet potent stem cell 
population drives anti-pathogen CD8+ T lymphopoiesis. 
 
Antigen-driven T cell expansion is structured according to a classical proliferative 
hierarchy entailing a linear differentiation pathway anchored in a rare yet potent 
stem cell population that progressively gives rise to increasingly specialized 
cytotoxic effector T cells.  This finding greatly clarifies longstanding questions 
concerning the developmental nature of danger-driven lymphopoiesis, and 
provides an answer to the mystery of how antigen-specific effector T cells can be 
generated with such tremendous dispatch and abundance while nevertheless 
avoiding severe degradation of the underlying genome integrity needed to 
preserve the clonal lineage.  In short, following activation by encounter with 
antigen coupled with danger signaling, T stem cells are ontogenetically set-aside 
and programmatically endowed with a panoply of defense mechanisms and 
genome-protective activities that in toto conduce to maintaining a vital reserve of 
self-renewing generative capacity. This in turn underwrites immunocompetence 
against future antigen encounters. 
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5.1.2 A salvage pathway of Teffector to Tmemory cell dedifferentiation 
maximizes proliferative reserve available for future immunity and reveals 
dual cellular pathways to immunological memory. 
 
Chapter 2 presented data indicating that intermediately-differentiated effector 
CD8+ T cells, having arisen from T stem cells by way of antigen-driven 
proliferation, can convert into self-renewing CD8+ T stem cells (also called 
“central memory”) following the resolution of infection and the termination of 
antigen signaling.  This process of a cell reacquiring stemness characteristics 
that it had lost consequent to differentiation is consistent with dedifferentiation, a 
phenomenon well-known in amphibian biology but poorly understood in 
mammalian development.  Once thought impossible in higher organisms, pivotal 
research in the 1990’s (Wilmut et al., 1997) and in the 2000’s (Takahashi and 
Yamanaka, 2006) upended the traditional, Waddington-esque understanding of 
unyielding epigenetic gravity by elucidating the existence and extraordinary 
potential of mammalian dedifferentiation (e.g. organismal cloning and the in vitro 
induction of developmental pluripotency in fully differentiated cells).  Though 
these initial achievements occurred exclusively in highly contrived, experimental 
circumstances, they nevertheless fomented further inquiry and lead to 
recognition by the Nobel Prize for Physiology or Medicine in 2012.  More recent 
findings have extended these groundbreaking observations in vivo, including 
during the regeneration of spermatogenesis (Nakagawa et al., 2010) and 
epithelial differentiation following injury (Takeda et al., 2011; Tata et al., 2013), 
and in the pathological context of tumorigenesis (Krivtsov et al., 2006).  
Nevertheless, to date there have not been any reports of physiological 
dedifferentiation in the immuno-hematopoietic system. 
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 Thus, the observation of potential physiological dedifferentiation in the 
adaptive immune system is novel and may bear substantial implications for basic 
principles in developmental biology, genome integrity maintenance and the 
architecture of aging, and mechanisms of malignant transformation of non-stem 
progenitor cells into cancer stem cells. 
 
5.1.3 T cell activation triggers reawakening of an ancient DNA parasite, with 
implications for an irreversible molecular clock embedded in T stem cells. 
 
The coupled observations during memory and effector T cell differentiation of the 
inversely correlated expression of the LINE-1 retrotransposon and one of its 
principle restriction factors, Apobec3, may represent a new frontier in 
immunology and developmental biology more generally.  First discovered during 
the dawn of modern eukaryotic whole genome study (Adams et al.,1980), L1 
transposons for decades have often been considered genetic detritus whose 
extensive repeat sequences principally served to confound early genome 
sequencing efforts.  Recently however, L1 transposons have emerged as major 
players in physiology, pathology, aging, and evolution (Gorbunova et al., 2014) – 
as foretold by Barbara McClintock’s trailblazing research on “jumping genes” 
(McClintock, 1950).  Retrotransposition into quasi-random locations throughout 
the genome and can be substantially genotoxic, by way of either insertional 
mutagenesis or the introduction of double strand breaks.  Accordingly, cells have 
evolved to expend considerable efforts to suppress L1 expression. 
 
 The data presented in Chapter 3 indicate that L1 repression is disrupted 
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by antiviral T cell activation.  L1 expression closely correlated with extent of 
effector differentiation, with the greatest expression in terminally differentiated 
effector cells, and the least in minimally differentiated CD62Lhi T stem cells.  This 
phenomenon may have several major implications, including: 
 
- L1 copy number may appreciably increase as a function of extent of 
differentiation; conversely, overall genome integrity may diminish consequent 
to L1-mediated insertional mutagenesis and/or double strand breaks. 
 
- Though T stem cells robustly express the L1 restriction factor Apobec3, a 
modest level of L1 expression nevertheless escapes this putative 
suppression.  Thus, at a much slower rate – relative to differentiated effector 
T cells – L1 copy number may increase in T stem cells, especially following 
repeated rounds of activation and/or proliferation.  Since T stem cells are self-
renewing and apparently long-lived, L1 abundance therein may represent an 
irreversible molecular clock that can be measured in a variety of experimental 
and possibly even clinical/diagnostic applications. It is worth noting that all 
present molecular clocks (e.g. telomere length) are known to be reversible in 
at least some cases, and may therefore be incompletely reliable. 
 
- A notable corollary of these notions is the possibility of ubiquitous genotypic 
mosaicism in antigen-experienced T cells. That is, given activation-induced 
L1 derepression and random retrotransposition, it is highly possible that every 
single descendent of an activated progenitor T cell bears a unique genome 
characterized by distinct L1 insertion sites. 
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- A further corollary is that shared and unique L1 insertion sites can be used to 
reconstruct developmental phylogenies and thereby retrospectively delineate 
lineage relationships in vivo, potentially in both model organism systems and 
humans, and in the absence of transgenic manipulations that can confound 
similar approaches that rely on genetic engineering or transduction with 
exogenous retroviruses.  
 
- The research herein on effector and memory T cell differentiation has been 
significantly informed by the rich literature of progenitor cell biology that has 
matured since Charles Leblond’s pioneering research on mammalian tissue 
turnover in vivo using tritiated thymidine (Leblond et al., 1959).  In turn it may 
be possible that the lessons concerning T stemness and the dynamics of 
effector differentiation gained in this dissertation research can inform novel, 
general principles in developmental biology.  In particular, if differentiation of 
effector T cells from a relatively quiescent, geno-protective T stem cell source 
entails derepression of LINE-1 retrotransposons, it is reasonable to 
hypothesize that a similar phenomenon might characterize classical 
proliferative hierarchies in other tissues, for example those that subserve 
ongoing hematopoiesis, epitheliogenesis, neurogenesis, and 
spermatogenesis.  Are terminally differentiated hematopoietic cells (e.g. 
granulocytes), neurons, and epithelial cells characterized by the scars of 
accrued L1 retrotransposition? Does L1 copy number slowly increase in other 
stem cell populations in blood, gut, skin, brain, etc.? 
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In addition to these implications, the phenomenon of L1 derepression 
consequent to T cell activation prompts several questions, including: 
 
- Is LINE-1 re-expression related to – either casually or consequentially – the 
substantial epigenetic remodeling entailed in the transitions from a quiescent 
naïve lymphocyte through to a blasting, cytotoxic effector T cell?  There are 
some indications in the literature that this may be the case – for example, 
iPSC reprogramming is known to precipitate retrotransposon derepression 
(Klawitter et al., 2016), and epigenetic therapy of lung cancers (e.g. with 
HDAC or DNMT inhibitors) has been reported to relax suppression of dormant 
endogenous retroviruses in an interferon-dependent manner (Chiappinelli et 
al., 2015).  Given that genetic parasites comprise not just a fraction but rather 
the majority of our genome (de Koning et al., 2011), a reshuffling of these 
elements may be an inescapable intermediate in major and/or rapid 
transformations of epigenetic states. 
 
- While L1 transposons comprise nearly a fifth of the genome, they are in fact a 
minority of the total complement of endogenous replicating elements. This 
prompts the question of whether other known DNA parasites (for example so-
called Alu transposons, or endogenous retroviruses) also are derepressed by 
T cell activation and effector differentiation, and if they might also pose a risk 
of insertional mutagenesis. 
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5.1.4 Effector T cell differentiation as a microcosm of organismal aging, 
and a specialized role for stem cells as guardians of genome integrity. 
 
While stem cells are commonly regarded as residing in an amorphous, 
undifferentiated state, for some time thinkers have proposed that instead they 
represent a highly specialized cell type that can efficiently conserve genome 
integrity in order to retard malignant transformation or aging (Cairns, 1975; 
Schofield, 1978).  Nevertheless, evidentiary support for this fundamental 
proposition in stem cell biology is remarkably limited.  In this light, the data in 
Chapters 2 and 3 substantially enrich this idea, revealing that multiple 
independent pathways that can regulate genomic integrity are enriched in T stem 
cells, and conversely, relatively suppressed in terminally differentiated effector 
cells.  These include: 
 
§ telomerase activity 
§ responsiveness to DNA damage via H2AX phosphorylation 
§ expression of the endogenous retroelement restriction factor Apobec3  
§ cell surface membrane efflux of environmental toxins via ABC transporters 
 
 These observations concerning geno-protective activities are 
complemented by data on genome integrity itself.  Specifically, comet assay 
measurements indicated that chromatin integrity is significantly diminished in 
terminally differentiated effector cells a week after initial activation of precursor 
naïve T cells.  This suggests the possibility that antiviral T cell differentiation may 
represent a microcosm of organismal aging, which is also characterized – both 
causally and consequentially – by accumulation of senescent cells and declining 
genome integrity.  That these processes which unfold over a lifespan occur in the 
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context of infection within just a week is biologically interesting in its own right, 
and additionally may offer opportunities for dissecting mechanisms of aging in a 
tractable, short-term experimental system.  For example, rapamycin was the first 
drug discovered to increase mammalian lifespan (Harrison et al., 2009).  
However, this advance came only by way of years-long, resource-intensive 
experimentation.  In contrast, during the critical first week of antiviral T cell 
differentiation, in vivo treatment with rapamycin increases the abundance of 
CD62Lhi T stem cells (Figure 2.9), and thereby putatively enhances the genome 
integrity of the entire antigen-specific “tissue”.  Anti-pathogen T cell differentiation 
may thus be a useful context in which to rapidly screen various pharmacological 
or other interventions for potential anti-aging effects. 
 
5.1.5 Heightened expression of environmental signaling receptors on and 
hyperactivation sensitivity of T stem cells 
 
In the first decade of the 20th century Paul Ehrlich proposed the deeply 
controversial idea that the immune system might play a central physiological role 
not only in defense against infectious disease but also susceptibility to cancer 
(Ehrlich, 1909).  Despite promising early experimental and clinical explorations of 
this concept by Ehrlich and Robert Koch in Europe and William Coley in New 
York, further development of immunotherapy suffered from a feeble theoretical 
framework and fell out of favor as the post-war vogues of radiotherapy and 
chemotherapy captured medical attention to the exclusion of alternative 
approaches. Half a century later, Lewis Thomas and Macfarlane Burnet re-
energized the notion on firmer theoretical grounds (Thomas, 1959; Burnet, 1967), 
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and Burnet helpfully coined the term “immunosurveillance”. Evidentiary support 
trickled in for several decades and finally exploded in recent years as two 
different immunotherapy modalities began generating dramatic clinical results, 
including complete and durable regression of even disseminated, metastatic 
tumors: autologous transplantation of T cells reprogrammed ex vivo, and 
pharmacological blockade of inhibitory / checkpoint receptors.   
 
 Despite these gains, meaningful clinical response to immunotherapies is 
achieved in only a minority of patients.  Investigators globally are now focused on 
understanding this heterogeneity in efficacy in order to realize the full potential of 
Ehrlich’s century-old idea. In this vein, important observations have revealed that 
the success of anti-tumor T cell transplantation therapy is a function of self-
renewal capacity (Gattinoni et al., 2005; Gattinoni et al., 2011). In parallel, 
seminal research from multiple groups around the globe has shown that 
expression of inhibitory receptors including PD-1 is a major impediment to anti-
tumor T cell efficacy, and that pharmacological blockade of PD-1 signaling can 
overcome this obstacle to unleash anti-tumor immunity (Wherry and Kurachi, 
2015; Chen and Mellman, 2017).   
 
 Thus the central issues facing the field include the separate but related 
matters of 1) unfettering and 2) sustaining T cell proliferation that can mediate 
anti-tumor immunity.  What is the nature of proliferative capacity in antigen-
specific T cell populations, and how can it be maximized?  What are the 
mechanisms of inhibitory receptor blockade, particularly with respect to 
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differential sensitivity of and impact upon subsets of antigen-specific T cells – 
which in turn are endowed with differing self-renewal capacities? 
 
 The characterizations of T stem cell biology here offer substantial potential 
to elucidate both of these intertwined issues.  In particular, T stem cells are a 
principal locus of proliferative reserve from which legions of effector T cells are 
spawned. They exist at a nexus of intense environmental signaling and therefore 
robustly express multiple inhibitory receptors, including PD-1, and at least in the 
contexts so far examined, to an extent greater than other T cell subpopulations. 
The data detailed in Chapter 4 suggests that prolonged stimulation of T stem 
cells genetically lacking PD-1 braking function results in depletion of this 
quantitatively minor yet physiologically central subpopulation, perhaps conducing 
to accelerated immunosenescence.   Both from the perspectives of maximizing 
proliferative potential and avoiding immunosenescence, and understanding the 
biology of inhibitory receptors like PD-1 and the mechanisms and consequences 
of blockade thereof, further understanding of the nature of T stem cells will be 
important. 
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APPENDIX A: MATERIALS AND METHODS 
 
Mice and infections 
All animals were purchased from Jackson Laboratories or Charles River 
Laboratories, or bred at the University of Pennsylvania (Philadelphia, PA). 
Experiments were performed in accordance with protocols approved by the 
University of Pennsylvania Institutional Animal Care and Use Committee. BAC-
transgenic Blimp-1-YFP reporter mice were from E. Meffre (Yale University, New 
Haven, CT), Fucci reporter mice (Sakaue-Sawano et al., 2008) were from 
Yongwon Choi (University of Pennsylvania, Philadelphia, PA).  Mice deficient for 
TCF-1, PD-1, and LAG-3 were gifts of Avinash Bhandoola (National Cancer 
Institute, Bethesda, MD), Arlene Sharpe (Harvard Medical School, Boston, MA), 
and Dario Vignali (University of Pittsburgh School of Medicine, Pittsburgh, PA), 
respectively.  Nur77GFP reporter mice and CD90.1+ mice were obtained from 
Jackson Laboratories.  Deficiency, reporter, and congenic alleles were all bred 
on to a P14 TCR-transgenic (Pircher et al., 1989) C57Bl/6 background. 
 
 Mice were infected with 2 × 105 plaque-forming units (PFUs) of 
lymphocytic choriomeningitis virus (LCMV) Armstrong strain intraperitoneally or 
2-4 ×106 PFU LCMV clone 13 strain intravenously, as previously described 
(Wherry et al., 2003). Viruses were grown and titered as previously described 
(Wherry et al., 2003). 
 
Adoptive transfers and lymphocyte isolation 
At indicated days pi, spleens and lymph nodes were harvested from CD90.2+ 
donor mice. CD90.1+ P14 CD8+ T cells were negatively purified by way of 
staining with biotinylated monoclonal antibodies (CD4 #RM4-5, CD19 #1D3, 
CD90.2 #53-2.1, TER-119, NK1.1 # PK136, Ly-6G #1A8) followed by counter-
staining with streptavidin-conjugated magnetic beads (EasySep Streptavidin 
RapidSpheres, from STEMCELL Technologies of Vancouver, Canada) and 
magnetic separation.  Subsequently sorted cell populations were adoptively 
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transferred intravenously into recipient mice.  In some experiments, before 
transfer cells were labeled with 10 μM of the proliferation tracking vital dye 
CellTrace Violet (“CTV”, from Thermo Fisher Scientific of Waltham, MA) for 10 
minutes in the dark at 24°C. 
 
BrdU treatment and detection 
Animals were treated with 2 mg of BrdU (Sigma-Aldrich of St. Louis, MO) i.p. 24 
hours prior to tissue harvest and analysis. BrdU incorporation was assessed by 
the BrdU Flow Kit per manufacturer’s instructions (BD Biosciences of Franklin 
Lakes, NJ). 
 
Flow cytometry 
Cells were stained with LIVE/DEAD Fixable Dead Cell Stain (Thermo Fisher 
Scientific) to discern cell viability. Surface staining was performed at 4° in the 
dark for 45 minutes in RPMI-1640 medium supplemented with 5 mM HEPES.  
Intracellular staining was performed using the Foxp3 / Transcription Factor 
Staining Buffer Set (Affymetrix, of San Diego, CA) or Cytofix/Cytoperm reagents 
(BD Biosciences) per manufacturer’s instructions.  Monoclonal antibodies were 
purchased from BD Biosciences; BioLegend of San Diego, CA; Affymetrix; Cell 
Signaling Technology of Danvers, MA; EMD Millipore of Billerica, MA; and 
SouthernBiotech of Birmingham, AL; and included: CD8α #53-6.7, CD8β 
#YTS156.7.7, CD16/32 #93, CD27 #LG.7F9, CD43 #1B11, CD44 #IM7, CD45.1 
#A20, CD62L #MEL-14, CD90.1 #OX-7, CCR7 #4B12, IL-7Rα #A7R34, PD-1 
#RMP1-30, LAG-3 #C9B7W, CTLA-4 #UC10-4F10-11, CD5 #53-7.3, CXCR5 
#L138D7, KLRG1 #2F1, CX3CR1 #SA011F11, IFN-γ #XMG1.2, TNF-α #MP6-
XT22, IL-2 #JES6-SH4, T-bet #4B10, Eomes #Dan11mag, TCF-1 #C63D9, 
pSer139-H2AX #JBW301, Ki-67.  For intracellular cytokine staining, single-cell 
suspensions were pre-treated for 1 hour with 0.1 mM TAPI-2 (Jabbari and Harty, 
2006) and then incubated for 5 hours at 37°C in the presence of brefeldin A (BD 
Biosciences), with or without 1 µM GP33-41 peptide.  MHC class I peptide 
tetramers were made and used as described previously (Wherry et al., 2003). 
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Data were acquired on a LSR II Flow Cytometer (BD Biosciences) and analyzed 
with FlowJo software (FlowJo LLC of Ashland, OR). Cell sorting was performed 
using a FACSAria II (BD Biosciences). 
 
Ex vivo irradiation and pSer139-H2AX inducibility assay 
Single cell suspensions of splenocytes were exposed to 0 or 250 rads of gamma 
irradiation and incubated for 90 minutes at 37°C in RPMI supplemented with 10% 
FBS.  Cells were then stained for surface antigens and intracellular pSer139-
H2AX and acquired flow cytometrically.  
 
Doxorubicin treatment 
At the indicated time point post infection, mice were treated intravenously with 
PBS or doxorubicin at 8 mg/kg or 16 mg/kg. 
 
Comet assay 
The alkaline comet assay was performed as described (Olive and Banáth, 2006), 
with minor modifications. Briefly, a single-cell suspension of splenocytes was 
embedded in molten agarose on CometSlides (Trevigen of Gaithersburg, MD) 
and subjected to alkaline lysis for 1 hr.  Following electrophoresis cells were 
stained with ethidium bromide and 100-300 cells per slide were imaged 
microscopically.  Tail moments were evaluated using CASP software (Końca et 
al., 2003). 
 
Telomerase activity assay 
The Telomeric Repeat Amplification protocol was performed as described 
(Herbert et al., 2006). Heat-inactivated 293T cells were used as a negative 
control. 
 
Side population assay 
The side population assay was performed as described (Lin and Goodell., 2006), 
with minor adaptations. Briefly, a single cell suspension was stained with 
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Hoechst 33342 and incubated for 90 minutes at 37°C. Cells were washed, 
stained with surface antibodies and 7-AAD for viability discrimination at 4°C, and 
finally resuspended and evaluated using an LSR II equipped with a 355 nm 
ultraviolet laser. 
 
Statistical Analysis 
Student’s t test (paired and unpaired), and ANOVA tests were performed using 
Prism software (Graphpad, La Jolla, CA). Asterisks indicate statistical 
significance (p < 0.05).  Error bars depict mean ± SEM. 
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